1
|
Goldschmidt I, Chichelnitskiy E, Götz J, Rübsamen N, Karch A, Jäger V, Kelly D, Lloyd C, Debray D, Girard M, d'Antiga L, di Giorgio A, Hierro L, Pawlowska J, Klaudel-Dreszler M, McLin V, Korff S, Falk C, Baumann U. Early steroids after pediatric liver transplantation protect against T-cell-mediated rejection: Results from the ChilSFree study. Liver Transpl 2024; 30:288-301. [PMID: 37678230 DOI: 10.1097/lvt.0000000000000255] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/17/2023] [Accepted: 08/14/2023] [Indexed: 09/09/2023]
Abstract
Steroid-free immunosuppression protocols gained popularity in pediatric liver transplantation (pLT) after the introduction of IL-2-receptor blockade for induction therapy. We analyzed the clinical and immunologic outcome data of the multicenter prospective observational ChilSFree study to compare the impact of steroid-free versus steroid-containing immunosuppressive therapy following pLT in a real-life scenario. Two hundred forty-six children [55.3% male, age at pLT median: 2.4 (range: 0.2-17.9) y] transplanted for biliary atresia (43%), metabolic liver disease (9%), acute liver failure (4%), hepatoblastoma (9%), and other chronic end-stage liver diseases (39%) underwent immune monitoring and clinical data documentation over the first year after pLT. Patient and graft survival at 1 year was 98.0% and 92.7%, respectively. Primary immunosuppression was basiliximab induction followed by tacrolimus (Tac) monotherapy (55%), Tac plus steroid tapering over 3 months (29%), or cyclosporine and steroid tapering (7%). One center used intraoperative steroids instead of basiliximab followed by Tac plus mycophenolate mofetil (7% of patients). N = 124 biopsy-proven T-cell-mediated rejections were documented in n = 82 (33.3%) patients. T-cell-mediated rejection occurred early (median: 41 d, range: 3-366 d) after pLT. Patients initially treated with Tac plus steroids experienced significantly fewer episodes of rejection than patients treated with Tac alone (chi-square p <0.01). The use of steroids was associated with earlier downregulation of proinflammatory cytokines interferon (IFN)-γ, Interleukin (IL)-6, CX motif chemokin ligand (CXCL)8, IL-7, and IL-12p70. Both primary immunosuppression with Tac plus steroids and living donor liver transplantation were independent predictors of rejection-free survival 1 year after pLT on logistic regression analysis. Adjunctive steroid therapy after pLT leads to earlier suppression of the post-pLT proinflammatory response and significantly reduced rejection rates during the first year after pLT (15.9%). Fifty-one percent of patients initially treated without steroids remain steroid-free over the first 12 months without rejection.
Collapse
Affiliation(s)
- Imeke Goldschmidt
- Department of Paediatric Liver, Kidney and Metabolic Diseases, Division of Paediatric Gastroenterology and Hepatology, Hannover Medical School, Hannover, Germany
| | | | - Juliane Götz
- Department of Paediatric Liver, Kidney and Metabolic Diseases, Division of Paediatric Gastroenterology and Hepatology, Hannover Medical School, Hannover, Germany
| | - Nicole Rübsamen
- Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany
| | - André Karch
- Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany
| | - Veronika Jäger
- Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany
| | - Deirdre Kelly
- Liver Unit, Birmingham Women's & Children's Hospital, University of Birmingham, Birmingham, UK
| | - Carla Lloyd
- Liver Unit, Birmingham Women's & Children's Hospital, University of Birmingham, Birmingham, UK
| | - Dominique Debray
- Pediatric Hepatology Unit, Hôpital Necker-Enfants malades, Paris, France
| | - Muriel Girard
- Pediatric Hepatology Unit, Hôpital Necker-Enfants malades, Paris, France
| | - Lorenzo d'Antiga
- Paediatric Liver, GI and Transplantation, Ospedali Riuniti di Bergamo, Bergamo, Italy
| | - Angelo di Giorgio
- Paediatric Liver, GI and Transplantation, Ospedali Riuniti di Bergamo, Bergamo, Italy
| | - Loreto Hierro
- Servicio de Hepatología y Transplante, Hospital Infantil Universitario La Paz Madrid, Madrid, Spain
| | - Joana Pawlowska
- Centrum Zdrowia Dziecka, Al. Dzieci Polskich, Warszawa, Poland
| | | | - Valerie McLin
- Department of Pediatrics, Gynecology, and Obstetrics, Swiss Pediatric Liver Center, University Hospitals Geneva, University of Geneva, Geneva, Switzerland
| | - Simona Korff
- Department of Pediatrics, Gynecology, and Obstetrics, Swiss Pediatric Liver Center, University Hospitals Geneva, University of Geneva, Geneva, Switzerland
| | - Christine Falk
- Institute of Transplant Immunology, Hannover Medical School, Hannover, Germany
| | - Ulrich Baumann
- Department of Paediatric Liver, Kidney and Metabolic Diseases, Division of Paediatric Gastroenterology and Hepatology, Hannover Medical School, Hannover, Germany
| |
Collapse
|
2
|
McKiernan P, Bernabeu JQ, Girard M, Indolfi G, Lurz E, Trivedi P. Opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis. JHEP Rep 2024; 6:100949. [PMID: 38192535 PMCID: PMC10772241 DOI: 10.1016/j.jhepr.2023.100949] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/29/2023] [Revised: 10/10/2023] [Accepted: 10/17/2023] [Indexed: 01/10/2024] Open
Abstract
Background & Aims Progressive familial intrahepatic cholestasis (PFIC) relates to a group of rare, debilitating, liver disorders which typically present in early childhood, but have also been reported in adults. Without early detection and effective treatment, PFIC can result in end-stage liver disease. The aim of the paper was to put forward recommendations that promote standardisation of the management of PFIC in clinical practice. Methods A committee of six specialists came together to discuss the challenges faced by physicians in the management of PFIC. The committee agreed on two key areas where expert guidance is required to optimise care: (1) how to diagnose and treat patients with a clinical presentation of PFIC in the absence of clear genetic test results/whilst awaiting results, and (2) how to monitor disease progression and response to treatment. A systematic literature review was undertaken to contextualise and inform the recommendations. Results An algorithm was developed for the diagnosis and treatment of children with suspected PFIC. The algorithm recommends the use of licensed inhibitors of ileal bile acid transporters as the first-line treatment for patients with PFIC and suggests that genetic testing be used to confirm genotype whilst treatment is initiated in patients in whom PFIC is suspected. The authors recommend referring patients to an experienced centre, and ensuring that monitoring includes measurements of pruritus, serum bile acid levels, growth, and quality of life following diagnosis and during treatment. Conclusions The algorithm presented within this paper offers guidance to optimise the management of paediatric PFIC. The authors hope that these recommendations will help to standardise the management of PFIC in the absence of clear clinical guidelines. Impact and implications This opinion paper outlines a consistent approach to the contemporaneous diagnosis, monitoring, referral and management of children with progressive familial intrahepatic cholestasis. This should assist physicians given the recent developments in genetic diagnosis and the availability of effective drug therapy. This manuscript will also help to raise awareness of current developments and educate health planners on the place for new drug therapies in progressive familial intrahepatic cholestasis.
Collapse
Affiliation(s)
- Patrick McKiernan
- Liver Unit and Small Bowel Transplantation, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK
| | - Jesus Quintero Bernabeu
- Pediatric Hepatology and Liver Transplant Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - Muriel Girard
- Pediatric Hepatology Unit, Hôpital Necker-Enfants Malades, and Université Paris Cité, Paris, France
| | - Giuseppe Indolfi
- Paediatric and Liver Unit, Meyer Children's Hospital IRCCS, Florence, Italy
- Department NEUROFARBA, University of Florence, Florence, Italy
| | - Eberhard Lurz
- Dr. von Hauner Children’s Hospital, LMU Munich University Hospital, Munich, Germany
| | - Palak Trivedi
- National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, Centre for Liver and Gastrointestinal Research, University of Birmingham College of Medical and Dental Sciences, Birmingham, UK
- Institute of Immunology and Immunotherapy, University of Birmingham College of Medical and Dental Sciences, Birmingham, UK
- Liver Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
| |
Collapse
|
3
|
Spelman T, Herring WL, Acosta C, Hyde R, Jokubaitis VG, Pucci E, Lugaresi A, Laureys G, Havrdova EK, Horakova D, Izquierdo G, Eichau S, Ozakbas S, Alroughani R, Kalincik T, Duquette P, Girard M, Petersen T, Patti F, Csepany T, Granella F, Grand'Maison F, Ferraro D, Karabudak R, Jose Sa M, Trojano M, van Pesch V, Van Wijmeersch B, Cartechini E, McCombe P, Gerlach O, Spitaleri D, Rozsa C, Hodgkinson S, Bergamaschi R, Gouider R, Soysal A, Castillo-Triviño, Prevost J, Garber J, de Gans K, Ampapa R, Simo M, Sanchez-Menoyo JL, Iuliano G, Sas A, van der Walt A, John N, Gray O, Hughes S, De Luca G, Onofrj M, Buzzard K, Skibina O, Terzi M, Slee M, Solaro C, Oreja-Guevara, Ramo-Tello C, Fragoso Y, Shaygannejad V, Moore F, Rajda C, Aguera Morales E, Butzkueven H. Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom. J Med Econ 2024; 27:109-125. [PMID: 38085684 DOI: 10.1080/13696998.2023.2293379] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/28/2023] [Accepted: 12/07/2023] [Indexed: 12/23/2023]
Abstract
AIM To evaluate the real-world comparative effectiveness and the cost-effectiveness, from a UK National Health Service perspective, of natalizumab versus fingolimod in patients with rapidly evolving severe relapsing-remitting multiple sclerosis (RES-RRMS). METHODS Real-world data from the MSBase Registry were obtained for patients with RES-RRMS who were previously either naive to disease-modifying therapies or had been treated with interferon-based therapies, glatiramer acetate, dimethyl fumarate, or teriflunomide (collectively known as BRACETD). Matched cohorts were selected by 3-way multinomial propensity score matching, and the annualized relapse rate (ARR) and 6-month-confirmed disability worsening (CDW6M) and improvement (CDI6M) were compared between treatment groups. Comparative effectiveness results were used in a cost-effectiveness model comparing natalizumab and fingolimod, using an established Markov structure over a lifetime horizon with health states based on the Expanded Disability Status Scale. Additional model data sources included the UK MS Survey 2015, published literature, and publicly available sources. RESULTS In the comparative effectiveness analysis, we found a significantly lower ARR for patients starting natalizumab compared with fingolimod (rate ratio [RR] = 0.65; 95% confidence interval [CI], 0.57-0.73) or BRACETD (RR = 0.46; 95% CI, 0.42-0.53). Similarly, CDI6M was higher for patients starting natalizumab compared with fingolimod (hazard ratio [HR] = 1.25; 95% CI, 1.01-1.55) and BRACETD (HR = 1.46; 95% CI, 1.16-1.85). In patients starting fingolimod, we found a lower ARR (RR = 0.72; 95% CI, 0.65-0.80) compared with starting BRACETD, but no difference in CDI6M (HR = 1.17; 95% CI, 0.91-1.50). Differences in CDW6M were not found between the treatment groups. In the base-case cost-effectiveness analysis, natalizumab dominated fingolimod (0.302 higher quality-adjusted life-years [QALYs] and £17,141 lower predicted lifetime costs). Similar cost-effectiveness results were observed across sensitivity analyses. CONCLUSIONS This MSBase Registry analysis suggests that natalizumab improves clinical outcomes when compared with fingolimod, which translates to higher QALYs and lower costs in UK patients with RES-RRMS.
Collapse
Affiliation(s)
- T Spelman
- MSBase Foundation, Melbourne, VIC, Australia
- Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden
| | - W L Herring
- Health Economics, RTI Health Solutions, NC, USA
- Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden
| | - C Acosta
- Value and Access, Biogen, Baar, Switzerland
| | - R Hyde
- Medical, Biogen, Baar, Switzerland
| | - V G Jokubaitis
- Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia
| | - E Pucci
- Neurology Unit, AST-Fermo, Fermo, Italy
| | - A Lugaresi
- Dipartamento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy
- IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy
| | - G Laureys
- Department of Neurology, University Hospital Ghent, Ghent, Belgium
| | - E K Havrdova
- Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
| | - D Horakova
- Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
| | - G Izquierdo
- Department of Neurology, Hospital Universitario Virgen Macarena, Seville, Spain
| | - S Eichau
- Department of Neurology, Hospital Universitario Virgen Macarena, Seville, Spain
| | - S Ozakbas
- Izmir University of Economics, Medical Point Hospital, Izmir, Turkey
| | - R Alroughani
- Division of Neurology, Department of Medicine, Amiri Hospital, Sharq, Kuwait
| | - T Kalincik
- Neuroimmunology Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia
- CORe, Department of Medicine, University of Melbourne, Melbourne, Australia
| | - P Duquette
- CHUM and Universite de Montreal, Montreal, Canada
| | - M Girard
- CHUM and Universite de Montreal, Montreal, Canada
| | - T Petersen
- Aarhus University Hospital, Arhus C, Denmark
| | - F Patti
- Department of Medical and Surgical Sciences and Advanced Technologies, GF Ingrassia, Catania, Italy
- UOS Sclerosi Multipla, AOU Policlinico "G Rodloico-San Marco", University of Catania, Italy
| | - T Csepany
- Department of Neurology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
| | - F Granella
- Department of Medicine and Surgery, University of Parma, Parma, Italy
- Department of General Medicine, Parma University Hospital, Parma, Italy
| | | | - D Ferraro
- Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, Italy
| | | | - M Jose Sa
- Department of Neurology, Centro Hospitalar Universitario de Sao Joao, Porto, Portugal
- Faculty of Health Sciences, University Fernando Pessoa, Porto, Portugal
| | - M Trojano
- School of Medicine, University of Bari, Bari, Italy
| | - V van Pesch
- Cliniques Universitaires Saint-Luc, Brussels, Belgium
- Université Catholique de Louvain, Belgium
| | - B Van Wijmeersch
- University MS Centre, Hasselt-Pelt and Noorderhart Rehabilitation & MS, Pelt and Hasselt University, Hasselt, Belgium
| | | | - P McCombe
- University of Queensland, Brisbane, Australia
- Royal Brisbane and Women's Hospital, Herston, Australia
| | - O Gerlach
- Academic MS Center Zuyd, Department of Neurology, Zuyderland Medical Center, Sittard-Geleen, The Netherlands
- School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands
| | - D Spitaleri
- Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino, Avellino, Italy
| | - C Rozsa
- Jahn Ferenc Teaching Hospital, Budapest, Hungary
| | - S Hodgkinson
- Immune Tolerance Laboratory Ingham Institute and Department of Medicine, UNSW, Sydney, Australia
| | | | - R Gouider
- Department of Neurology, LR18SP03 and Clinical Investigation Center Neurosciences and Mental Health, Razi University Hospital -, Mannouba, Tunis, Tunisia
- Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia
| | - A Soysal
- Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases, Istanbul, Turkey
| | - Castillo-Triviño
- Hospital Universitario Donostia and IIS Biodonostia, San Sebastián, Spain
| | - J Prevost
- CSSS Saint-Jérôme, Saint-Jerome, Canada
| | - J Garber
- Westmead Hospital, Sydney, Australia
| | - K de Gans
- Groene Hart Ziekenhuis, Gouda, Netherlands
| | - R Ampapa
- Nemocnice Jihlava, Jihlava, Czech Republic
| | - M Simo
- Department of Neurology, Semmelweis University Budapest, Budapest, Hungary
| | - J L Sanchez-Menoyo
- Department of Neurology, Galdakao-Usansolo University Hospital, Osakidetza Basque Health Service, Galdakao, Spain
- Biocruces-Bizkaia Health Research Institute, Spain
| | - G Iuliano
- Ospedali Riuniti di Salerno, Salerno, Italy
| | - A Sas
- Department of Neurology and Stroke, BAZ County Hospital, Miskolc, Hungary
| | - A van der Walt
- Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia
- Department of Neurology, The Alfred Hospital, Melbourne, Australia
| | - N John
- Monash University, Clayton, Australia
- Department of Neurology, Monash Health, Clayton, Australia
| | - O Gray
- South Eastern HSC Trust, Belfast, United Kingdom
| | - S Hughes
- Royal Victoria Hospital, Belfast, United Kingdom
| | - G De Luca
- MS Centre, Neurology Unit, "SS. Annunziata" University Hospital, University "G. d'Annunzio", Chieti, Italy
| | - M Onofrj
- Department of Neuroscience, Imaging, and Clinical Sciences, University G. d'Annunzio, Chieti, Italy
| | - K Buzzard
- Department of Neurosciences, Box Hill Hospital, Melbourne, Australia
- Monash University, Melbourne, Australia
- MS Centre, Royal Melbourne Hospital, Melbourne, Australia
| | - O Skibina
- Department of Neurology, The Alfred Hospital, Melbourne, Australia
- Monash University, Melbourne, Australia
- Department of Neurology, Box Hill Hospital, Melbourne, Australia
| | - M Terzi
- Medical Faculty, 19 Mayis University, Samsun, Turkey
| | - M Slee
- Flinders University, Adelaide, Australia
| | - C Solaro
- Department of Neurology, ASL3 Genovese, Genova, Italy
- Department of Rehabilitation, ML Novarese Hospital Moncrivello
| | - Oreja-Guevara
- Department of Neurology, Hospital Clinico San Carlos, Madrid, Spain
| | - C Ramo-Tello
- Department of Neuroscience, Hospital Germans Trias i Pujol, Badalona, Spain
| | - Y Fragoso
- Universidade Metropolitana de Santos, Santos, Brazil
| | | | - F Moore
- Department of Neurology, McGill University, Montreal, Canada
| | - C Rajda
- Department of Neurology, University of Szeged, Szeged, Hungary
| | - E Aguera Morales
- Department of Medicine and Surgery, University of Cordoba, Cordoba, Spain
- Maimonides Biomedical Research Institute of Cordoba (IMIBIC)
| | - H Butzkueven
- Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia
| |
Collapse
|
4
|
Hauser S, Lazarevic V, Tournoud M, Ruppé E, Santiago Allexant E, Guigon G, Schicklin S, Lanet V, Girard M, Mirande C, Gervasi G, Schrenzel J. A metagenomics method for the quantitative detection of bacterial pathogens causing hospital-associated and ventilator-associated pneumonia. Microbiol Spectr 2023; 11:e0129423. [PMID: 37889000 PMCID: PMC10715005 DOI: 10.1128/spectrum.01294-23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2023] [Accepted: 09/29/2023] [Indexed: 10/28/2023] Open
Abstract
IMPORTANCE The management of ventilator-associated pneumonia and hospital-acquired pneumonia requires rapid and accurate quantitative detection of the infecting pathogen. To this end, we propose a metagenomic sequencing assay that includes the use of an internal sample processing control for the quantitative detection of 20 relevant bacterial species from bronchoalveolar lavage samples.
Collapse
Affiliation(s)
| | - V. Lazarevic
- Genomic Research Laboratory, Service of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland
| | | | - E. Ruppé
- Genomic Research Laboratory, Service of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland
| | | | | | | | - V. Lanet
- bioMérieux, Marcy-l'Étoile, France
| | - M. Girard
- Genomic Research Laboratory, Service of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland
| | - C. Mirande
- bioMérieux, La Balme-les-Grottes, France
| | | | - J. Schrenzel
- Genomic Research Laboratory, Service of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland
| |
Collapse
|
5
|
Naus S, Maasakkers JD, Gautam R, Omara M, Stikker R, Veenstra AK, Nathan B, Irakulis-Loitxate I, Guanter L, Pandey S, Girard M, Lorente A, Borsdorff T, Aben I. Assessing the Relative Importance of Satellite-Detected Methane Superemitters in Quantifying Total Emissions for Oil and Gas Production Areas in Algeria. Environ Sci Technol 2023; 57:19545-19556. [PMID: 37956986 DOI: 10.1021/acs.est.3c04746] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2023]
Abstract
Methane emissions from oil and gas production provide an important contribution to global warming. We investigate 2020 emissions from the largest gas field in Algeria, Hassi R'Mel, and the oil-production-dominated area Hassi Messaoud. We use methane data from the high-resolution (20 m) Sentinel-2 instruments to identify and estimate emission time series for 11 superemitters (including 10 unlit flares). We integrate this information in a transport model inversion that uses methane data from the coarser (7 km × 5.5 km) but higher-precision TROPOMI instrument to estimate emissions from both the 11 superemitters (>1 t/h individually) and the remaining diffuse area source (not detected as point sources with Sentinel-2). Compared to a bottom-up inventory for 2019 that is aligned with UNFCCC-reported emissions, we find that 2020 emissions in Hassi R'Mel (0.16 [0.11-0.22] Tg/yr) are lower by 53 [24-73]%, and emissions in Hassi Messaoud (0.22 [0.13-0.28] Tg/yr) are higher by 79 [4-188]%. Our analysis indicates that a larger fraction of Algeria's methane emissions (∼75%) come from oil production than national reporting suggests (5%). Although in both regions the diffuse area source constitutes the majority of emissions, relatively few satellite-detected superemitters provide a significant contribution (24 [12-40]% in Hassi R'Mel; 49 [27-71]% in Hassi Messaoud), indicating that mitigation efforts should address both. Our synergistic use of Sentinel-2 and TROPOMI can produce a unique and detailed emission characterization of oil and gas production areas.
Collapse
Affiliation(s)
- S Naus
- SRON Netherlands Institute for Space Research, Leiden 3584 CA, Netherlands
| | - J D Maasakkers
- SRON Netherlands Institute for Space Research, Leiden 3584 CA, Netherlands
| | - R Gautam
- Environmental Defense Fund, Washington, District of Columbia 20009, United States
| | - M Omara
- Environmental Defense Fund, Washington, District of Columbia 20009, United States
| | - R Stikker
- SRON Netherlands Institute for Space Research, Leiden 3584 CA, Netherlands
| | - A K Veenstra
- SRON Netherlands Institute for Space Research, Leiden 3584 CA, Netherlands
| | - B Nathan
- SRON Netherlands Institute for Space Research, Leiden 3584 CA, Netherlands
| | - I Irakulis-Loitxate
- Research Institute of Water and Environmental Engineering (IIAMA), Universitat Politécnica de Valéncia (UPV), Valencia 46022, Spain
- International Methane Emission Observatory, United Nations Environment Program, Paris 75015, France
| | - L Guanter
- Environmental Defense Fund, Washington, District of Columbia 20009, United States
- Research Institute of Water and Environmental Engineering (IIAMA), Universitat Politécnica de Valéncia (UPV), Valencia 46022, Spain
| | - S Pandey
- SRON Netherlands Institute for Space Research, Leiden 3584 CA, Netherlands
- Jet Propulsion Laboratory, California Institute of Technology, Pasadena, California 91011, United States
| | - M Girard
- GHGSat Inc., Montréal H2W 1Y5, Canada
| | - A Lorente
- SRON Netherlands Institute for Space Research, Leiden 3584 CA, Netherlands
- Environmental Defense Fund, Washington, District of Columbia 20009, United States
| | - T Borsdorff
- SRON Netherlands Institute for Space Research, Leiden 3584 CA, Netherlands
| | - I Aben
- SRON Netherlands Institute for Space Research, Leiden 3584 CA, Netherlands
| |
Collapse
|
6
|
Alkhoury C, Henneman NF, Petrenko V, Shibayama Y, Segaloni A, Gadault A, Nemazanyy I, Le Guillou E, Wolide AD, Antoniadou K, Tong X, Tamaru T, Ozawa T, Girard M, Hnia K, Lutter D, Dibner C, Panasyuk G. Class 3 PI3K coactivates the circadian clock to promote rhythmic de novo purine synthesis. Nat Cell Biol 2023:10.1038/s41556-023-01171-3. [PMID: 37414850 PMCID: PMC10344785 DOI: 10.1038/s41556-023-01171-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2022] [Accepted: 05/22/2023] [Indexed: 07/08/2023]
Abstract
Metabolic demands fluctuate rhythmically and rely on coordination between the circadian clock and nutrient-sensing signalling pathways, yet mechanisms of their interaction remain not fully understood. Surprisingly, we find that class 3 phosphatidylinositol-3-kinase (PI3K), known best for its essential role as a lipid kinase in endocytosis and lysosomal degradation by autophagy, has an overlooked nuclear function in gene transcription as a coactivator of the heterodimeric transcription factor and circadian driver Bmal1-Clock. Canonical pro-catabolic functions of class 3 PI3K in trafficking rely on the indispensable complex between the lipid kinase Vps34 and regulatory subunit Vps15. We demonstrate that although both subunits of class 3 PI3K interact with RNA polymerase II and co-localize with active transcription sites, exclusive loss of Vps15 in cells blunts the transcriptional activity of Bmal1-Clock. Thus, we establish non-redundancy between nuclear Vps34 and Vps15, reflected by the persistent nuclear pool of Vps15 in Vps34-depleted cells and the ability of Vps15 to coactivate Bmal1-Clock independently of its complex with Vps34. In physiology we find that Vps15 is required for metabolic rhythmicity in liver and, unexpectedly, it promotes pro-anabolic de novo purine nucleotide synthesis. We show that Vps15 activates the transcription of Ppat, a key enzyme for the production of inosine monophosphate, a central metabolic intermediate for purine synthesis. Finally, we demonstrate that in fasting, which represses clock transcriptional activity, Vps15 levels are decreased on the promoters of Bmal1 targets, Nr1d1 and Ppat. Our findings open avenues for establishing the complexity for nuclear class 3 PI3K signalling for temporal regulation of energy homeostasis.
Collapse
Affiliation(s)
- Chantal Alkhoury
- Institut Necker-Enfants Malades (INEM), Paris, France
- INSERM U1151/CNRS UMR 8253, Paris, France
- Université Paris Cité, Paris, France
| | - Nathaniel F Henneman
- Institut Necker-Enfants Malades (INEM), Paris, France
- INSERM U1151/CNRS UMR 8253, Paris, France
- Université Paris Cité, Paris, France
| | - Volodymyr Petrenko
- The Thoracic and Endocrine Surgery Division, Department of Surgery, University Hospital of Geneva, Geneva, Switzerland
- Department of Cell Physiology and Metabolism, University of Geneva, Geneva, Switzerland
- Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland
- Institute of Genetics and Genomics in Geneva (iGE3), Geneva, Switzerland
| | - Yui Shibayama
- Institut Necker-Enfants Malades (INEM), Paris, France
- INSERM U1151/CNRS UMR 8253, Paris, France
- Université Paris Cité, Paris, France
| | - Arianna Segaloni
- Institut Necker-Enfants Malades (INEM), Paris, France
- INSERM U1151/CNRS UMR 8253, Paris, France
- Université Paris Cité, Paris, France
| | - Alexis Gadault
- Institut Necker-Enfants Malades (INEM), Paris, France
- INSERM U1151/CNRS UMR 8253, Paris, France
- Université Paris Cité, Paris, France
| | - Ivan Nemazanyy
- Platform for Metabolic Analyses, Structure Fédérative de Recherche Necker, INSERM US24/CNRS, UAR 3633, Paris, France
| | - Edouard Le Guillou
- Institut Necker-Enfants Malades (INEM), Paris, France
- INSERM U1151/CNRS UMR 8253, Paris, France
- Université Paris Cité, Paris, France
| | - Amare Desalegn Wolide
- Computational Discovery Research, Institute for Diabetes and Obesity (IDO), Helmholtz Diabetes Center (HDC), Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany
- Division of Metabolic Diseases, Department of Medicine, Technische Universität München (TUM), Munich, Germany
- German Center for Diabetes Research (DZD), Neuherberg, Germany
| | - Konstantina Antoniadou
- Institut Necker-Enfants Malades (INEM), Paris, France
- INSERM U1151/CNRS UMR 8253, Paris, France
- Université Paris Cité, Paris, France
| | - Xin Tong
- Department of Molecular and Integrative Physiology, Caswell Diabetes Institute, University of Michigan Medical School, Ann Arbor, MI, USA
| | - Teruya Tamaru
- Department of Physiology, Toho University School of Medicine, Tokyo, Japan
| | - Takeaki Ozawa
- Department of Chemistry, School of Science, The University of Tokyo, Tokyo, Japan
| | - Muriel Girard
- Institut Necker-Enfants Malades (INEM), Paris, France
- INSERM U1151/CNRS UMR 8253, Paris, France
- Université Paris Cité, Paris, France
| | - Karim Hnia
- Institute of Cardiovascular and Metabolic Diseases (I2MC), INSERM-UMR 1297, University Paul Sabatier, Toulouse, France
| | - Dominik Lutter
- Computational Discovery Research, Institute for Diabetes and Obesity (IDO), Helmholtz Diabetes Center (HDC), Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany
- German Center for Diabetes Research (DZD), Neuherberg, Germany
| | - Charna Dibner
- The Thoracic and Endocrine Surgery Division, Department of Surgery, University Hospital of Geneva, Geneva, Switzerland
- Department of Cell Physiology and Metabolism, University of Geneva, Geneva, Switzerland
- Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland
- Institute of Genetics and Genomics in Geneva (iGE3), Geneva, Switzerland
| | - Ganna Panasyuk
- Institut Necker-Enfants Malades (INEM), Paris, France.
- INSERM U1151/CNRS UMR 8253, Paris, France.
- Université Paris Cité, Paris, France.
| |
Collapse
|
7
|
Goldschmidt I, Chichelnitskiy E, Rübsamen N, Jaeger VK, Karch A, D’Antiga L, Di Giorgio A, Nicastro E, Kelly DA, McLin V, Korff S, Debray D, Girard M, Hierro L, Klaudel-Dreszler M, Markiewicz-Kijewska M, Falk C, Baumann U. Diagnosing Acute Cellular Rejection after Paediatric Liver Transplantation-Is There Room for Interleukin Profiles? Children (Basel) 2023; 10:children10010128. [PMID: 36670678 PMCID: PMC9857115 DOI: 10.3390/children10010128] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 10/25/2022] [Revised: 12/12/2022] [Accepted: 12/30/2022] [Indexed: 01/11/2023]
Abstract
BACKGROUND The current gold standard to diagnose T-cell-mediated acute rejection (TCMR) requires liver histology. Using data from the ChilSFree study on immune response after paediatric liver transplantation (pLT), we aimed to assess whether soluble cytokines can serve as an alternative diagnostic tool in children suspected to have TCMR. METHODS A total of n = 53 blood samples obtained on the day of or up to 3 days before liver biopsy performed for suspected TCMR at median 18 days (range 7-427) after pLT in n = 50 children (38% female, age at pLT 1.8 (0.5-17.5) years) were analysed for circulating cytokine levels using Luminex-based Multiplex technology. Diagnostic accuracy of cytokine concentrations was assessed using a multivariable model based on elastic net regression and gradient boosting machine analysis. RESULTS TCMR was present in 68% of biopsies. There was strong evidence that patients with TCMR had increased levels of soluble CXCL8, CXCL9, CXCL10, IL-16, IL-18, HGF, CCL4, MIF, SCGF-β, and HGF before biopsy. There was some evidence for increased levels of sCD25, ICAM-1, IL-6, IL-3, and CCL11. Diagnostic value of both single cytokine levels and a combination of cytokines and clinical markers was poor, with AUROCs not exceeding 0.7. CONCLUSION Patients with TCMR showed raised levels of cytokines and chemokines reflective of T-cell activation and chemotaxis. Despite giving insight into the mechanisms of TCMR, the diagnostic value of soluble cytokines for the confirmation of TCMR in a clinical scenario of suspected TCMR is poor.
Collapse
Affiliation(s)
- Imeke Goldschmidt
- Department of Paediatric Liver, Kidney and Metabolic Diseases, Division of Paediatric Gastroenterology and Hepatology, Hannover Medical School, 30625 Hannover, Germany
- Correspondence:
| | - Evgeny Chichelnitskiy
- Institute of Transplant Immunology, Hannover Medical School, 30625 Hannover, Germany
| | - Nicole Rübsamen
- Institute of Epidemiology and Social Medicine, University of Münster, 48149 Münster, Germany
| | - Veronika K. Jaeger
- Institute of Epidemiology and Social Medicine, University of Münster, 48149 Münster, Germany
| | - André Karch
- Institute of Epidemiology and Social Medicine, University of Münster, 48149 Münster, Germany
| | - Lorenzo D’Antiga
- Paediatric Hepatology, Gastroenterology and Transplantation, Hospital Papa Giovanni XXIII, 24128 Bergamo, Italy
| | - Angelo Di Giorgio
- Paediatric Hepatology, Gastroenterology and Transplantation, Hospital Papa Giovanni XXIII, 24128 Bergamo, Italy
| | - Emanuele Nicastro
- Paediatric Hepatology, Gastroenterology and Transplantation, Hospital Papa Giovanni XXIII, 24128 Bergamo, Italy
| | - Deirdre A. Kelly
- Liver Unit, Birmingham Children’s Hospital, Birmingham B4 6NH, UK
| | - Valerie McLin
- Department Pédiatrie, Services Spécialités Pédiatriques, Hôpitaux Universitaires de Genève, Rue Gabrielle-Perret-Gentil 4, 1211 Genève, Switzerland
| | - Simona Korff
- Department Pédiatrie, Services Spécialités Pédiatriques, Hôpitaux Universitaires de Genève, Rue Gabrielle-Perret-Gentil 4, 1211 Genève, Switzerland
| | - Dominique Debray
- Pediatric Liver Unit, Department of Paediatric Surgery, Hôpital Necker-Enfants malades, 75015 Paris, France
| | - Muriel Girard
- Pediatric Liver Unit, Department of Paediatric Surgery, Hôpital Necker-Enfants malades, 75015 Paris, France
| | - Loreto Hierro
- Servicio de Hepatologìa y Transplante, Hospital Infantil Universitario La Paz Madrid, 28046 Madrid, Spain
| | | | | | - Christine Falk
- Institute of Transplant Immunology, Hannover Medical School, 30625 Hannover, Germany
| | - Ulrich Baumann
- Department of Paediatric Liver, Kidney and Metabolic Diseases, Division of Paediatric Gastroenterology and Hepatology, Hannover Medical School, 30625 Hannover, Germany
| |
Collapse
|
8
|
Hajji H, Imbard A, Spraul A, Taibi L, Barbier V, Habes D, Brassier A, Arnoux JB, Bouchereau J, Pichard S, Sissaoui S, Lacaille F, Girard M, Debray D, de Lonlay P, Schiff M. Initial presentation, management and follow-up data of 33 treated patients with hereditary tyrosinemia type 1 in the absence of newborn screening. Mol Genet Metab Rep 2022; 33:100933. [DOI: 10.1016/j.ymgmr.2022.100933] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2022] [Revised: 10/30/2022] [Accepted: 10/30/2022] [Indexed: 11/11/2022] Open
|
9
|
Hukkinen M, Wong M, Demir Z, Salem RH, Debray D, Renolleau S, Sissaoui S, Lacaille F, Girard M, Oualha M, Querciagrossa S, Fabre M, Lozach C, Clement R, Lasne D, Borgel D, Capito C, Chardot C. Antithrombin supplementation for prevention of vascular thrombosis after pediatric liver transplantation. J Pediatr Surg 2022; 57:666-675. [PMID: 35871859 DOI: 10.1016/j.jpedsurg.2022.06.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/30/2021] [Revised: 05/23/2022] [Accepted: 06/12/2022] [Indexed: 11/27/2022]
Abstract
AIMS After liver transplantation (LT), synthesis of coagulation factors by the graft recovers faster for pro thrombotic than anti thrombotic factors, resulting in a potential pro thrombotic imbalance. We studied the thrombotic and hemorrhagic complications in our pediatric LT series, providing supplementation of fresh frozen plasma (FFP) and/or antithrombin (AT) in the prophylactic antithrombotic regimen. METHODS This was a retrospective observational single center study. All isolated pediatric LTs performed between 1/11/2009 and 31/12/2019 (n = 181) were included. Postoperatively, in addition to low molecular weight heparin, 22 patients (12%) received FFP (10 ml/kg twice daily for 10 days), 27 patients (15%) were given FFP (reduced duration) and AT (50-100 IU/kg/day if AT activity remained <70%), and 132 (73%) received AT only. Complications, outcome, and coagulation profiles in postoperative days 0-10 were analyzed. RESULTS In all three treatment groups, AT activity normalized by day 4 while prothrombin remained <70% of normal until day 9. Hepatic artery thrombosis (HAT), portal vein thrombosis (PVT), and hemorrhagic complications occurred in 2.8%, 3.3%, and 3.9% of LTs. One- and 5-year patient and graft survival were 88% (±2.4% Standard Error) and 84% (±2.5%), and 86% (±2.6%) and 84% (±2.7%), respectively, without difference between groups. HAT were associated with low AT on days 0 and 1, and PVT with low AT on day 0. CONCLUSIONS Low antithrombin activity after LT was associated with postoperative thromboses. FFP and/or AT supplementation allowed early normalization of AT activity, while thrombotic or hemorrhagic complications were rare, suggesting efficient and safe management of post-LT coagulopathy.
Collapse
Affiliation(s)
- Maria Hukkinen
- Pediatric Surgery Unit, Hôpital Universitaire Necker-Enfants Malades, 149 rue de Sèvres, Paris 75015, France
| | - Michela Wong
- Pediatric Surgery Unit, Hôpital Universitaire Necker-Enfants Malades, 149 rue de Sèvres, Paris 75015, France
| | - Zeynep Demir
- Pediatric Hepatology Unit, Hôpital Universitaire Necker-Enfants Malades, 149 rue de Sèvres, Paris 75015, France
| | - Radhia Hadj Salem
- Pediatric Hepatology Unit, Hôpital Universitaire Necker-Enfants Malades, 149 rue de Sèvres, Paris 75015, France
| | - Dominique Debray
- Pediatric Hepatology Unit, Hôpital Universitaire Necker-Enfants Malades, 149 rue de Sèvres, Paris 75015, France; Université Paris Cité, 85 Bd Saint Germain, Paris 75006, France
| | - Sylvain Renolleau
- Pediatric Intensive Care Unit, Hôpital Universitaire Necker-Enfants Malades, 149 rue de Sèvres, Paris 75015, France; Université Paris Cité, 85 Bd Saint Germain, Paris 75006, France
| | - Samira Sissaoui
- Pediatric Hepatology Unit, Hôpital Universitaire Necker-Enfants Malades, 149 rue de Sèvres, Paris 75015, France
| | - Florence Lacaille
- Pediatric Hepatology Unit, Hôpital Universitaire Necker-Enfants Malades, 149 rue de Sèvres, Paris 75015, France
| | - Muriel Girard
- Pediatric Hepatology Unit, Hôpital Universitaire Necker-Enfants Malades, 149 rue de Sèvres, Paris 75015, France; Université Paris Cité, 85 Bd Saint Germain, Paris 75006, France
| | - Mehdi Oualha
- Pediatric Intensive Care Unit, Hôpital Universitaire Necker-Enfants Malades, 149 rue de Sèvres, Paris 75015, France; Université Paris Cité, 85 Bd Saint Germain, Paris 75006, France
| | - Stefania Querciagrossa
- Pediatric Anesthesiology Department, Hôpital Universitaire Necker-Enfants Malades, 149 rue de Sèvres, Paris 75015, France
| | - Monique Fabre
- Pathology Department, Hôpital Universitaire Necker-Enfants Malades, 149 rue de Sèvres, Paris 75015, France
| | - Cecile Lozach
- Radiology Department, Hôpital Universitaire Necker-Enfants Malades, 149 rue de Sèvres, Paris 75015, France
| | - Rozenn Clement
- Pharmacy, Hôpital Universitaire Necker-Enfants Malades, 149 rue de Sèvres, Paris 75015, France
| | - Dominique Lasne
- Université Paris Cité, 85 Bd Saint Germain, Paris 75006, France; Biological Hematology Laboratories, Hôpital Universitaire Necker-Enfants Malades, 149 rue de Sèvres, Paris 75015, France
| | - Delphine Borgel
- Université Paris Cité, 85 Bd Saint Germain, Paris 75006, France; Biological Hematology Laboratories, Hôpital Universitaire Necker-Enfants Malades, 149 rue de Sèvres, Paris 75015, France
| | - Carmen Capito
- Pediatric Surgery Unit, Hôpital Universitaire Necker-Enfants Malades, 149 rue de Sèvres, Paris 75015, France; Université Paris Cité, 85 Bd Saint Germain, Paris 75006, France.
| | - Christophe Chardot
- Pediatric Surgery Unit, Hôpital Universitaire Necker-Enfants Malades, 149 rue de Sèvres, Paris 75015, France; Université Paris Cité, 85 Bd Saint Germain, Paris 75006, France
| |
Collapse
|
10
|
Paquet A, Calvet B, Lacroix A, Girard M. Sensory Processing in Depression: Assessment and Intervention Perspective. Clin Psychol Psychother 2022; 29:1567-1579. [DOI: 10.1002/cpp.2785] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2022] [Revised: 08/02/2022] [Accepted: 08/30/2022] [Indexed: 11/08/2022]
Affiliation(s)
- A. Paquet
- Unité de Recherche et d’Innovation, Centre Hospitalier Esquirol Limoges France
- INSERM, Univ. Limoges, IRD, U1094 Tropical Neuroepidemiology Institute of Epidemiology and Tropical Neurology, GEIST Limoges France
| | - B. Calvet
- Unité de Recherche et d’Innovation, Centre Hospitalier Esquirol Limoges France
- INSERM, Univ. Limoges, IRD, U1094 Tropical Neuroepidemiology Institute of Epidemiology and Tropical Neurology, GEIST Limoges France
| | - A. Lacroix
- Unité de Recherche et d’Innovation, Centre Hospitalier Esquirol Limoges France
- INSERM, Univ. Limoges, IRD, U1094 Tropical Neuroepidemiology Institute of Epidemiology and Tropical Neurology, GEIST Limoges France
| | - M. Girard
- Unité de Recherche et d’Innovation, Centre Hospitalier Esquirol Limoges France
- INSERM, Univ. Limoges, IRD, U1094 Tropical Neuroepidemiology Institute of Epidemiology and Tropical Neurology, GEIST Limoges France
| |
Collapse
|
11
|
Paquet A, Lacroix A, Calvet B, Girard M. Psychomotor semiology in depression: a standardized clinical psychomotor approach. BMC Psychiatry 2022; 22:474. [PMID: 35841086 PMCID: PMC9287955 DOI: 10.1186/s12888-022-04086-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/14/2021] [Accepted: 06/23/2022] [Indexed: 12/03/2022] Open
Abstract
BACKGROUND Although psychomotor symptoms are associated with the clinical symptomatology of depression, they are rarely assessed and standardized clinical evaluation tools are lacking. Psychomotor retardation is sometimes assessed through direct patient observations by clinicians or through a clinical observation grid, in the absence of a standardized psychomotor assessment. In this pilot study, we evaluated the feasibility of standardized psychomotor examination of patients with major depressive disorder (MDD) and detailed a psychomotor semiology in these patients. METHODS We used a standardized psychomotor assessment to examine 25 patients with MDD and 25 age- and sex-matched healthy controls (HC) and compared their psychomotor profiles. Using standardized tests, we assessed muscle tone and posture, gross motor skills, perceptual-motor skills, and body image/organization. Clinical assessments of depressive symptoms (levels of psychomotor retardation, anxiety, and self-esteem) comprised this detailed psychomotor examination. RESULTS All participants were examined using the standardized psychomotor assessment. The main results of the psychomotor examination highlighted low body image of MDD participants (p < 0.001). Significant differences between groups were found in passive muscle tone, posture, emotional control, jumping, manual dexterity, walking, and praxis. Among these psychomotor variables, body image, passivity, jumping and rhythm scores predicted an MDD diagnosis. CONCLUSIONS Beyond the psychomotor retardation known to be present in MDD patients, this examination revealed an entire psychomotor symptomatology characterized by elevated muscle tone, poor body image associated with poor self-esteem, slowness in global motor skills and manual praxis, and poor rhythmic adaptation. In light of these results, we encourage clinicians to consider using a standardized tool to conduct detailed psychomotor examination of patients with depressive disorders. TRIAL REGISTRATION ClinicalTrials.gov identifier: NCT04031937 , 24/07/2019.
Collapse
Affiliation(s)
- A. Paquet
- grid.477071.20000 0000 9883 9701Department of research and innovation, Centre Hospitalier Esquirol, Limoges, France ,grid.9966.00000 0001 2165 4861INSERM, Univ. Limoges, IRD, U1094 Tropical Neuroepidemiology, Institute of Epidemiology and Tropical Neurology, GEIST, Limoges, France ,grid.463845.80000 0004 0638 6872University Paris-Saclay, UVSQ, Inserm U1018, CESP, Team DevPsy, Villejuif, France
| | - A. Lacroix
- grid.477071.20000 0000 9883 9701Department of research and innovation, Centre Hospitalier Esquirol, Limoges, France
| | - B. Calvet
- grid.477071.20000 0000 9883 9701Department of research and innovation, Centre Hospitalier Esquirol, Limoges, France ,grid.9966.00000 0001 2165 4861INSERM, Univ. Limoges, IRD, U1094 Tropical Neuroepidemiology, Institute of Epidemiology and Tropical Neurology, GEIST, Limoges, France
| | - M. Girard
- grid.477071.20000 0000 9883 9701Department of research and innovation, Centre Hospitalier Esquirol, Limoges, France ,grid.9966.00000 0001 2165 4861INSERM, Univ. Limoges, IRD, U1094 Tropical Neuroepidemiology, Institute of Epidemiology and Tropical Neurology, GEIST, Limoges, France
| |
Collapse
|
12
|
Pontoizeau C, Simon-Sola M, Gaborit C, Nguyen V, Rotaru I, Tual N, Colella P, Girard M, Biferi MG, Arnoux JB, Rötig A, Ottolenghi C, de Lonlay P, Mingozzi F, Cavazzana M, Schiff M. Neonatal gene therapy achieves sustained disease rescue of maple syrup urine disease in mice. Nat Commun 2022; 13:3278. [PMID: 35672312 PMCID: PMC9174284 DOI: 10.1038/s41467-022-30880-w] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2020] [Accepted: 05/17/2022] [Indexed: 11/21/2022] Open
Abstract
Maple syrup urine disease (MSUD) is a rare recessively inherited metabolic disorder causing accumulation of branched chain amino acids leading to neonatal death, if untreated. Treatment for MSUD represents an unmet need because the current treatment with life-long low-protein diet is challenging to maintain, and despite treatment the risk of acute decompensations and neuropsychiatric symptoms remains. Here, based on significant liver contribution to the catabolism of the branched chain amino acid leucine, we develop a liver-directed adeno-associated virus (AAV8) gene therapy for MSUD. We establish and characterize the Bckdha (branched chain keto acid dehydrogenase a)−/− mouse that exhibits a lethal neonatal phenotype mimicking human MSUD. Animals were treated at P0 with intravenous human BCKDHA AAV8 vectors under the control of either a ubiquitous or a liver-specific promoter. BCKDHA gene transfer rescued the lethal phenotype. While the use of a ubiquitous promoter fully and sustainably rescued the disease (long-term survival, normal phenotype and correction of biochemical abnormalities), liver-specific expression of BCKDHA led to partial, though sustained rescue. Here we show efficacy of gene therapy for MSUD demonstrating its potential for clinical translation. Maple syrup urine disease (MSUD) is a rare inborn error of metabolism, which is currently treated with life-long low-protein diet that can be challenging to maintain. Here the authors develop an AAV8-directed gene therapy providing sustainable disease rescue in a mouse model of MSUD.
Collapse
Affiliation(s)
- Clément Pontoizeau
- Necker Hospital, APHP, Biochemistry, Metabolomics Unit, Paris Cité University, Paris, France. .,Necker Hospital, APHP, Reference Center for Inborn Error of Metabolism, Pediatrics Department, Paris Cité University, Filière G2M, Paris, France. .,Inserm UMR_S1163, Institut Imagine, Paris, France.
| | | | | | | | - Irina Rotaru
- Inserm UMR_S1163, Institut Imagine, Paris, France
| | - Nolan Tual
- Inserm UMR_S1163, Institut Imagine, Paris, France
| | | | - Muriel Girard
- Necker Hospital, APHP, Pediatric Hepatology Unit, Pediatrics Department, Paris Cité University, Paris, France.,Inserm U1151, Institut Necker Enfants Malades, Paris, France
| | - Maria-Grazia Biferi
- Sorbonne University, Inserm, Institute of Myology, Centre of Research in Myology, Paris, France
| | - Jean-Baptiste Arnoux
- Necker Hospital, APHP, Reference Center for Inborn Error of Metabolism, Pediatrics Department, Paris Cité University, Filière G2M, Paris, France
| | - Agnès Rötig
- Inserm UMR_S1163, Institut Imagine, Paris, France
| | - Chris Ottolenghi
- Necker Hospital, APHP, Biochemistry, Metabolomics Unit, Paris Cité University, Paris, France.,Necker Hospital, APHP, Reference Center for Inborn Error of Metabolism, Pediatrics Department, Paris Cité University, Filière G2M, Paris, France.,Inserm UMR_S1163, Institut Imagine, Paris, France
| | - Pascale de Lonlay
- Necker Hospital, APHP, Reference Center for Inborn Error of Metabolism, Pediatrics Department, Paris Cité University, Filière G2M, Paris, France.,Inserm U1151, Institut Necker Enfants Malades, Paris, France
| | | | - Marina Cavazzana
- Inserm UMR_S1163, Institut Imagine, Paris, France.,Necker Hospital, APHP, Biotherapies Department, Paris Cité University, Paris, France
| | - Manuel Schiff
- Necker Hospital, APHP, Reference Center for Inborn Error of Metabolism, Pediatrics Department, Paris Cité University, Filière G2M, Paris, France. .,Inserm UMR_S1163, Institut Imagine, Paris, France.
| |
Collapse
|
13
|
Finkelstein N, Dayam RM, Law J, Goetgebuer R, Chao G, Abe KT, Sutton M, Stempak JM, Pereira D, Croitoru D, Acheampong L, Rizwan S, Rymaszewski K, Milgrom R, Ganatra D, Batista NV, Girard M, Lau I, Law R, Cheung M, Rathod B, Kitaygorodsky J, Samson R, Hu Q, Haroon N, Inman R, Piguet V, Silverberg M, Grigras AC, Watts TH, Chandran V. POS1217 ANTI-TNF THERAPY FOR IMMUNE MEDIATED INFLAMMATORY DISEASES MAY BE ASSOCIATED WITH LOWER ANTIBODY LEVELS AND VIRUS NEUTRALIZATION EFFICACY FOLLOWING SARS-CoV-2 mRNA VACCINATION. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.1667] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BackgroundThe impact of immunosuppressants on COVID-19 vaccination response and durability in patients with immune-mediated inflammatory diseases (IMID) is yet to be fully characterized. Humoral response may be attenuated in these patients especially those on B cell depleting therapy and higher doses of corticosteroids, but data regarding other immunosuppressants are scarce.ObjectivesWe aimed to investigate antibody and T cell responses and durability to SARS-CoV-2 mRNA vaccines (BNT162b and/or mRNA 1273) in IMID patients on immunomodulatory maintenance therapy other than B-cell depleting therapy and corticosteroids.MethodsThis prospective observational cohort study examined the immunogenicity of SARS-CoV-2 mRNA vaccines in adult patients with IMIDs (psoriatic arthritis, psoriasis, inflammatory bowel disease and rheumatoid arthritis) with or without maintenance immunosuppressive therapies (anti-TNF, methotrexate/azathioprine [MTX/AZA], anti-TNF + MTX/AZA, anti IL12/23, anti-IL-17, anti-IL23) compared to healthy controls. Automated ELISA for IgGs to spike trimer, spike receptor binding domain (RBD) and the nucleocapsid (NP) and T-cell release of 9 cytokines (IFNg, IL2, IL4, IL17A, TNF) and cytotoxic molecules (sFasL, GzmA, GzmB, Perforinin) in cell culture supernatants following stimulation with spike or NP peptide arrays were conducted at 4 time points: T1=pre vaccination, T2=median 26 days after dose 1, T3=median 16 days after dose 2 and T4=median 106 days after dose 2. Neutralization assays against four SARS-CoV-2 variants (wild type, delta, beta and gamma) were conducted at T3.ResultsWe followed 150 subjects: 26 healthy controls and 124 IMID patients: 9 untreated, 44 on anti-TNF, 16 on anti-TNF with MTX/AZA, 10 on anti-IL23, 28 on anti-IL12/23, 9 on anti-IL17, 8 on MTX/AZA (Table 1). Most patients mounted antibody and T cell responses with increases from dose 1 to dose 2 (100% seroconversion at T3) and some decline by T4, with variability within groups. Antibody levels and neutralization efficacy was lower in anti-TNFgroups (anti-TNF, anti-TNF + MTX/AZA) compared to controls and waned by T4 (Figure 1). T cell responses were not consistently different between groups. Pooled data showed a higher antibody response to mRNA-1273 compared to BNT162b.Table 1.Baseline characteristics of study participantsControluntreated IMIDAnti- TNFAnti- TNF +MTX/AZAAnti-IL-23Anti -IL-12/23Anti -IL-17MTX/AZAn=26n=9n=44n=16n=10n=28n=9n=8p-valueIMID*N/A IBD9301002704 Psoriasis1318122 PA0732172 AS0830010 RA1100011Age median years [IQR]36 [26-46]33 [27-41]38 [30-51]53 [44-59]48 [45-61]34 [28-47]49 [46-61]42 [31-55]<0.001^Sex male (%)16 (62)5 (56)18 (41)8 (50)5 (50)13 (46)6 (67)4 (50)0.772~BMImedian kg/m2 [IQR]25 [23-28]26 [22-27]22 [24-26]26 [24-28]27 [24-35]22 [21-24]32 [26-34]26[25-33]0.001^Vaccine interval median days [IQR]74 [35-84]54 [31-64]60 [45-69]64 [50-72]74 [35-84]62 [49-69]65 [52-75]58 [21-97]0.372^*multiple IMIDs per patient possibleFigure 1.Antibody responses (A) Anti spike and anti RBD IgG levels at indicated time points. Blue line represents median ratio in convalescent patients. The red line is the seropositivity threshold: the median antibody level of those that pass both a 1% false positive rate and show ≥3SD from the log means of the negative controls. (B) Relative ratio of RBD, spike and NP across time. Black and gray lines indicate median and mean values, respectively. *p≤0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001ConclusionFollowing 2 doses of mRNA vaccination there is 100% seroconversion in IMID patients on maintenance therapy. Antibody levels and neutralization efficacy in anti-TNF group are lower than controls, and wane substantially by 3 months after dose 2. These findings highlight the need for third dose in patients undergoing treatment with anti-TNF therapy and continued monitoring of immunity in these patient groups, taking into consideration newer variants and additional vaccine doses.AcknowledgementsThis work was funded by a donation from Juan and Stefania Speck and by grants VR-1 172711, VS1-175545, FDN-143250, GA1- 177703 and GA2- 177716, from Canadian Institutes of Health Research and COVID Immunity task force and by Sinai Health FoundationDisclosure of InterestsNaomi Finkelstein: None declared, Roya M. Dayam: None declared, Jaclyn Law: None declared, Rogier Goetgebuer: None declared, Gary Chao: None declared, Kento T. Abe: None declared, Mitchell Sutton: None declared, Joanne M. Stempak: None declared, Daniel Pereira: None declared, David Croitoru: None declared, Lily Acheampong: None declared, Saima Rizwan: None declared, Klaudia Rymaszewski: None declared, Raquel Milgrom: None declared, Darshini Ganatra: None declared, Nathalia V. Batista: None declared, Melanie Girard: None declared, Irene Lau: None declared, Ryan Law: None declared, Michelle Cheung: None declared, Bhavisha Rathod: None declared, Julia Kitaygorodsky: None declared, Reuben Samson: None declared, Queenie Hu: None declared, Nigil Haroon: None declared, Robert Inman Consultant of: AbbVie, Janssen, Lilly, Novartis., Grant/research support from: AbbVie, Novartis, Vincent Piguet Consultant of: AbbVie, Almirall, Celgene, Janssen, Kyowa Kirin Co. Ltd, LEO Pharma,Novartis, Pfizer, Sanofi, UCB, and Union Therapeutic, Grant/research support from: Unrestricted educational grants from AbbVie, Bausch Health, Celgene, Janssen, LEO Pharma, Lilly, L’Oréal, NAOS, Novartis, Pfizer, Pierre-Fabre, Sandoz, and Sanofi, Mark Silverberg Speakers bureau: AbbVie, Janssen, Takeda, Pfizer, Gilead and Amgen, Consultant of: AbbVie, Janssen, Takeda, Pfizer, Gilead and Amgen, Grant/research support from: AbbVie, Janssen, Takeda, Pfizer, Gilead and Amgen, Anne-Claude Grigras: None declared, Tania H. Watts: None declared, Vinod Chandran Consultant of: AbbVie, Amgen, BMS, Eli Lilly, Janssen, Novartis, Pfizer and UCB, Grant/research support from: AbbVie, Amgen, Eli-Lilly.
Collapse
|
14
|
Lefort M, Sharmin S, Andersen JB, Vukusic S, Casey R, Debouverie M, Edan G, Ciron J, Ruet A, De Sèze J, Maillart E, Zephir H, Labauge P, Defer G, Lebrun-Frenay C, Moreau T, Berger E, Clavelou P, Pelletier J, Stankoff B, Gout O, Thouvenot E, Heinzlef O, Al-Khedr A, Bourre B, Casez O, Cabre P, Montcuquet A, Wahab A, Camdessanché JP, Maurousset A, Ben Nasr H, Hankiewicz K, Pottier C, Maubeuge N, Dimitri-Boulos D, Nifle C, Laplaud DA, Horakova D, Havrdova EK, Alroughani R, Izquierdo G, Eichau S, Ozakbas S, Patti F, Onofrj M, Lugaresi A, Terzi M, Grammond P, Grand'Maison F, Yamout B, Prat A, Girard M, Duquette P, Boz C, Trojano M, McCombe P, Slee M, Lechner-Scott J, Turkoglu R, Sola P, Ferraro D, Granella F, Shaygannejad V, Prevost J, Maimone D, Skibina O, Buzzard K, Van der Walt A, Karabudak R, Van Wijmeersch B, Csepany T, Spitaleri D, Vucic S, Koch-Henriksen N, Sellebjerg F, Soerensen PS, Hilt Christensen CC, Rasmussen PV, Jensen MB, Frederiksen JL, Bramow S, Mathiesen HK, Schreiber KI, Butzkueven H, Magyari M, Kalincik T, Leray E. Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis. BMC Med Res Methodol 2022; 22:155. [PMID: 35637426 PMCID: PMC9150358 DOI: 10.1186/s12874-022-01623-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2022] [Accepted: 04/25/2022] [Indexed: 11/18/2022] Open
Abstract
Background Natalizumab and fingolimod are used as high-efficacy treatments in relapsing–remitting multiple sclerosis. Several observational studies comparing these two drugs have shown variable results, using different methods to control treatment indication bias and manage censoring. The objective of this empirical study was to elucidate the impact of methods of causal inference on the results of comparative effectiveness studies. Methods Data from three observational multiple sclerosis registries (MSBase, the Danish MS Registry and French OFSEP registry) were combined. Four clinical outcomes were studied. Propensity scores were used to match or weigh the compared groups, allowing for estimating average treatment effect for treated or average treatment effect for the entire population. Analyses were conducted both in intention-to-treat and per-protocol frameworks. The impact of the positivity assumption was also assessed. Results Overall, 5,148 relapsing–remitting multiple sclerosis patients were included. In this well-powered sample, the 95% confidence intervals of the estimates overlapped widely. Propensity scores weighting and propensity scores matching procedures led to consistent results. Some differences were observed between average treatment effect for the entire population and average treatment effect for treated estimates. Intention-to-treat analyses were more conservative than per-protocol analyses. The most pronounced irregularities in outcomes and propensity scores were introduced by violation of the positivity assumption. Conclusions This applied study elucidates the influence of methodological decisions on the results of comparative effectiveness studies of treatments for multiple sclerosis. According to our results, there are no material differences between conclusions obtained with propensity scores matching or propensity scores weighting given that a study is sufficiently powered, models are correctly specified and positivity assumption is fulfilled. Supplementary Information The online version contains supplementary material available at 10.1186/s12874-022-01623-8.
Collapse
Affiliation(s)
- M Lefort
- Arènes - UMR 6051, RSMS (Recherche sur les Services et Management en Santé) - U 1309, Univ Rennes, EHESP, CNRS, Inserm, Rennes, France.,Univ Rennes, CHU Rennes, Investigation Clinique de Rennes)], CIC 1414 [(Centre d, 35000, InsermRennes, France
| | - S Sharmin
- Department of Medicine, University of Melbourne, Melbourne, Australia.,Melbourne MS Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia
| | - J B Andersen
- Department of Neurology, The Danish Multiple Sclerosis Registry, Copenhagen University Hospital, Rigshospitalet Glostrup, Denmark
| | - S Vukusic
- Service de Neurologie, Sclérose en Plaques, Pathologies de La Myéline Et Neuro-Inflammation, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677, Lyon/Bron, France.,Centre Des Neurosciences de Lyon, UMR5292, Observatoire Français de La Sclérose en Plaques, INSERM, 1028 et CNRS, 69003, Lyon, France.,Université, Claude Bernard Lyon 1, Faculté de médecine Lyon Est, 69000, Lyon, France
| | - R Casey
- Service de Neurologie, Sclérose en Plaques, Pathologies de La Myéline Et Neuro-Inflammation, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677, Lyon/Bron, France.,Centre Des Neurosciences de Lyon, UMR5292, Observatoire Français de La Sclérose en Plaques, INSERM, 1028 et CNRS, 69003, Lyon, France.,Université, Claude Bernard Lyon 1, Faculté de médecine Lyon Est, 69000, Lyon, France.,Eugene Devic EDMUS Foundation, 69677, Lyon/Bron, France
| | - M Debouverie
- Centre Hospitalier Régional Universitaire de Nancy, Hôpital Central, Service de neurologie, Nancy, France
| | - G Edan
- Centre Hospitalier Universitaire de Rennes, Hôpital Pontchaillou, Service de neurologie, Rennes, France
| | - J Ciron
- Centre Hospitalier Universitaire de Toulouse, Hôpital Purpan, CRC-SEP, Département de neurologie, Toulouse, France
| | - A Ruet
- Centre Hospitalier Universitaire de Bordeaux, Hôpital Pellegrin, Service de neurologie, Bordeaux, France
| | - J De Sèze
- Service des maladies inflammatoires du système nerveux - neurologie, centre d'investigation clinique de Strasbourg, Hôpitaux Universitaire de Strasbourg, Hôpital de Hautepierre, INSERM 1434, Strasbourg, France
| | - E Maillart
- Assistance Publique Des Hôpitaux de Paris, Hôpital de La Pitié-Salpêtrière, Service de neurologie, Paris, France
| | - H Zephir
- Centre Hospitalier Universitaire de Lille, Hôpital Salengro, Service de neurologie D, Lille, France
| | - P Labauge
- Centre Hospitalier Universitaire de Montpellier, Hôpital Gui de Chauliac, Service de neurologie, Montpellier, France
| | - G Defer
- Centre Hospitalier Universitaire de Caen Normandie, Hôpital Côte de Nacre, Service de neurologie, Caen, France
| | - C Lebrun-Frenay
- Centre Hospitalier Universitaire de Nice, UR2CA-URRIS,, Université Nice Côte d'Azur, Hôpital, Pasteur 2, Service de neurologie, Nice, France
| | - T Moreau
- Centre Hospitalier Universitaire Dijon Bourgogne, Hôpital François Mitterrand, Maladies Inflammatoires du Système Nerveux Et Neurologie Générale, Service de neurologie, Dijon, France
| | - E Berger
- Centre Hospitalier Régional Universitaire de Besançon, Hôpital Jean Minjoz, Service de neurologie, Besançon, France
| | - P Clavelou
- Centre Hospitalier Universitaire de Clermont-Ferrand, Hôpital Gabriel-Montpied, Service de neurologie, Clermont-Ferrand, France
| | - J Pelletier
- Service de Neurologie, Aix Marseille Univ, APHM, Hôpital de La Timone, Pôle de Neurosciences Cliniques, 13005, Marseille, France
| | - B Stankoff
- Assistance Publique Des Hôpitaux de Paris, Hôpital Saint-Antoine, Service de neurologie, Paris, France
| | - O Gout
- Fondation Adolphe de Rothschild de L'œil Et du Cerveau, Service de neurologie, Paris, France
| | - E Thouvenot
- Centre Hospitalier Universitaire de Nîmes, Hôpital Carémeau, Service de neurologie, Nîmes, France
| | - O Heinzlef
- Centre Hospitalier Intercommunal de Poissy Saint-Germain-en-Laye, Service de neurologie, Poissy, France
| | - A Al-Khedr
- Centre Hospitalier Universitaire d'Amiens Picardie, Site sud, Service de neurologie, Amiens, France
| | - B Bourre
- Rouen University Hospital, 76000, Rouen, France
| | - O Casez
- Centre Hospitalier Universitaire Grenoble-Alpes, Site nord, Service de neurologie, Grenoble/La Tronche, France
| | - P Cabre
- Centre Hospitalier Universitaire de Martinique, Hôpital Pierre Zobda-Quitman, Service de neurologie, Fort-de-France, France
| | - A Montcuquet
- Centre Hospitalier Universitaire Limoges, Hôpital Dupuytren, Service de neurologie, Limoges, France
| | - A Wahab
- Assistance Publique Des Hôpitaux de Paris, Hôpital Henri Mondor, Service de neurologie, Créteil, France
| | - J P Camdessanché
- Centre Hospitalier Universitaire de Saint-Étienne, Hôpital Nord, Service de neurologie, Saint-Étienne, France
| | - A Maurousset
- Centre Hospitalier Régional Universitaire de Tours, Hôpital Bretonneau, Service de neurologie, Tours, France
| | - H Ben Nasr
- Centre Hospitalier Sud Francilien, Service de neurologie, Corbeil-Essonnes, France
| | - K Hankiewicz
- Centre Hospitalier de Saint-Denis, Hôpital Casanova, Service de neurologie, Saint-Denis, France
| | - C Pottier
- Centre Hospitalier de Pontoise, Service de neurologie, Pontoise, France
| | - N Maubeuge
- Centre Hospitalier Universitaire de Poitiers, Site de La Milétrie, Service de neurologie, Poitiers, France
| | - D Dimitri-Boulos
- Assistance Publique Des Hôpitaux de Paris, Hôpital Bicêtre, Service de neurologie, Le Kremlin-Bicêtre, France
| | - C Nifle
- Centre Hospitalier de Versailles, Hôpital André-Mignot, Service de neurologie, Le Chesnay, France
| | - D A Laplaud
- CHU de Nantes, Service de Neurologie & CIC015 INSERM, 44093, Nantes, France.,INSERM CR1064, 44000, Nantes, France
| | - D Horakova
- Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic
| | - E K Havrdova
- Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic
| | - R Alroughani
- Division of Neurology, Department of Medicine, Amiri Hospital, Sharq, Kuwait
| | - G Izquierdo
- Hospital Universitario Virgen Macarena, Seville, Spain
| | - S Eichau
- Hospital Universitario Virgen Macarena, Seville, Spain
| | - S Ozakbas
- Dokuz Eylul University, Konak/Izmir, Turkey
| | - F Patti
- GF Ingrassia Department, University of Catania, Catania, Italy.,Policlinico G Rodolico, Catania, Italy
| | - M Onofrj
- Department of Neuroscience, Imaging, and Clinical Sciences, University G. d'Annunzio, Chieti, Italy
| | - A Lugaresi
- Dipartimento Di Scienze Biomediche E Neuromotorie, Università Di Bologna, Bologna, Italy.,IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bologna, Italy
| | - M Terzi
- Medical Faculty, 19 Mayis University, Samsun, Turkey
| | - P Grammond
- CISSS Chaudiere-Appalache, Levis, Canada
| | | | - B Yamout
- Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon
| | - A Prat
- Hopital Notre Dame, Montreal, Canada.,CHUM and Universite de Montreal, Montreal, Canada
| | - M Girard
- Hopital Notre Dame, Montreal, Canada.,CHUM and Universite de Montreal, Montreal, Canada
| | - P Duquette
- Hopital Notre Dame, Montreal, Canada.,CHUM and Universite de Montreal, Montreal, Canada
| | - C Boz
- KTU Medical Faculty Farabi Hospital, Trabzon, Turkey
| | - M Trojano
- Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy
| | - P McCombe
- University of Queensland, Brisbane, Australia.,Royal Brisbane and Women's Hospital, Herston, Australia
| | - M Slee
- Flinders University, Adelaide, Australia
| | - J Lechner-Scott
- School of Medicine and Public Health, University Newcastle, Newcastle, Australia.,Department of Neurology, John Hunter Hospital, Hunter New England Health, Newcastle, Australia
| | - R Turkoglu
- Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey
| | - P Sola
- Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, Italy
| | - D Ferraro
- Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, Italy
| | - F Granella
- Department of Medicine and Surgery, University of Parma, Parma, Italy.,Department of Emergency and General Medicine, Parma University Hospital, Parma, Italy
| | | | - J Prevost
- CSSS Saint-Jérôme, Saint-Jerome, Canada
| | | | - O Skibina
- Monash University, Melbourne, Australia
| | - K Buzzard
- Monash University, Melbourne, Australia
| | | | | | - B Van Wijmeersch
- Rehabilitation and MS-Centre Overpelt and Hasselt University, Hasselt, Belgium
| | - T Csepany
- Department of Neurology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
| | - D Spitaleri
- Azienda Ospedaliera Di Rilievo Nazionale San Giuseppe Moscati Avellino, Avellino, Italy
| | - S Vucic
- Westmead Hospital, Sydney, Australia
| | - N Koch-Henriksen
- Department of Clinical Epidemiology, Aarhus University Hospital Aarhus, Aarhus, Denmark
| | - F Sellebjerg
- Danish Multiple Sclerosis Centre, Department of Neurology, Copenhagen University Hospital, Rigshospitalet Glostrup, 2600, Glostrup, Denmark
| | - P S Soerensen
- Danish Multiple Sclerosis Centre, Department of Neurology, Copenhagen University Hospital, Rigshospitalet Glostrup, 2600, Glostrup, Denmark
| | - C C Hilt Christensen
- Department of Neurology, Aalborg University Hospital, Multiple Sclerosis Unit, Aalborg, Denmark
| | - P V Rasmussen
- Aarhus University Hospital, Neurology, PJJ Boulevard, DK-8200, Aarhus N, Denmark
| | - M B Jensen
- Department of Neurology, University Hospital of Northern Sealand, Copenhagen, Denmark
| | - J L Frederiksen
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
| | - S Bramow
- Danish Multiple Sclerosis Centre, Department of Neurology, Copenhagen University Hospital, Rigshospitalet Glostrup, 2600, Glostrup, Denmark
| | - H K Mathiesen
- Department of Neurology, Copenhagen University Hospital Herlev, Copenhagen, Denmark
| | - K I Schreiber
- Danish Multiple Sclerosis Centre, Department of Neurology, Copenhagen University Hospital, Rigshospitalet Glostrup, 2600, Glostrup, Denmark
| | - H Butzkueven
- Central Clinical School, Monash University, Melbourne, Australia.,Department of Neurology, The Alfred Hospital, Melbourne, Australia.,Department of Neurology, Box Hill Hospital, Monash University, Melbourne, Australia
| | - M Magyari
- Melbourne MS Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia.,Danish Multiple Sclerosis Centre, Department of Neurology, Copenhagen University Hospital, Rigshospitalet Glostrup, 2600, Glostrup, Denmark
| | - T Kalincik
- Department of Medicine, University of Melbourne, Melbourne, Australia.
| | - E Leray
- Arènes - UMR 6051, RSMS (Recherche sur les Services et Management en Santé) - U 1309, Univ Rennes, EHESP, CNRS, Inserm, Rennes, France. .,Univ Rennes, CHU Rennes, Investigation Clinique de Rennes)], CIC 1414 [(Centre d, 35000, InsermRennes, France.
| |
Collapse
|
15
|
Shibayama Y, Alkhoury C, Nemazanyy I, F Henneman N, Cagnard N, Girard M, Atsumi T, Panasyuk G. Class 3 phosphoinositide 3-kinase promotes hepatic glucocorticoid receptor stability and transcriptional activity. Acta Physiol (Oxf) 2022; 235:e13793. [PMID: 35094500 PMCID: PMC9539506 DOI: 10.1111/apha.13793] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2021] [Revised: 01/18/2022] [Accepted: 01/24/2022] [Indexed: 12/16/2022]
Abstract
Aim Lipid kinase class 3 phosphoinositide 3‐kinase (PI3K) and nuclear receptor transcription factor glucocorticoid receptor (GR) play essential physiological roles in metabolic adaptation to fasting by activating lysosomal degradation by autophagy and metabolic gene expression, yet their functional interaction is unknown. The requirement of class 3 PI3K for GR function was investigated in liver tissue. Methods Inactivation of class 3 PI3K was achieved through deletion of its essential regulatory subunit Vps15, by expressing Cre‐recombinase in the livers of Vps15f/f mice. The response to both 24‐h fasting and synthetic GR ligand, dexamethasone (DEX) was evaluated in control and mutant mice. Liver tissue was analysed by immunoblot, RT‐qPCR, and LC‐MS. Results Vps15 mutant mice show decreased transcript levels of GR targets, coupled with lower nuclear levels of total and phosphorylated on Ser211, GR protein. Acute DEX treatment and 24‐h fasting both failed to re‐activate expression of GR targets in the livers of Vps15 mutant mice to the levels observed in controls. Decreased levels of endogenous GR ligand corticosterone and lower expression of 11β‐hydroxysteroid dehydrogenase 1 (11β‐HSD1), a metabolic enzyme that controls corticosterone availability, were found in the livers of Vps15 mutants. Hepatic Vps15 depletion resulted in the activation of nuclear Akt1 signalling, which was paralleled by increased polyubiquitination of GR. Conclusion In the liver, class 3 PI3K is required for corticosterone metabolism and GR transcriptional activity.
Collapse
Affiliation(s)
- Yui Shibayama
- Institut Necker‐Enfants Malades (INEM) Paris France
- INSERM U1151/CNRS UMR 8253 Paris France
- Université de Paris Paris France
- Department of Rheumatology Endocrinology and Nephrology Faculty of Medicine and Graduate School of Medicine Hokkaido University Sapporo Japan
| | - Chantal Alkhoury
- Institut Necker‐Enfants Malades (INEM) Paris France
- INSERM U1151/CNRS UMR 8253 Paris France
- Université de Paris Paris France
| | - Ivan Nemazanyy
- Platform for Metabolic Analyses Structure Fédérative de Recherche Necker INSERM US24/CNRS UAR 3633 Paris France
| | - Nathaniel F Henneman
- Institut Necker‐Enfants Malades (INEM) Paris France
- INSERM U1151/CNRS UMR 8253 Paris France
- Université de Paris Paris France
| | - Nicolas Cagnard
- Bio‐Informatique Platform Structure Fédérative de Recherche Necker INSERM US24/CNRS UAR 3633 Paris France
| | - Muriel Girard
- Institut Necker‐Enfants Malades (INEM) Paris France
- INSERM U1151/CNRS UMR 8253 Paris France
- Université de Paris Paris France
- Pediatric Hepatology Unit Hôpital Necker‐Enfants Malades Assistance Publique‐Hôpitaux de Paris Paris France
| | - Tatsuya Atsumi
- Department of Rheumatology Endocrinology and Nephrology Faculty of Medicine and Graduate School of Medicine Hokkaido University Sapporo Japan
| | - Ganna Panasyuk
- Institut Necker‐Enfants Malades (INEM) Paris France
- INSERM U1151/CNRS UMR 8253 Paris France
- Université de Paris Paris France
| |
Collapse
|
16
|
Goetz V, Yang DD, Lacaille F, Pelosi M, Angoulvant F, Brassier A, Arnoux JB, Schiff M, Heilbronner C, Salvador E, Debray D, Oualha M, Renolleau S, Girard M, de Lonlay P. What are the clues for an inherited metabolic disorder in Reye syndrome? A single Centre study of 58 children. Mol Genet Metab 2022; 135:320-326. [PMID: 35221207 DOI: 10.1016/j.ymgme.2022.02.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/06/2021] [Revised: 01/26/2022] [Accepted: 02/08/2022] [Indexed: 11/17/2022]
Abstract
OBJECTIVES Reye Syndrome is an acute encephalopathy with increased liver enzymes and blood ammonia, without jaundice. The prevalence of an underlying inherited metabolic disorder (IMD) is unclear, nor the clinical or biological factors directing toward this diagnosis. Our aims were to define these clues in a large series of patients. PATIENTS AND METHODS We retrospectively studied all patients with Reye admitted in our institution from 1995. We defined 3 groups: Group 1 with a confirmed IMD, Group 2 considered as free of IMD, Group 3 unclassified. Statistical analysis compared patients in Groups 1 and 2, to find criteria for a diagnosis of IMD. RESULTS Fifty-eight children were included; 41 (71%) had a confirmed IMD, 12 (20%) were free of IMD, and 5 remained unclassified. IMDs included Urea Cycle Disorders (51%), Fatty-Acid Oxidation Disorders (24%), ketogenesis defects (5%), other mitochondrial energy metabolism defects (10%), NBAS mutation (7%), Glycosylation Disorders (2%). In Group 2, the trigger was a viral infection, or a drug, deferasirox in three children. Univariate analysis showed that onset before 2 years-old, recurrent Reye and the association with rhabdomyolysis were significantly associated with IMD. Blood ammonia was a poor discriminating marker. All children were admitted into the intensive care unit, 23% needed continuous venovenous hemodialysis and one died from brain oedema. CONCLUSION Metabolic tests should be performed early in all cases of Reye, regardless of triggers. As they can be inconclusive, we suggest to systematically go to Next-Generation Sequencing study. These children should be transferred early to a specialized unit.
Collapse
Affiliation(s)
- Violette Goetz
- Reference Centre of Inherited Metabolic Diseases, Necker-Enfants malades Hospital, APHP, Filière G2M, Metab ERN, Université de Paris, Paris, France.
| | - David Dawei Yang
- Hopitaux de Paris, Pediatric Emergency Department, Necker-Enfants malades Hospital, Université de Paris, Paris, France
| | - Florence Lacaille
- Gastroenterology-Hepatology-Nutrition Unit, Reference Center for Rare Paediatric Liver Diseases, Necker-Enfants malades Hospital, APHP, Filière Filfoie, Université de Paris, Paris, France
| | - Michele Pelosi
- Reference Centre of Inherited Metabolic Diseases, Necker-Enfants malades Hospital, APHP, Filière G2M, Metab ERN, Université de Paris, Paris, France
| | - François Angoulvant
- Hopitaux de Paris, Pediatric Emergency Department, Necker-Enfants malades Hospital, Université de Paris, Paris, France
| | - Anais Brassier
- Reference Centre of Inherited Metabolic Diseases, Necker-Enfants malades Hospital, APHP, Filière G2M, Metab ERN, Université de Paris, Paris, France
| | - Jean-Baptiste Arnoux
- Reference Centre of Inherited Metabolic Diseases, Necker-Enfants malades Hospital, APHP, Filière G2M, Metab ERN, Université de Paris, Paris, France
| | - Manuel Schiff
- Reference Centre of Inherited Metabolic Diseases, Necker-Enfants malades Hospital, APHP, Filière G2M, Metab ERN, Université de Paris, Paris, France; Inserm UMR-S1163, Institut Imagine, Paris, France
| | - Claire Heilbronner
- Pediatric intensive Care Unit, Necker-Enfants malades Hospital, APHP, Université de Paris, Paris, France
| | - Elodie Salvador
- Pediatric intensive Care Unit, Necker-Enfants malades Hospital, APHP, Université de Paris, Paris, France
| | - Dominique Debray
- Pediatric hepatology unit, Reference Center for Rare Paediatric Liver Diseases, Necker-Enfants malades Hospital, APHP, Filière Filfoie, Université de Paris, Paris, France
| | - Mehdi Oualha
- Pediatric intensive Care Unit, Necker-Enfants malades Hospital, APHP, Université de Paris, Paris, France
| | - Sylvain Renolleau
- Pediatric intensive Care Unit, Necker-Enfants malades Hospital, APHP, Université de Paris, Paris, France
| | - Muriel Girard
- Pediatric hepatology unit, Reference Center for Rare Paediatric Liver Diseases, Necker-Enfants malades Hospital, APHP, Filière Filfoie, Université de Paris, Paris, France
| | - Pascale de Lonlay
- Reference Centre of Inherited Metabolic Diseases, Necker-Enfants malades Hospital, APHP, Filière G2M, Metab ERN, Université de Paris, Paris, France
| |
Collapse
|
17
|
Dana J, Girard M, Franchi-Abella S, Berteloot L, Benoit-Cherifi M, Imbert-Bismut F, Sermet-Gaudelus I, Debray D. Comparison of Transient Elastography, ShearWave Elastography, Magnetic Resonance Elastography and FibroTest as routine diagnostic markers for assessing liver fibrosis in children with Cystic Fibrosis. Clin Res Hepatol Gastroenterol 2022; 46:101855. [PMID: 34933150 DOI: 10.1016/j.clinre.2021.101855] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/22/2021] [Revised: 12/10/2021] [Accepted: 12/10/2021] [Indexed: 02/04/2023]
Abstract
BACKGROUND AND OBJECTIVE Reliable markers are needed for early diagnosis and follow-up of liver disease in Cystic Fibrosis (CF). The objective was to evaluate the diagnostic performance of Transient Elastography (TE), Real-Time ShearWave Ultrasound Elastography (SWE), Magnetic Resonance Elastography (MRE) and the FibroTest as markers of Cystic Fibrosis Liver Disease (CFLD). METHODS A monocentric prospective cross-modality comparison study was proposed to all children (6 to 18 years of age) attending the CF center. Based on liver ultrasound findings, participants were classified into 3 groups: multinodular liver or portal hypertension (Nodular US/PH, advanced CFLD), heterogeneous increased echogenicity (Heterogeneous US, CFLD) or neither (Normal/Homogeneous US, no CFLD). The 4 tests were performed on the same day. The primary outcome was the FibroTest value and liver stiffness measurements (LSM). RESULTS 55 participants (mean age 12.6 ± 3.3 years; 25 girls) were included between 2015 and 2018: 23 in group Nodular US/PH, 8 in group Heterogeneous US and 24 in group Normal/Homogeneous US (including 4 with steatosis). LSM on TE, SWE and MRE were higher in participants with CFLD (groups Nodular US/PH and Heterogeneous US) compared to others (group Normal/Homogeneous US) (p<0.01), while FibroTest values did not differ (p = 0.09). The optimal cut-off values for predicting CFLD on TE, SWE and MRE were 8.7 (AUC=0.83, Se=0.71, Sp=0.96), 7.8 (AUC=0.85, Se=0.73, Sp=0.96) and 4.15 kPa (AUC=0.68, Se=0.73, Sp=0.64), respectively. LSM predicted the occurrence of major liver-related events at 3 years. TE and SWE were highly correlated (Spearman's ρ=0.9) and concordant in identifying advanced CFLD (Cohen's κ=0.84) while MRE was moderately correlated and concordant with TE (ρ=0.41; κ=36) and SWE (ρ=0.5; κ=0.50). CONCLUSION This study demonstrated excellent diagnostic performance of TE, SWE and MRE for the diagnosis of CFLD.
Collapse
Affiliation(s)
- Jérémy Dana
- Department of Pediatric Radiology, Hôpital Necker-Enfants Malades, AP-HP, Paris, France; IHU-Strasbourg (Institut Hospitalo-Universitaire), Strasbourg, France; Institut National de la Santé et de la Recherche Médicale (Inserm), U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France.
| | - Muriel Girard
- Pediatric Hepatology unit, Centre de Référence Maladies Rares (CRMR) de l'atrésie des voies biliaires et cholestases génétiques (AVB-CG), National network for rare liver diseases (Filfoie), ERN rare liver, Hôpital Necker-Enfants Malades, AP-HP, Université de Paris, Paris, France; Inserm U1151, Institut Necker-Enfants Malades, Paris, France
| | - Stéphanie Franchi-Abella
- Department of Pediatric Radiology, APHP-Bicêtre Hospital, UMR BioMaps Paris-Saclay, Paris Saclay University, Kremlin-Bicêtre, France
| | - Laureline Berteloot
- Department of Pediatric Radiology, Hôpital Necker-Enfants Malades, AP-HP, Paris, France
| | | | - Françoise Imbert-Bismut
- Department of Metabolic Biochemistry, Hôpital Pitié Salpétrière Charlefoix, AP-HP, Paris, France; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Institute of Cardiometabolism and Nutrition (ICAN), Paris, France
| | - Isabelle Sermet-Gaudelus
- Centre de Référence Maladies Rares (CRMR), Mucoviscidose et maladies de CFTR, European Respiratory Network Lung, Hôpital Necker-Enfants Malades, AP-HP, Université de Paris, Paris, France; Inserm U1121, Necker-Enfants Malades Institute, Paris, France
| | - Dominique Debray
- Pediatric Hepatology unit, Centre de Référence Maladies Rares (CRMR) de l'atrésie des voies biliaires et cholestases génétiques (AVB-CG), National network for rare liver diseases (Filfoie), ERN rare liver, Hôpital Necker-Enfants Malades, AP-HP, Université de Paris, Paris, France; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Institute of Cardiometabolism and Nutrition (ICAN), Paris, France
| |
Collapse
|
18
|
Junge N, Di Giorgio A, Girard M, Demir Z, Kaminska D, Janowska M, Urbonas V, Varnas D, Maggiore G, Alterio T, Leiskau C, Vondran FWR, Richter N, D’Antiga L, Mikolajczyk R, Pfister ED, Baumann U. Cold Ischemia Time and Graft Fibrosis Are Associated with Autoantibodies after Pediatric Liver Transplantation: A Retrospective Cohort Study of the European Reference Network TransplantChild. Children 2022; 9:children9020275. [PMID: 35204995 PMCID: PMC8870233 DOI: 10.3390/children9020275] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/07/2022] [Revised: 02/02/2022] [Accepted: 02/15/2022] [Indexed: 11/25/2022]
Abstract
The reported prevalence of autoantibodies (AAB) (ANA, SMA, LKM, SLA) after pediatric liver transplantation (pLTX) varies considerably from 26–75%, but their clinical impact on outcome is uncertain. We aimed to study the prevalence of AAB after pLTX, their association with donor-, transplant-, and recipient-characteristics, and their relation to outcome. In our multicenter retrospective study, we aimed to clarify conflicting results from earlier studies. Six ERN TransplantChild centers reported data on 242 patients, of whom 61% were AAB positive. Prevalence varied across these centers. Independent of the interval between pLTX and AAB analysis, a one-hour increase in CIT resulted in an odds ratio (OR) of 1.37 (95% CI 1.11–1.69) for SMA positivity and an OR of 1.42 (95%CI 1.18–1.72) for ANA positivity. Steroid-free immunosuppression (IS) versus steroid-including IS (OR 5.28; 95% CI 1.45–19.28) was a risk factor for SMA positivity. Liver enzymes were not associated with ANA or SMA positivity. We did not observe an association of rejection activity index with ANA or SMA. However, the liver fibrosis score in follow-up biopsies was associated with ANA titer and donor age. In conclusion, this first multicenter study on AAB after pLTX showed high AAB prevalence and varied widely between centers. Longer CIT and prednisolone-free-IS were associated with AAB positivity, whereas AAB were not indicative of rejection, but instead were associated with graft fibrosis. The detection of AAB may be a marker of liver fibrosis and may be taken into consideration when indications for liver biopsy and immunosuppressive regimes, or reduction of immunosuppression in long-term follow-up, are being discussed. Prospective immunological profiling of pLTX patients, including AAB, is important to further improve our understanding of transplant immunology and silent graft fibrosis.
Collapse
Affiliation(s)
- Norman Junge
- Division for Pediatric Gastroenterology and Hepatology, Department of Peadiatric Kidney, Liver, and Metabolic Diseases, Hannover Medical School, 30625 Hannover, Germany; (C.L.); (E.-D.P.); (U.B.)
- Correspondence: ; Tel.: +49-511-532-3233; Fax: +49-511-532-3294
| | - Angelo Di Giorgio
- Department of Paediatric Hepatology, Gastroenterology and Transplantation, Azienda Ospedaliera Papa Giovanni XXIII, 24127 Bergamo, Italy; (A.D.G.); (L.D.)
| | - Muriel Girard
- Hépatologie Pédiatrique–Transplantation Hépatique, Hospital Necker Enfants-Malades, 75015 Paris, France; (M.G.); (Z.D.)
| | - Zeynep Demir
- Hépatologie Pédiatrique–Transplantation Hépatique, Hospital Necker Enfants-Malades, 75015 Paris, France; (M.G.); (Z.D.)
| | - Diana Kaminska
- Department of Gastroenterology, Hepatology, Nutritional Disorders and Pediatrics, The Children’s Memorial Health Institute, 04-730 Warsaw, Poland;
| | - Maria Janowska
- Department of Pediatric Surgery & Organ Transplantation, The Children’s Memorial Health Institute, 04-730 Warsaw, Poland;
| | - Vaidotas Urbonas
- Clinic of Children’s Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania; (V.U.); (D.V.)
| | - Dominykas Varnas
- Clinic of Children’s Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania; (V.U.); (D.V.)
| | - Giuseppe Maggiore
- Gastrointestinal, Liver, Nutrition Disorders Unit, Liver Transplantation Center, IRCCS Pediatric Hospital Bambino Gesù, 00165 Rome, Italy; (G.M.); (T.A.)
| | - Tommaso Alterio
- Gastrointestinal, Liver, Nutrition Disorders Unit, Liver Transplantation Center, IRCCS Pediatric Hospital Bambino Gesù, 00165 Rome, Italy; (G.M.); (T.A.)
| | - Christoph Leiskau
- Division for Pediatric Gastroenterology and Hepatology, Department of Peadiatric Kidney, Liver, and Metabolic Diseases, Hannover Medical School, 30625 Hannover, Germany; (C.L.); (E.-D.P.); (U.B.)
- Department of Pediatrics and Adolescent Medicine, Division of Pediatric Neurology, University Medical Center Göttingen, Georg August University, 37075 Göttingen, Germany
| | - Florian W. R. Vondran
- Department of General, Visceral and Transplant Surgery, Hannover Medical School, 30625 Hannover, Germany; (F.W.R.V.); (N.R.)
| | - Nicolas Richter
- Department of General, Visceral and Transplant Surgery, Hannover Medical School, 30625 Hannover, Germany; (F.W.R.V.); (N.R.)
| | - Lorenzo D’Antiga
- Department of Paediatric Hepatology, Gastroenterology and Transplantation, Azienda Ospedaliera Papa Giovanni XXIII, 24127 Bergamo, Italy; (A.D.G.); (L.D.)
| | - Rafael Mikolajczyk
- Institute for Medical Epidemiology, Biometrics and Informatics, Interdisciplinary Center for Health Sciences, Medical Faculty of the Martin Luther University Halle-Wittenberg, 06112 Halle, Germany;
| | - Eva-Doreen Pfister
- Division for Pediatric Gastroenterology and Hepatology, Department of Peadiatric Kidney, Liver, and Metabolic Diseases, Hannover Medical School, 30625 Hannover, Germany; (C.L.); (E.-D.P.); (U.B.)
| | - Ulrich Baumann
- Division for Pediatric Gastroenterology and Hepatology, Department of Peadiatric Kidney, Liver, and Metabolic Diseases, Hannover Medical School, 30625 Hannover, Germany; (C.L.); (E.-D.P.); (U.B.)
| |
Collapse
|
19
|
Passone CDGB, Vermillac G, Staels W, Besancon A, Kariyawasam D, Godot C, Lambe C, Talbotec C, Girard M, Chardot C, Berteloot L, Hachem T, Lapillonne A, Poidvin A, Storey C, Neve M, Stan C, Dugelay E, Fauret-Amsellem AL, Capri Y, Cavé H, Ybarra M, Chandra V, Scharfmann R, Bismuth E, Polak M, Carel JC, Pigneur B, Beltrand J. Mitchell-Riley Syndrome: Improving Clinical Outcomes and Searching for Functional Impact of RFX-6 Mutations. Front Endocrinol (Lausanne) 2022; 13:802351. [PMID: 35813646 PMCID: PMC9257252 DOI: 10.3389/fendo.2022.802351] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/26/2021] [Accepted: 05/02/2022] [Indexed: 11/13/2022] Open
Abstract
AIMS/HYPOTHESIS Caused by biallelic mutations of the gene encoding the transcription factor RFX6, the rare Mitchell-Riley syndrome (MRS) comprises neonatal diabetes, pancreatic hypoplasia, gallbladder agenesis or hypoplasia, duodenal atresia, and severe chronic diarrhea. So far, sixteen cases have been reported, all with a poor prognosis. This study discusses the multidisciplinary intensive clinical management of 4 new cases of MRS that survived over the first 2 years of life. Moreover, it demonstrates how the mutations impair the RFX6 function. METHODS Clinical records were analyzed and described in detail. The functional impact of two RFX6R181W and RFX6V506G variants was assessed by measuring their ability to transactivate insulin transcription and genes that encode the L-type calcium channels required for normal pancreatic beta-cell function. RESULTS All four patients were small for gestational age (SGA) and prenatally diagnosed with duodenal atresia. They presented with neonatal diabetes early in life and were treated with intravenous insulin therapy before switching to subcutaneous insulin pump therapy. All patients faced recurrent hypoglycemic episodes, exacerbated when parenteral nutrition (PN) was disconnected. A sensor-augmented insulin pump therapy with a predictive low-glucose suspension system was installed with good results. One patient had a homozygous c.1517T>G (p.Val506Gly) mutation, two patients had a homozygous p.Arg181Trp mutation, and one patient presented with new compound heterozygosity. The RFX6V506G and RFX6R181W mutations failed to transactivate the expression of insulin and genes that encode L-type calcium channel subunits required for normal pancreatic beta-cell function. CONCLUSIONS/INTERPRETATION Multidisciplinary and intensive disease management improved the clinical outcomes in four patients with MRS, including adjustment of parenteral/oral nutrition progression and advanced diabetes technologies. A better understanding of RFX6 function, in both intestine and pancreas cells, may break ground in new therapies, particularly regarding the use of drugs that modulate the enteroendocrine system.
Collapse
Affiliation(s)
- Caroline de Gouveia Buff Passone
- Department of Endocrinology, Metabolism and Diabetes, Inserm U1016, Cochin Institute, Paris, France
- Pediatric Endocrinology, Gynecology and Diabetology, Centre de Référence des Pathologies Gynécologiques Rares et des Maladies Endocriniennes Rares de la Croissance et du Développement, Hôpital Universitaire Necker Enfants Malades, Université Paris Descartes, Paris, France
- *Correspondence: Caroline de Gouveia Buff Passone, ; orcid.org/0000-0003-2639-352X
| | - Gaëlle Vermillac
- Pediatric Endocrinology, Gynecology and Diabetology, Centre de Référence des Pathologies Gynécologiques Rares et des Maladies Endocriniennes Rares de la Croissance et du Développement, Hôpital Universitaire Necker Enfants Malades, Université Paris Descartes, Paris, France
| | - Willem Staels
- Department of Endocrinology, Metabolism and Diabetes, Inserm U1016, Cochin Institute, Paris, France
- Beta Cell Neogenesis (BENE) Research Group, Vrije Universiteit Brussel (VUB), Brussels, Belgium
- Division of Pediatric Endocrinology, Department of Pediatrics, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium
| | - Alix Besancon
- Pediatric Endocrinology, Gynecology and Diabetology, Centre de Référence des Pathologies Gynécologiques Rares et des Maladies Endocriniennes Rares de la Croissance et du Développement, Hôpital Universitaire Necker Enfants Malades, Université Paris Descartes, Paris, France
| | - Dulanjalee Kariyawasam
- Pediatric Endocrinology, Gynecology and Diabetology, Centre de Référence des Pathologies Gynécologiques Rares et des Maladies Endocriniennes Rares de la Croissance et du Développement, Hôpital Universitaire Necker Enfants Malades, Université Paris Descartes, Paris, France
- Imagine Institute, Hôpital Universitaire Necker Enfants Malades, Université Paris Descartes, Paris, France
| | - Cécile Godot
- Pediatric Endocrinology, Gynecology and Diabetology, Centre de Référence des Pathologies Gynécologiques Rares et des Maladies Endocriniennes Rares de la Croissance et du Développement, Hôpital Universitaire Necker Enfants Malades, Université Paris Descartes, Paris, France
| | - Cécile Lambe
- Pediatric Gastroentherology Hepatology and Nutrition Unit, Hôpital Universitaire Necker Enfants Malades, Université Paris Descartes, Paris, France
| | - Cécile Talbotec
- Pediatric Gastroentherology Hepatology and Nutrition Unit, Hôpital Universitaire Necker Enfants Malades, Université Paris Descartes, Paris, France
- INSERM UMR S 1139, Faculté de Pharmacie de Paris, Université de Paris, Paris, France
| | - Muriel Girard
- Hepatology Unit, Hôpital Universitaire Necker Enfants Malades, Université de Paris, Inserm U1151, Centre de Référence Maladie rares Atresie des voies biliaires et cholestases génétiques et Filière de soin Filfoie, Paris, France
| | - Christophe Chardot
- Pediatric Surgery Department, Hôpital Universitaire Necker Enfants Malades, Université Paris Descartes, Paris, France
| | - Laureline Berteloot
- Pediatric Radiology Department, Hôpital Universitaire Necker Enfants Malades, Université Paris Descartes, Paris, France/INSERM U1163, Institut Imagine, Paris, France
| | - Taymme Hachem
- Neonatal Intensive Care Unit, Hôpital Universitaire Necker Enfants Malades, EHU 7328 Université Paris Descartes, Paris, France
| | - Alexandre Lapillonne
- Neonatal Intensive Care Unit, Hôpital Universitaire Necker Enfants Malades, EHU 7328 Université Paris Descartes, Paris, France
| | - Amélie Poidvin
- Université Paris Cité, Hôpital Universitaire Robert-Debré, Service d’Endocrinologie Diabétologie Pédiatrique et CRMR Prisis, Paris, France
| | - Caroline Storey
- Université Paris Cité, Hôpital Universitaire Robert-Debré, Service d’Endocrinologie Diabétologie Pédiatrique et CRMR Prisis, Paris, France
| | - Mathieu Neve
- Pediatric Department Hôpital d’Enfants de Margency Croix-Rouge française, Margency, France
| | - Cosmina Stan
- Pediatric Department Hôpital d’Enfants de Margency Croix-Rouge française, Margency, France
| | - Emmanuelle Dugelay
- Department of Pediatric Gastroenterology and Nutrition, Hôpital Universitaire Robert-Debré, Paris, France
| | | | - Yline Capri
- Genetic Department, Hopital Universitaire Robert Debré, Paris, France
| | - Hélène Cavé
- Genetic Department, Hopital Universitaire Robert Debré, Paris, France
| | - Marina Ybarra
- Research Center of Sainte Justine University Hospital, Université de Montréal, Montreal, QC, Canada
| | - Vikash Chandra
- Department of Endocrinology, Metabolism and Diabetes, Inserm U1016, Cochin Institute, Paris, France
- Biomedicum Stem Cell Center, Faculty of Medicine, University of Helsinki, Helsinki, Finland
| | - Raphaël Scharfmann
- Department of Endocrinology, Metabolism and Diabetes, Inserm U1016, Cochin Institute, Paris, France
| | - Elise Bismuth
- Université Paris Cité, Hôpital Universitaire Robert-Debré, Service d’Endocrinologie Diabétologie Pédiatrique et CRMR Prisis, Paris, France
| | - Michel Polak
- Pediatric Endocrinology, Gynecology and Diabetology, Centre de Référence des Pathologies Gynécologiques Rares et des Maladies Endocriniennes Rares de la Croissance et du Développement, Hôpital Universitaire Necker Enfants Malades, Université Paris Descartes, Paris, France
| | - Jean Claude Carel
- Université Paris Cité, Hôpital Universitaire Robert-Debré, Service d’Endocrinologie Diabétologie Pédiatrique et CRMR Prisis, Paris, France
| | - Bénédicte Pigneur
- Pediatric Gastroentherology Hepatology and Nutrition Unit, Hôpital Universitaire Necker Enfants Malades, Université Paris Descartes, Paris, France
| | - Jacques Beltrand
- Department of Endocrinology, Metabolism and Diabetes, Inserm U1016, Cochin Institute, Paris, France
- Pediatric Endocrinology, Gynecology and Diabetology, Centre de Référence des Pathologies Gynécologiques Rares et des Maladies Endocriniennes Rares de la Croissance et du Développement, Hôpital Universitaire Necker Enfants Malades, Université Paris Descartes, Paris, France
- Imagine Institute, Hôpital Universitaire Necker Enfants Malades, Université Paris Descartes, Paris, France
| |
Collapse
|
20
|
Drummond D, Dana J, Berteloot L, Schneider-Futschik EK, Chedevergne F, Bailly-Botuha C, Nguyen-Khoa T, Cornet M, Le Bourgeois M, Debray D, Girard M, Sermet-Gaudelus I. Lumacaftor-ivacaftor effects on cystic fibrosis-related liver involvement in adolescents with homozygous F508 del-CFTR. J Cyst Fibros 2021; 21:212-219. [PMID: 34454846 DOI: 10.1016/j.jcf.2021.07.018] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2020] [Revised: 07/24/2021] [Accepted: 07/28/2021] [Indexed: 10/20/2022]
Abstract
BACKGROUND The effects of lumacaftor-ivacaftor on cystic fibrosis transmembrane conductance regulator (CFTR)-associated liver disease remain unclear. The objective of the study was to describe the effect of this treatment on features of liver involvement in a cystic fibrosis (CF) adolescent population homozygous for F508del. METHODS Clinical characteristics, liver blood tests, abdominal ultrasonography (US), and pancreas and liver proton density fat fraction (PDFF) by magnetic resonance imaging, were obtained at treatment initiation and at 12 months for all patients. Biomarkers of CFTR activity (sweat chloride test, nasal potential difference, and intestinal current measurement) were assessed at initiation and at 6 months therapy. RESULTS Of the 37 patients who started ivacaftor/lumacaftor treatment, 28 were eligible for analysis. In this group, before treatment initiation, 4 patients were diagnosed with multinodular liver and portal hypertension, 19 with other forms of CF liver involvement, and 5 with no signs of liver involvement. During treatment, no hepatic adverse reactions were documented, and no patient developed liver failure. Serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and gammaglutamyl transferase (GGT) decreased significantly following initiation of lumacaftor-ivacaftor, and remained so after 12 months treatment. This was not correlated with changes in clinical status, liver and pancreas US and PDFF, fecal elastase, or lumacaftor-ivacaftor serum levels. The most "responsive" patients demonstrated a significant increase in biomarkers of CFTR activity. CONCLUSIONS These results may suggest a potential beneficial effect of CFTR modulators on CF liver disease and warrant further investigation in larger, prospective studies.
Collapse
Affiliation(s)
- David Drummond
- Service de Pneumologie et Allergologie Pédiatriques, Centre de Référence Maladies Rares Mucoviscidose et Maladies apparentées, Centre de Ressources et de Compétences pour la Mucoviscidose, Hôpital Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP)-Centre, Université de Paris, Paris, France; Université de Paris, Paris, France
| | - Jérémy Dana
- Université de Paris, Paris, France; Service d'Imagerie pédiatrique, Hôpital Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP)-Centre, Université de Paris, Paris, France; Université de Strasbourg, Inserm U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France; Institut Hospitalo-Universitaire, Strasbourg, France
| | - Laureline Berteloot
- Service d'Imagerie pédiatrique, Hôpital Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP)-Centre, Université de Paris, Paris, France
| | - Elena K Schneider-Futschik
- Department of Pharmacology & Therapeutics, Lung Health Research Centre, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Australia; Laboratoire de Biochimie, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP)-Centre, Université de Paris, Paris, France
| | - Frédérique Chedevergne
- Service de Pneumologie et Allergologie Pédiatriques, Centre de Référence Maladies Rares Mucoviscidose et Maladies apparentées, Centre de Ressources et de Compétences pour la Mucoviscidose, Hôpital Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP)-Centre, Université de Paris, Paris, France
| | - Céline Bailly-Botuha
- Service de Pneumologie et Allergologie Pédiatriques, Centre de Référence Maladies Rares Mucoviscidose et Maladies apparentées, Centre de Ressources et de Compétences pour la Mucoviscidose, Hôpital Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP)-Centre, Université de Paris, Paris, France
| | - Thao Nguyen-Khoa
- Service de Pneumologie et Allergologie Pédiatriques, Centre de Référence Maladies Rares Mucoviscidose et Maladies apparentées, Centre de Ressources et de Compétences pour la Mucoviscidose, Hôpital Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP)-Centre, Université de Paris, Paris, France; Laboratoire de Biochimie, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP)-Centre, Université de Paris, Paris, France
| | - Mathieu Cornet
- Service de Pneumologie et Allergologie Pédiatriques, Centre de Référence Maladies Rares Mucoviscidose et Maladies apparentées, Centre de Ressources et de Compétences pour la Mucoviscidose, Hôpital Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP)-Centre, Université de Paris, Paris, France; Université de Paris, Paris, France; INSERM U1151, Institut Necker Enfants Malades, Paris, France
| | - Muriel Le Bourgeois
- Service de Pneumologie et Allergologie Pédiatriques, Centre de Référence Maladies Rares Mucoviscidose et Maladies apparentées, Centre de Ressources et de Compétences pour la Mucoviscidose, Hôpital Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP)-Centre, Université de Paris, Paris, France
| | - Dominique Debray
- Université de Paris, Paris, France; Unité d'Hépatologie pédiatrique, Hôpital Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP)-Centre, Université de Paris, Paris, France
| | - Muriel Girard
- Université de Paris, Paris, France; Department of Pharmacology & Therapeutics, Lung Health Research Centre, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Australia; Unité d'Hépatologie pédiatrique, Hôpital Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP)-Centre, Université de Paris, Paris, France
| | - Isabelle Sermet-Gaudelus
- Service de Pneumologie et Allergologie Pédiatriques, Centre de Référence Maladies Rares Mucoviscidose et Maladies apparentées, Centre de Ressources et de Compétences pour la Mucoviscidose, Hôpital Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP)-Centre, Université de Paris, Paris, France; Université de Paris, Paris, France; Department of Pharmacology & Therapeutics, Lung Health Research Centre, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Australia; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Institute of Cardiometabolism and Nutrition (ICAN), Paris, France.
| |
Collapse
|
21
|
Bahans C, Leymarie S, Malauzat D, Girard M, Demiot C. Ethical considerations of the dynamics of clinical trials in an epidemic context: Studies on COVID-19. ACTA ACUST UNITED AC 2020; 16:100621. [PMID: 33349794 PMCID: PMC7744003 DOI: 10.1016/j.jemep.2020.100621] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2020] [Accepted: 12/11/2020] [Indexed: 01/27/2023]
Abstract
The COVID-19 epidemic has led to the intense mobilization of all health professionals, including those involved in research. From the very beginning, research ethics committees (RECs) have been called upon and mobilized to carry out the scientific and ethical evaluations of research projects to achieve a sound analysis of their risk/benefit balance. The aim of this article is to present an ethical reflection on the challenges and consequences of the fast-track procedure for the evaluation of COVID-19 research projects in the context of a public health emergency. Indeed, a large number of protocols of reduced rigor were hastily prepared without collaboration between researchers and in the absence of national regulation. As a result, a number of ethical dilemmas have emerged concerning the opposing needs of pragmatism imposed by the emergency context and the ethical principles that should govern the conduct of research. Moreover, the dispersion of these individual projects, aggravated by excessive media coverage of specific treatments, has resulted in a weakened impact of the research in the epidemic context. This article provides suggestions for the ethical management of ongoing and upcoming research, giving RECs the opportunity to adapt their evaluations to avoid allowing the pragmatism of the emergency context to subvert the inviolability of the epistemological and ethical principles of research on humans. This reflection may strengthen the ethical basis for the formulation of their decisions.
Collapse
Affiliation(s)
- C Bahans
- Comité de Protection des Personnes Sud-Ouest et Outre-Mer IV- Centre Hospitalier Esquirol, Cabanis Haut, 15, rue du Docteur-Marcland - BP 61730, 87025 Limoges Cedex, France.,Centre Hospitalier Universitaire de Limoges, Département de Pédiatrie, 8, avenue Dominique-Larrey, 87000 Limoges, France
| | - S Leymarie
- Comité de Protection des Personnes Sud-Ouest et Outre-Mer IV- Centre Hospitalier Esquirol, Cabanis Haut, 15, rue du Docteur-Marcland - BP 61730, 87025 Limoges Cedex, France.,Centre Hospitalier Universitaire de Limoges, Pôle Thorax Abdomen, 16, rue Bernard-Descottes, 87000 Limoges, France
| | - D Malauzat
- Comité de Protection des Personnes Sud-Ouest et Outre-Mer IV- Centre Hospitalier Esquirol, Cabanis Haut, 15, rue du Docteur-Marcland - BP 61730, 87025 Limoges Cedex, France
| | - M Girard
- Comité de Protection des Personnes Sud-Ouest et Outre-Mer IV- Centre Hospitalier Esquirol, Cabanis Haut, 15, rue du Docteur-Marcland - BP 61730, 87025 Limoges Cedex, France.,Centre Hospitalier Esquirol, Unité de Recherche et de Neurostimulation, 15, rue du Docteur-Marcland - BP 61730, 87025 Limoges Cedex, France
| | - C Demiot
- Comité de Protection des Personnes Sud-Ouest et Outre-Mer IV- Centre Hospitalier Esquirol, Cabanis Haut, 15, rue du Docteur-Marcland - BP 61730, 87025 Limoges Cedex, France.,Service de Pharmacologie, Faculté de Médecine et Pharmacie, 2, rue du Dr Marcland, 87025 Limoges Cedex, France
| |
Collapse
|
22
|
Girard M, Douillard C, Debray D, Lacaille F, Schiff M, Vuillaumier-Barrot S, Dupré T, Fabre M, Damaj L, Kuster A, Torre S, Mention K, McLin V, Dobbelaere D, Borgel D, Bauchard E, Seta N, Bruneel A, De Lonlay P. Long term outcome of MPI-CDG patients on D-mannose therapy. J Inherit Metab Dis 2020; 43:1360-1369. [PMID: 33098580 DOI: 10.1002/jimd.12289] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/26/2020] [Revised: 06/27/2020] [Accepted: 07/15/2020] [Indexed: 11/10/2022]
Abstract
Mannose phosphate isomerase MPI-CDG (formerly CDG-1b) is a potentially fatal inherited metabolic disease which is readily treatable with oral D-mannose. We retrospectively reviewed long-term outcomes of patients with MPI-CDG, all but one of whom were treated with D-mannose. Clinical, biological, and histological data were reviewed at diagnosis and on D-mannose treatment. Nine patients were diagnosed with MPI-CDG at a median age of 3 months. The presenting symptoms were diarrhea (n = 9), hepatomegaly (n = 9), hypoglycemia (n = 8), and protein loosing enteropathy (n = 7). All patients survived except the untreated one who died at 2 years of age. Oral D-mannose was started in eight patients at a median age of 7 months (mean 38 months), with a median follow-up on treatment of 14 years 9 months (1.5-20 years). On treatment, two patients developed severe portal hypertension, two developed venous thrombosis, and 1 displayed altered kidney function. Poor compliance with D-mannose was correlated with recurrence of diarrhea, thrombosis, and abnormal biological parameters including coagulation factors and transferrin profiles. Liver fibrosis persisted despite treatment, but two patients showed improved liver architecture during follow-up. This study highlights (i) the efficacy and safety of D-mannose treatment with a median follow-up on treatment of almost 15 years (ii) the need for life-long treatment (iii) the risk of relapse with poor compliance, (iii) the importance of portal hypertension screening (iv) the need to be aware of venous and renal complications in adulthood.
Collapse
Affiliation(s)
- Muriel Girard
- Paediatic Liver Unit, National Reference Center for Biliary Atresia and Genetic Cholestasis and French Network for Rare Liver Disease (Filfoie) Necker-Enfants-Malades University Hospital, APHP, Paris, France
- Inserm U1151, Institut Necker Enfants-Malades, Paris, France
- Université de Paris, Paris, France
| | - Claire Douillard
- Endocrinology and Metabolism department, Reference Metabolism Center of inborn metabolic diseases, Lille University Hospital, Paris, France
| | - Dominique Debray
- Paediatic Liver Unit, National Reference Center for Biliary Atresia and Genetic Cholestasis and French Network for Rare Liver Disease (Filfoie) Necker-Enfants-Malades University Hospital, APHP, Paris, France
- Université de Paris, Paris, France
| | - Florence Lacaille
- Department of Gastroenterology-Hepatology-Nutrition, Necker-Enfants-Malades University Hospital, APHP, Paris, France
| | - Manuel Schiff
- Université de Paris, Paris, France
- Reference Center of inherited Metabolic Diseases, Necker-Enfants-Malades University hospital, APHP, Paris, France
- Inserm U1163, Institut Imagine, Paris, France
| | - Sandrine Vuillaumier-Barrot
- Université de Paris, Paris, France
- Biochemistry and Genetic Department, AP-HP, Bichat Hospital, Paris, France
- Centre de recherche sur l'inflammation, Inserm U1149, Paris, France
| | - Thierry Dupré
- Université de Paris, Paris, France
- Biochemistry and Genetic Department, AP-HP, Bichat Hospital, Paris, France
- Centre de recherche sur l'inflammation, Inserm U1149, Paris, France
| | - Monique Fabre
- Department of Pathology, Necker-Enfants-Malades University hospital, APHP, Université de Paris, Paris, France
| | - Lena Damaj
- Department of Pediatrics, Competence Center of Inherited Metabolic Disorders, Rennes Hospital, Rennes, France
| | - Alice Kuster
- Department of Pediatric Intensive care, Competence Center of Inherited Metabolic Disorders, Nantes Hospital, Nantes, France
| | - Stéphanie Torre
- Department of Neonatal Pediatrics and Intensive Care, Rouen University Hospital, Rouen, France
| | - Karine Mention
- Department of Pediatric Metabolism, Reference Center of Inherited Metabolic Disorders, Jeanne de Flandre Hospital, Lille, France
| | - Valérie McLin
- Swiss Pediatric Liver Center, Department of Pediatrics, Gynecology, and Obstetrics, University Geneva Hospitals, Geneva, Switzerland
| | - Dries Dobbelaere
- Department of Pediatric Metabolism, Reference Center of Inherited Metabolic Disorders, Jeanne de Flandre Hospital, Lille, France
| | - Delphine Borgel
- Hematology Department, Necker-Enfants-Malades University Hospital, APHP, Paris, France
- INSERM-URM-S1176, Université Paris Saclay, Le Kremlin-Bicêtre, France
| | - Eric Bauchard
- Reference Center of inherited Metabolic Diseases, Necker-Enfants-Malades University hospital, APHP, Paris, France
| | - Nathalie Seta
- Université de Paris, Paris, France
- Biochemistry, Bichat Hospital, AP-HP, Paris, France
| | - Arnaud Bruneel
- Biochemistry, Bichat Hospital, AP-HP, Paris, France
- INSERM UMR1193, Mécanismes cellulaires et moléculaires de l'adaptation au stress et cancérogenèse, Paris-Saclay University, Châtenay-Malabry, France
| | - Pascale De Lonlay
- Inserm U1151, Institut Necker Enfants-Malades, Paris, France
- Université de Paris, Paris, France
- Reference Center of inherited Metabolic Diseases, Necker-Enfants-Malades University hospital, APHP, Paris, France
| |
Collapse
|
23
|
Guérin F, Franchi Abella S, McLin V, Ackermann O, Girard M, Cervoni JP, Savale L, Hernandez-Gea V, Valla D, Hillaire S, Dutheil D, Bureau C, Gonzales E, Plessier A. Congenital portosystemic shunts: Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver. Clin Res Hepatol Gastroenterol 2020; 44:452-459. [PMID: 32279979 DOI: 10.1016/j.clinre.2020.03.004] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/26/2020] [Accepted: 03/03/2020] [Indexed: 02/07/2023]
Affiliation(s)
- Florent Guérin
- Department of Visceral Pediatric surgery, FHU Hépatinov, Bicêtre Hospital, AP-HP, Paris-Saclay, 78, rue du Général-Leclerc, 94270 Le Kremlin-Bicêtre, France; UMRS-1193, Inserm, Paris-Saclay University, 91400 Orsay, France.
| | - Stéphanie Franchi Abella
- Department of Pediatric Radiology, FHU Hépatinov, Bicêtre Hospital, AP-HP, Paris-Saclay, 78, rue du Général-Leclerc, 94270 Le Kremlin-Bicêtre, France
| | - Valérie McLin
- Swiss Pediatric Liver Center, Pediatric Gastroenterology, Hepatology, and Nutrition Unit, Department of Pediatrics, Gynecology and Obstetrics, University of Geneva, Geneva, Switzerland
| | - Oanez Ackermann
- UMRS-1193, Inserm, Paris-Saclay University, 91400 Orsay, France; Department of Pediatric Hepatology, FHU Hépatinov, Bicêtre Hospital, AP-HP, Paris-Saclay, 78, rue du Général-Leclerc, 94270 Le Kremlin-Bicêtre, France; French Network for Rare Liver Diseases (FILFOIE), European Reference Network (ERN) "Rare-Liver" Saint-Antoine Hospital, AP-HP, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France
| | - Muriel Girard
- French Network for Rare Liver Diseases (FILFOIE), European Reference Network (ERN) "Rare-Liver" Saint-Antoine Hospital, AP-HP, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France; Department of Pediatric Hepatology, Hôpital Necker - enfants maladies, AP-HP, 149, rue de Sèvres, 75743 Paris cedex 15, France
| | - Jean Paul Cervoni
- Department of Hepatology, Jean Minjoz Hospital, University Hospital of Besançon, 3, boulevard Alexandre-Fleming, 25030 Besançon cedex, France
| | - Laurent Savale
- Department of Pulmonary Medicine, Bicêtre Hospital, AP-HP, 78, rue du Général-Leclerc, 94270 Le Kremlin-Bicêtre, France
| | - Virginia Hernandez-Gea
- Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic, Institut de Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona. Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (CIBERehd). Health Care Provider of the European Reference Network onRare Liver Disorders (ERN-Liver), Spain
| | - Dominique Valla
- French Network for Rare Liver Diseases (FILFOIE), European Reference Network (ERN) "Rare-Liver" Saint-Antoine Hospital, AP-HP, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France; Department of Hepatology, DHU Unity, Beaujon Hospital, AP-HP, 100, boulevard du Général-Leclerc, 92118 Clichy, France; Inserm, center for research in inflammation, University of Paris, 75018 Paris, France
| | - Sophie Hillaire
- Department of Internal medicine, Foch Hospital, 40, rue Worth, 92150 Suresnes, France
| | - Danielle Dutheil
- Department of Hepatology, Association of patients with vascular liver diseases (AMVF), Beaujon Hospital, 100, boulevard du Général-Leclerc, 92118 Clichy, France
| | - Christophe Bureau
- Department of Gastroenterology and Hepatology, Rangueil Hospital, University Hospital of Toulouse, 1, avenue du Professeur-Jean-Poulhès, 31400 Toulouse, France
| | - Emmanuel Gonzales
- UMRS-1193, Inserm, Paris-Saclay University, 91400 Orsay, France; Department of Pediatric Hepatology, FHU Hépatinov, Bicêtre Hospital, AP-HP, Paris-Saclay, 78, rue du Général-Leclerc, 94270 Le Kremlin-Bicêtre, France; French Network for Rare Liver Diseases (FILFOIE), European Reference Network (ERN) "Rare-Liver" Saint-Antoine Hospital, AP-HP, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France
| | - Aurélie Plessier
- French Network for Rare Liver Diseases (FILFOIE), European Reference Network (ERN) "Rare-Liver" Saint-Antoine Hospital, AP-HP, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France; Department of Hepatology, DHU Unity, Beaujon Hospital, AP-HP, 100, boulevard du Général-Leclerc, 92118 Clichy, France
| |
Collapse
|
24
|
Čechová A, Altassan R, Borgel D, Bruneel A, Correia J, Girard M, Harroche A, Kiec-Wilk B, Mohnike K, Pascreau T, Pawliński Ł, Radenkovic S, Vuillaumier-Barrot S, Aldamiz-Echevarria L, Couce ML, Martins EG, Quelhas D, Morava E, de Lonlay P, Witters P, Honzík T. Consensus guideline for the diagnosis and management of mannose phosphate isomerase-congenital disorder of glycosylation. J Inherit Metab Dis 2020; 43:671-693. [PMID: 32266963 PMCID: PMC7574589 DOI: 10.1002/jimd.12241] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/07/2020] [Revised: 03/17/2020] [Accepted: 04/03/2020] [Indexed: 12/19/2022]
Abstract
Mannose phosphate isomerase-congenital disorder of glycosylation (MPI-CDG) deficiency is a rare subtype of congenital disorders of protein N-glycosylation. It is characterised by deficiency of MPI caused by pathogenic variants in MPI gene. The manifestation of MPI-CDG is different from other CDGs as the patients suffer dominantly from gastrointestinal and hepatic involvement whereas they usually do not present intellectual disability or neurological impairment. It is also one of the few treatable subtypes of CDGs with proven effect of oral mannose. This article covers a complex review of the literature and recommendations for the management of MPI-CDG with an emphasis on the clinical aspect of the disease. A team of international experts elaborated summaries and recommendations for diagnostics, differential diagnosis, management, and treatment of each system/organ involvement based on evidence-based data and experts' opinions. Those guidelines also reveal more questions about MPI-CDG which need to be further studied.
Collapse
Affiliation(s)
- Anna Čechová
- Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
| | - Ruqaiah Altassan
- Medical Genetic Department, King Faisal Specialist Hospital and Research Center, Alfaisal University, Riyadh, Saudi Arabia
| | - Delphine Borgel
- Service d’Hématologie Biologique, Hôpital Necker, Assistance Publique-Hôpitaux de Paris, Université Paris-Saclay, Paris, France
| | - Arnaud Bruneel
- Department of Biochemistry, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France
- INSERM UMR1193, Mécanismes Cellulaires et Moléculaires de l’Adaptation au Stress et Cancérogenèse, Université Paris-Saclay, Châtenay-Malabry, France
| | - Joana Correia
- Centro de Referência Doenças Hereditárias do Metabolismo - Centro Hospitalar Universitário do Porto (CHUP), Porto, Portugal
| | - Muriel Girard
- Reference Center of Liver Diseases, Necker Hospital, Assistance Publique-Hôpitaux de Paris, University Paris Descartes, Paris, France
| | - Annie Harroche
- Hemophilia Care Centre, Hematology Unit, Hôpital Necker, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Beata Kiec-Wilk
- Department of Metabolic Diseases JUMC, Krakow and NSSU University Hospital, Krakow, Poland
| | - Klaus Mohnike
- Department of Paediatrics, Otto-von-Guericke University, Magdeburg, Germany
| | - Tiffany Pascreau
- Service d’Hématologie Biologique, Hôpital Necker, Assistance Publique-Hôpitaux de Paris, Université Paris-Saclay, Paris, France
| | - Łukasz Pawliński
- Department of Metabolic Diseases JUMC, Krakow and NSSU University Hospital, Krakow, Poland
| | - Silvia Radenkovic
- Metabolomics Expertise Center, CCB-VIB, Leuven, Belgium
- Department of Clinical Genomics and Laboratory of Medical Pathology, Mayo Clinic, Rochester, Minnesota
| | - Sandrine Vuillaumier-Barrot
- Department of Biochemistry, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France
- INSERM U1149, Centre de Recherche sur l’Inflammation (CRI) and Universitá Paris 7 Denis Diderot, Paris, France
| | - Luis Aldamiz-Echevarria
- Group of Metabolism, Biocruces Bizkaia Health Research Institute, Linked Clinical Group of Rare Diseases CIBER (CIBERER), Barakaldo, Spain
| | - Maria Luz Couce
- Department of Pediatrics, Congenital Metabolic Unit, University Clinical Hospital of Santiago, University of Santiago de Compostela, IDIS, CIBERER, MetabERN, Santiago de Compostela, Spain
| | - Esmeralda G. Martins
- Centro de Referência Doenças Hereditárias do Metabolismo - Centro Hospitalar Universitário do Porto (CHUP), Porto, Portugal
| | - Dulce Quelhas
- Centro de Genética Médica Jacinto de Magalhães, Centro de Referência Doenças Hereditárias do Metabolismo - Centro Hospitalar Universitário do Porto (CHUP), Unit for Multidisciplinary Research in Biomedicine, ICBAS, UP, Porto, Portugal
| | - Eva Morava
- Department of Clinical Genomics, Mayo Clinic, Rochester, Minnesota
| | - Pascale de Lonlay
- Reference Center of Inherited Metabolic Diseases, Necker Hospital, APHP, University Paris Descartes, Filière G2M, MetabERN, Paris, France
| | - Peter Witters
- Department of Paediatrics and Metabolic Center, University Hospitals Leuven, Leuven, Belgium
- Department of Development and Regeneration, KU Leuven, Leuven, Belgium
| | - Tomáš Honzík
- Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
| |
Collapse
|
25
|
Abi Nader E, Girard M, Leruez-Ville M, Sissaoui S, Lacaille F, Roque-Afonso AM, Debray D. Seroprevalence of Hepatitis E virus infection in children after liver transplantation: A single-center experience in France. Clin Res Hepatol Gastroenterol 2020; 44:174-180. [PMID: 31266724 DOI: 10.1016/j.clinre.2019.06.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/25/2018] [Revised: 05/26/2019] [Accepted: 06/05/2019] [Indexed: 02/04/2023]
Abstract
INTRODUCTION Hepatitis E virus (HEV) is a major cause of acute viral hepatitis worldwide, usually asymptomatic in children. However, a growing number of publications over the last decade have documented cases of chronic hepatitis related to HEV-genotype 3 infection, and progressing to cirrhosis in immuno-compromised patients, particularly in adult kidney transplant recipients. The aim of our study was to evaluate the prevalence and severity of HEV infection among pediatric liver transplant (PLT) recipients managed in our center. MATERIAL AND METHODS Between November 1st 2014 and January 1st 2016, PLT recipients (less than 18 years-old) were screened for HEV infection [determined by HEV serology, HEV- immunoglobulin M (IgM) and immunoglobulin G (IgG), and HEV-ribonucleic acid (RNA) by reverse transcriptase polymerase chain reaction] at their annual follow-up visit. RESULTS Eighty children were tested for HEV infection a mean of 5.4±5.3 years after liver transplantation (LT). The main indication for LT was biliary atresia (n=47, 59%). The prevalence of HEV-IgG was 8% (n=6; age range 1.3 to 14.2 years-old at the time of HEV testing). Prevalence increased to 30% when considering only the 20 children with a past history of an unexplained episode of elevated transaminases since LT. None had HEV IgM, serum HEV-RNA, or increased transaminases at the time of HEV testing. Among the six IgG seropositive children, two had received intravenous immunoglobulins prior to screening and four children had a negative control (seroreversion) 3 to 42 months after the first testing. CONCLUSION The prevalence of HEV infection in our cohort is low and similar to other pediatric reports. We saw no cases of chronic hepatitis or fibrosis attributable to HEV. The lower immunosuppressive regimen used in PLT children compared to other solid organ transplant recipients may account for this good outcome.
Collapse
Affiliation(s)
- Elie Abi Nader
- Unit of Pediatric Hepatology, Reference Center for Rare Pediatric Liver Diseases, Necker-Enfants-Malades University Hospital, AP-HP, 149, Sèvres Street, 75015 Paris, France; University of Paris-Descartes, Sorbonne Paris-Cité, 75006 Paris, France.
| | - Muriel Girard
- Unit of Pediatric Hepatology, Reference Center for Rare Pediatric Liver Diseases, Necker-Enfants-Malades University Hospital, AP-HP, 149, Sèvres Street, 75015 Paris, France; University of Paris-Descartes, Sorbonne Paris-Cité, 75006 Paris, France
| | - Marianne Leruez-Ville
- Department of Virology, Necker-Enfants-Malades University Hospital, AP-HP, 75015 Paris, France
| | - Samira Sissaoui
- Unit of Pediatric Hepatology, Reference Center for Rare Pediatric Liver Diseases, Necker-Enfants-Malades University Hospital, AP-HP, 149, Sèvres Street, 75015 Paris, France
| | - Florence Lacaille
- Unit of Pediatric Hepatology, Reference Center for Rare Pediatric Liver Diseases, Necker-Enfants-Malades University Hospital, AP-HP, 149, Sèvres Street, 75015 Paris, France
| | - Anne-Marie Roque-Afonso
- Inserm U1993, Department of Virology, National Reference Center for Hepatitis A and Hepatitis E, Paul-Brousse Hospital, AP-HP, 94800 Villejuif, France; University of Paris-Sud, 91405 Paris, France
| | - Dominique Debray
- Unit of Pediatric Hepatology, Reference Center for Rare Pediatric Liver Diseases, Necker-Enfants-Malades University Hospital, AP-HP, 149, Sèvres Street, 75015 Paris, France; University of Paris-Descartes, Sorbonne Paris-Cité, 75006 Paris, France
| |
Collapse
|
26
|
Brignon L, Arnal M, Jésus P, Girard M, Clément J, Sazerat P, Nubukpo P, Charles E. Dépistage des troubles du comportement alimentaire à l’aide du SCOFF-F chez les sportifs de haut niveau en Nouvelle-Aquitaine. NUTR CLIN METAB 2020. [DOI: 10.1016/j.nupar.2020.02.233] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
27
|
Brassier A, Krug P, Lacaille F, Pontoizeau C, Krid S, Sissaoui S, Servais A, Arnoux JB, Legendre C, Charbit M, Scemla A, Francoz C, Benoist JF, Schiff M, Mochel F, Touati G, Broué P, Cano A, Tardieu M, Querciagrossa S, Grévent D, Boyer O, Dupic L, Oualha M, Girard M, Aigrain Y, Debray D, Capito C, Ottolenghi C, Salomon R, Chardot C, de Lonlay P. Long-term outcome of methylmalonic aciduria after kidney, liver, or combined liver-kidney transplantation: The French experience. J Inherit Metab Dis 2020; 43:234-243. [PMID: 31525265 DOI: 10.1002/jimd.12174] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/09/2019] [Revised: 08/21/2019] [Accepted: 09/04/2019] [Indexed: 12/16/2022]
Abstract
Organ transplantation is discussed in methylmalonic aciduria (MMA) for renal failure, and poor quality of life and neurological outcome. We retrospectively evaluated 23 French MMA patients after kidney (KT), liver-kidney (LKT), and liver transplantation (LT). Two patients died, one after LKT, one of hepatoblastoma after KT. One graft was lost early after KT. Of 18 evaluable patients, 12 previously on dialysis, 8 underwent KT (mean 12.5 years), 8 LKT (mean 7 years), and 2 LT (7 and 2.5 years). At a median follow-up of 7.3 (KT), 2.3 (LKT), and 1.0 years (LT), no metabolic decompensation occurred except in 1 KT. Plasma and urine MMA levels dramatically decreased, more after LKT. Protein intake was increased more significantly after LKT than KT. Enteral nutrition was stopped in 7/8 LKT, 1/8 KT. Early complications were frequent after LKT. Neurological disorders occurred in four LKT, reversible in one. Five years after KT, four patients had renal failure. The metabolic outcomes were much better after LKT than KT. LKT in MMA is difficult but improves the quality of life. KT will be rarely indicated. We need more long-term data to indicate early LT, in the hope to delay renal failure and prevent neurodevelopmental complications.
Collapse
Affiliation(s)
- Anaïs Brassier
- Reference Center of Inherited Metabolic Diseases, Hôpital Universitaire Necker-Enfants Malades, APHP, Imagine Institute, Filière G2M, MetabERN, INEM, University Paris Descartes, Paris, France
| | - Pauline Krug
- Reference Center of Pediatric Nephrology, Hôpital Universitaire Necker-Enfants Malades, APHP, Filière ORKID, ERKnet, University Paris Descartes, Paris, France
| | - Florence Lacaille
- Pediatric Hepatology Unit, Reference Center for rare pediatric liver diseases, Department of Gastroenterology-Hepatology-Nutrition, Hôpital Universitaire Necker-Enfants Malades, APHP, Filière Filfoie, ERN Transplantchild, Paris, France
| | - Clément Pontoizeau
- Reference Center of Inherited Metabolic Diseases, Hôpital Universitaire Necker-Enfants Malades, APHP, Imagine Institute, Filière G2M, MetabERN, INEM, University Paris Descartes, Paris, France
- Metabolic Biochemistry, Hôpital Universitaire Necker-Enfants Malades, APHP, Imagine Institute, Filière G2M, MetabERN, University Paris Descartes, Paris, France
| | - Saoussen Krid
- Reference Center of Pediatric Nephrology, Hôpital Universitaire Necker-Enfants Malades, APHP, Filière ORKID, ERKnet, University Paris Descartes, Paris, France
| | - Samira Sissaoui
- Pediatric Hepatology Unit, Reference Center for rare pediatric liver diseases, Department of Gastroenterology-Hepatology-Nutrition, Hôpital Universitaire Necker-Enfants Malades, APHP, Filière Filfoie, ERN Transplantchild, Paris, France
| | - Aude Servais
- Reference Center of Inherited Metabolic Diseases, Hôpital Universitaire Necker-Enfants Malades, APHP, Imagine Institute, Filière G2M, MetabERN, INEM, University Paris Descartes, Paris, France
- Unit of Adult Nephrology and Transplantation, Hôpital Universitaire Necker-Enfants Malades, APHP, Filière G2M, MetabERN, University Paris Descartes, Paris, France
| | - Jean-Baptiste Arnoux
- Reference Center of Inherited Metabolic Diseases, Hôpital Universitaire Necker-Enfants Malades, APHP, Imagine Institute, Filière G2M, MetabERN, INEM, University Paris Descartes, Paris, France
| | - Christophe Legendre
- Unit of Adult Nephrology and Transplantation, Hôpital Universitaire Necker-Enfants Malades, APHP, Filière G2M, MetabERN, University Paris Descartes, Paris, France
| | - Marina Charbit
- Reference Center of Pediatric Nephrology, Hôpital Universitaire Necker-Enfants Malades, APHP, Filière ORKID, ERKnet, University Paris Descartes, Paris, France
| | - Anne Scemla
- Reference Center of Inherited Metabolic Diseases, Hôpital Universitaire Necker-Enfants Malades, APHP, Imagine Institute, Filière G2M, MetabERN, INEM, University Paris Descartes, Paris, France
- Unit of Adult Nephrology and Transplantation, Hôpital Universitaire Necker-Enfants Malades, APHP, Filière G2M, MetabERN, University Paris Descartes, Paris, France
| | - Claire Francoz
- Unit of Adult Hepatology and Transplantation, Hôpital Beaujon, Paris, France
| | - Jean-François Benoist
- Metabolic Biochemistry, Hôpital Universitaire Robert-Debré, APHP, Filière G2M, MetabERN, University Paris Sud, Paris, France
| | - Manuel Schiff
- Reference Center of Inherited Metabolic Diseases, Hôpital Universitaire Robert-Debré, APHP, Filière G2M, MetabERN, Paris, France
| | - Fanny Mochel
- Reference Center of Inherited Metabolic Diseases, Hôpital La Pitié Salpêtrière, APHP, Filière G2M, Paris, France
| | - Guy Touati
- Reference Center of Inherited Metabolic Diseases, Hôpital Universitaire Necker-Enfants Malades, APHP, Imagine Institute, Filière G2M, MetabERN, INEM, University Paris Descartes, Paris, France
- Reference Center of Inherited Metabolic Diseases, Hôpital Purpan, Filière G2M, Toulouse, France
| | - Pierre Broué
- Reference Center of Inherited Metabolic Diseases, Hôpital Purpan, Filière G2M, Toulouse, France
| | - Aline Cano
- Reference Center of Inherited Metabolic Diseases, Hôpital La Timone, Filière G2M, MetabERN, Marseille, France
| | - Marine Tardieu
- Reference Center of Inherited Metabolic Diseases, CHRU, Filière G2M, Tours, France
| | - Stefania Querciagrossa
- Department of Anesthesia, Hôpital Universitaire Necker-Enfants Malades, APHP, University Paris Descartes, Paris, France
| | - David Grévent
- Department of Radiology, Hôpital Universitaire Necker-Enfants Malades, APHP, University Paris Descartes, Paris, France
| | - Olivia Boyer
- Reference Center of Pediatric Nephrology, Hôpital Universitaire Necker-Enfants Malades, APHP, Filière ORKID, ERKnet, University Paris Descartes, Paris, France
| | - Laurent Dupic
- Intensive Care Unit, Hôpital Universitaire Necker-Enfants Malades, APHP, University Paris Descartes, Paris, France
| | - Mehdi Oualha
- Intensive Care Unit, Hôpital Universitaire Necker-Enfants Malades, APHP, University Paris Descartes, Paris, France
| | - Muriel Girard
- Pediatric Hepatology Unit, Reference Center for rare pediatric liver diseases, Department of Gastroenterology-Hepatology-Nutrition, Hôpital Universitaire Necker-Enfants Malades, APHP, Filière Filfoie, ERN Transplantchild, Paris, France
| | - Yves Aigrain
- Unit of Pediatric Surgery and Transplantation, Hôpital Universitaire Necker-Enfants Malades, APHP, Filière Filfoie, ERN Transplantchild, University Paris Descartes, Paris, France
| | - Dominique Debray
- Pediatric Hepatology Unit, Reference Center for rare pediatric liver diseases, Department of Gastroenterology-Hepatology-Nutrition, Hôpital Universitaire Necker-Enfants Malades, APHP, Filière Filfoie, ERN Transplantchild, Paris, France
| | - Carmen Capito
- Unit of Pediatric Surgery and Transplantation, Hôpital Universitaire Necker-Enfants Malades, APHP, Filière Filfoie, ERN Transplantchild, University Paris Descartes, Paris, France
| | - Chris Ottolenghi
- Reference Center of Inherited Metabolic Diseases, Hôpital Universitaire Necker-Enfants Malades, APHP, Imagine Institute, Filière G2M, MetabERN, INEM, University Paris Descartes, Paris, France
- Metabolic Biochemistry, Hôpital Universitaire Necker-Enfants Malades, APHP, Imagine Institute, Filière G2M, MetabERN, University Paris Descartes, Paris, France
| | - Rémi Salomon
- Reference Center of Pediatric Nephrology, Hôpital Universitaire Necker-Enfants Malades, APHP, Filière ORKID, ERKnet, University Paris Descartes, Paris, France
| | - Christophe Chardot
- Unit of Pediatric Surgery and Transplantation, Hôpital Universitaire Necker-Enfants Malades, APHP, Filière Filfoie, ERN Transplantchild, University Paris Descartes, Paris, France
| | - Pascale de Lonlay
- Reference Center of Inherited Metabolic Diseases, Hôpital Universitaire Necker-Enfants Malades, APHP, Imagine Institute, Filière G2M, MetabERN, INEM, University Paris Descartes, Paris, France
| |
Collapse
|
28
|
Girard M, Hu D, Pradervand N, Neuenschwander S, Bee G. Chestnut extract but not sodium salicylate decreases the severity of diarrhea and enterotoxigenic Escherichia coli F4 shedding in artificially infected piglets. PLoS One 2020; 15:e0214267. [PMID: 32106264 PMCID: PMC7046202 DOI: 10.1371/journal.pone.0214267] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2019] [Accepted: 01/16/2020] [Indexed: 01/16/2023] Open
Abstract
The development of alternatives to antibiotics is crucial to limiting the incidence of antimicrobial resistance, especially in prophylactic and metaphylactic use to control post-weaning diarrhea (PWD). Feed additives, including bioactive compounds, could be a promising alternative. This study aimed to test two bioactive compounds, sodium salicylate (SA) and a chestnut extract (CE) containing hydrolysable tannins, on the occurrence of PWD. At weaning, 72 piglets were assigned to four treatments that combined two factors: CE supplementation (with 2% of CE (CE+) or without (CE-)) and SA supplementation (with 35 mg/kg BW of SA (SA+) or without (SA-)). Then, 4 days after weaning, all piglets were infected with a suspension at 108 CFU/ml of enterotoxigenic Escherichia coli (ETEC F4ac). Each piglet had free access to an electrolyte solution containing, or not, SA. This SA supplementation was administered for 5 days (i.e., from the day of infection (day 0) to 4 days post-infection (day 4). During the 2 weeks post-infection, supplementation with SA had no effect (P > 0.05) on growth performances nor on fecal scores. A significant SA × time interaction (P < 0.01) for fecal scores and the percentage of diarrhea indicated that piglets with SA did not recover faster and did have a second episode of diarrhea. In contrast to SA treatment, inclusion of CE increased (P < 0.05) growth performances and feed intake. In the first week post-infection, CE decreased (P < 0.001) the overall fecal scores, the percentage of piglets with diarrhea, the days in diarrhea, and ETEC shedding in the feces. There was a SA×CE interaction (P < 0.05) for ETEC shedding, suggesting a negative effect of combining SA with CE. This study highlighted that, in contrast to SA, CE could represent a promising alternative to antibiotics immediately after weaning for improving growth performance and reducing PWD.
Collapse
Affiliation(s)
- M. Girard
- Agroscope, Posieux, Fribourg, Switzerland
| | - D. Hu
- Institute of Agricultural Sciences, ETH Zürich, Zürich, Switzerland
| | | | | | - G. Bee
- Agroscope, Posieux, Fribourg, Switzerland
- * E-mail:
| |
Collapse
|
29
|
Corpechot C, Barbu V, Chazouillères O, Broué P, Girard M, Roquelaure B, Chrétien Y, Dong C, Lascols O, Housset C, Jéru I. Genetic contribution of ABCC2 to Dubin-Johnson syndrome and inherited cholestatic disorders. Liver Int 2020; 40:163-174. [PMID: 31544333 DOI: 10.1111/liv.14260] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/09/2019] [Revised: 08/27/2019] [Accepted: 09/10/2019] [Indexed: 01/18/2023]
Abstract
BACKGROUND AND AIMS The ABCC2 gene is implicated in Dubin-Johnson syndrome (DJS), a rare autosomal recessive liver disorder. The primary aim of this study was to determine the diagnostic value of ABCC2 genetic testing in the largest cohort of DJS reported to date. The high number of patients with cholestatic manifestations in this series prompted us to evaluate the genetic contribution of rare, potentially pathogenic ABCC2 variants to other inherited cholestatic disorders. METHODS The cohort study included 32 patients with clinical DJS diagnosis, and 372 patients referred for the following disorders: low phospholipid-associated cholelithiasis (LPAC) syndrome, intrahepatic cholestasis of pregnancy (ICP) and benign recurrent intrahepatic cholestasis (BRIC). ABCC2 was screened by next-generation sequencing. RESULTS Most patients with clinical DJS had positive genetic diagnosis (n = 30; 94%), with a great diversity of point mutations and copy number variations in ABCC2. Strikingly, eight (27%) of these patients showed transient cholestatic features at presentation: four neonatal cholestasis, two ICP, one contraceptive-induced cholestasis and one sporadic cholestasis. Conversely, the frequency of rare, heterozygous, potentially pathogenic ABCC2 variants in patients with LPAC, ICP or BRIC did not differ significantly from that of the general population. CONCLUSIONS This large series reveals that DJS is a highly homogeneous Mendelian disorder involving a large spectrum of ABCC2 variants. Genetic testing is crucial to establish early DJS diagnosis in patients with atypical presentations, such as neonatal cholestasis. This study also provides no evidence for the contribution of rare, potentially pathogenic ABCC2 variants to other inherited cholestatic disorders.
Collapse
Affiliation(s)
- Christophe Corpechot
- Centre de Référence des Maladies Inflammatoires des Voies Biliaires et des Hépatites Auto-Immunes (MIVB-H), Filière de Santé des Maladies Rares du Foie de l'enfant et de l'adulte (FILFOIE), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France.,INSERM, Centre de Recherche Saint-Antoine (CRSA), Institut Hospitalo-Universitaire de Cardio-métabolisme et Nutrition (ICAN), Sorbonne Université, Paris, France
| | - Véronique Barbu
- INSERM, Centre de Recherche Saint-Antoine (CRSA), Institut Hospitalo-Universitaire de Cardio-métabolisme et Nutrition (ICAN), Sorbonne Université, Paris, France.,Laboratoire Commun de Biologie et Génétique Moléculaires, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France
| | - Olivier Chazouillères
- Centre de Référence des Maladies Inflammatoires des Voies Biliaires et des Hépatites Auto-Immunes (MIVB-H), Filière de Santé des Maladies Rares du Foie de l'enfant et de l'adulte (FILFOIE), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France.,INSERM, Centre de Recherche Saint-Antoine (CRSA), Institut Hospitalo-Universitaire de Cardio-métabolisme et Nutrition (ICAN), Sorbonne Université, Paris, France
| | - Pierre Broué
- Centres de compétences maladies rares du foie de l'enfant et Centre de référence constitutif maladies héréditaires du métabolisme, Hépatologie Pédiatrique et Maladies Héréditaires du Métabolisme, Hôpitaux de Toulouse, Hôpital des Enfants, Toulouse, France
| | - Muriel Girard
- Service d'Hépato-Gastroentérologie et Nutrition Pédiatrique, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Paris, France.,INSERM U1151, Institut Necker Enfants-Malades, Université Paris Descartes, Paris, France
| | - Bertrand Roquelaure
- Service d'Hépato-Gastroentérologie et Nutrition Pédiatrique, Assistance Publique-Hôpitaux de Marseille, Hôpital de la Timone Enfants, Marseille, France
| | - Yves Chrétien
- Centre de Référence des Maladies Inflammatoires des Voies Biliaires et des Hépatites Auto-Immunes (MIVB-H), Filière de Santé des Maladies Rares du Foie de l'enfant et de l'adulte (FILFOIE), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France
| | - Catherine Dong
- Centre de Référence des Maladies Inflammatoires des Voies Biliaires et des Hépatites Auto-Immunes (MIVB-H), Filière de Santé des Maladies Rares du Foie de l'enfant et de l'adulte (FILFOIE), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France
| | - Olivier Lascols
- INSERM, Centre de Recherche Saint-Antoine (CRSA), Institut Hospitalo-Universitaire de Cardio-métabolisme et Nutrition (ICAN), Sorbonne Université, Paris, France.,Laboratoire Commun de Biologie et Génétique Moléculaires, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France
| | - Chantal Housset
- Centre de Référence des Maladies Inflammatoires des Voies Biliaires et des Hépatites Auto-Immunes (MIVB-H), Filière de Santé des Maladies Rares du Foie de l'enfant et de l'adulte (FILFOIE), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France.,INSERM, Centre de Recherche Saint-Antoine (CRSA), Institut Hospitalo-Universitaire de Cardio-métabolisme et Nutrition (ICAN), Sorbonne Université, Paris, France
| | - Isabelle Jéru
- INSERM, Centre de Recherche Saint-Antoine (CRSA), Institut Hospitalo-Universitaire de Cardio-métabolisme et Nutrition (ICAN), Sorbonne Université, Paris, France.,Laboratoire Commun de Biologie et Génétique Moléculaires, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France
| |
Collapse
|
30
|
Dudoignon B, Huber C, Michot C, Di Rocco F, Girard M, Lyonnet S, Rio M, Rabia SH, Daire VC, Baujat G. Expanding the phenotype in Adams-Oliver syndrome correlating with the genotype. Am J Med Genet A 2019; 182:29-37. [PMID: 31654484 DOI: 10.1002/ajmg.a.61364] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2019] [Revised: 08/30/2019] [Accepted: 09/05/2019] [Indexed: 12/17/2022]
Abstract
RATIONALE Adams-Oliver syndrome (AOS) is a genetic disorder characterized by the association of aplasia cutis congenita (ACC), terminal transverse limb defect (TTLD), congenital cardiac malformation (CCM), and minor features, such as cutaneous, neurological, and hepatic abnormalities (HAs). The aim of the study is to emphasize phenotype-genotype correlations in AOS. METHODS We studied 29 AOS patients. We recorded retrospectively detailed phenotype data, including clinical examination, biological analyses, and imaging. The molecular analysis was performed through whole exome sequencing (WES). RESULTS Twenty-nine patients (100%) presented with ACC, the principal inclusion criteria in the study. Seventeen of twenty-one (81%) had cutis marmorata telangiectasia congenita, 16/26 (62%) had TTLD, 14/23 (61%) had CCM, 7/20 (35%) had HAs, and 9/27 (33%) had neurological findings. WES was performed in 25 patients. Fourteen of twenty-five (56%) had alterations in the genes already described in AOS. CCM and HAs are particularly associated with the NOTCH1 genotype. TTLD is present in patients with DOCK6 and EOGT alterations. Neurological findings of variable degree were associated sometimes with DOCK6 and NOTCH1 rarely with EOGT. CONCLUSION AOS is characterized by a clinical and molecular variability. It appears that degrees of genotype-phenotype correlations exist for patients with identified pathogenic mutations, underlining the need to undertake a systematic but adjusted multidisciplinary assessment.
Collapse
Affiliation(s)
- Benjamin Dudoignon
- AP-HP, Service de Génétique Clinique, Necker-Enfants malades University Hospital, Paris, France
| | - Celine Huber
- INSERM, UMR1163, Iimagine Institute, Paris, France.,AP-HP, Reference Center for Skeletal Dysplasia, Paris, France
| | - Caroline Michot
- AP-HP, Service de Génétique Clinique, Necker-Enfants malades University Hospital, Paris, France.,INSERM, UMR1163, Iimagine Institute, Paris, France.,AP-HP, Reference Center for Skeletal Dysplasia, Paris, France
| | | | - Muriel Girard
- AP-HP, Liver Unit, National Reference Center for Biliary Atresia and Genetic Cholestasis, INSERM U1151/CNRS UMR 8253, Institut Necker-Enfants malades (INEM), Assistance Publique Hopitaux de Paris, Necker-Enfants malades Hospital, Paris, France
| | - Stanislas Lyonnet
- AP-HP, Service de Génétique Clinique, Necker-Enfants malades University Hospital, Paris, France
| | - Marlène Rio
- AP-HP, Service de Génétique Clinique, Necker-Enfants malades University Hospital, Paris, France
| | - Smail Hadj Rabia
- AP-HP, Department of Dermatology, Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), INSERM U1163, Descartes-Sorbonne Paris Cité University, Imagine Institute, Necker-Enfants malades University Hospital, Paris, France
| | - Valérie Cormier Daire
- AP-HP, Service de Génétique Clinique, Necker-Enfants malades University Hospital, Paris, France.,INSERM, UMR1163, Iimagine Institute, Paris, France.,AP-HP, Reference Center for Skeletal Dysplasia, Paris, France
| | - Geneviève Baujat
- AP-HP, Service de Génétique Clinique, Necker-Enfants malades University Hospital, Paris, France.,INSERM, UMR1163, Iimagine Institute, Paris, France.,AP-HP, Reference Center for Skeletal Dysplasia, Paris, France
| |
Collapse
|
31
|
Girard M, Arguin G, Longpré J, Sarret P, Gendron F. A287 CARACTÉRISATION DE LA SIGNALISATION P2Y 6 DANS LA MIGRATION CELLULAIRE . J Can Assoc Gastroenterol 2019. [DOI: 10.1093/jcag/gwz006.286] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- M Girard
- Biologie cellulaire, Université de Sherbrooke, Sherbrooke, QC, Canada
| | - G Arguin
- Biologie cellulaire, Université de Sherbrooke, Sherbrooke, QC, Canada
| | - J Longpré
- Biologie cellulaire, Université de Sherbrooke, Sherbrooke, QC, Canada
| | - P Sarret
- Biologie cellulaire, Université de Sherbrooke, Sherbrooke, QC, Canada
| | - F Gendron
- Biologie cellulaire, Université de Sherbrooke, Sherbrooke, QC, Canada
| |
Collapse
|
32
|
Adamczyk L, Adkins JK, Agakishiev G, Aggarwal MM, Ahammed Z, Alekseev I, Alford J, Anson CD, Aparin A, Arkhipkin D, Aschenauer EC, Averichev GS, Banerjee A, Beavis DR, Bellwied R, Bhasin A, Bhati AK, Bhattarai P, Bichsel H, Bielcik J, Bielcikova J, Bland LC, Bordyuzhin IG, Borowski W, Bouchet J, Brandin AV, Brovko SG, Bültmann S, Bunzarov I, Burton TP, Butterworth J, Caines H, Calderón de la Barca Sánchez M, Cebra D, Cendejas R, Cervantes MC, Chaloupka P, Chang Z, Chattopadhyay S, Chen HF, Chen JH, Chen L, Cheng J, Cherney M, Chikanian A, Christie W, Chwastowski J, Codrington MJM, Contin G, Cramer JG, Crawford HJ, Cui X, Das S, Davila Leyva A, De Silva LC, Debbe RR, Dedovich TG, Deng J, Derevschikov AA, Derradi de Souza R, Dhamija S, di Ruzza B, Didenko L, Dilks C, Ding F, Djawotho P, Dong X, Drachenberg JL, Draper JE, Du CM, Dunkelberger LE, Dunlop JC, Efimov LG, Engelage J, Engle KS, Eppley G, Eun L, Evdokimov O, Eyser O, Fatemi R, Fazio S, Fedorisin J, Filip P, Finch E, Fisyak Y, Flores CE, Gagliardi CA, Gangadharan DR, Garand D, Geurts F, Gibson A, Girard M, Gliske S, Greiner L, Grosnick D, Gunarathne DS, Guo Y, Gupta A, Gupta S, Guryn W, Haag B, Hamed A, Han LX, Haque R, Harris JW, Heppelmann S, Hirsch A, Hoffmann GW, Hofman DJ, Horvat S, Huang B, Huang HZ, Huang X, Huck P, Humanic TJ, Igo G, Jacobs WW, Jang H, Judd EG, Kabana S, Kalinkin D, Kang K, Kauder K, Ke HW, Keane D, Kechechyan A, Kesich A, Khan ZH, Kikola DP, Kisel I, Kisiel A, Koetke DD, Kollegger T, Konzer J, Koralt I, Kotchenda L, Kraishan AF, Kravtsov P, Krueger K, Kulakov I, Kumar L, Kycia RA, Lamont MAC, Landgraf JM, Landry KD, Lauret J, Lebedev A, Lednicky R, Lee JH, LeVine MJ, Li C, Li W, Li X, Li X, Li Y, Li ZM, Lisa MA, Liu F, Ljubicic T, Llope WJ, Lomnitz M, Longacre RS, Luo X, Ma GL, Ma YG, Madagodagettige Don DMMD, Mahapatra DP, Majka R, Margetis S, Markert C, Masui H, Matis HS, McDonald D, McShane TS, Minaev NG, Mioduszewski S, Mohanty B, Mondal MM, Morozov DA, Mustafa MK, Nandi BK, Nasim M, Nayak TK, Nelson JM, Nigmatkulov G, Nogach LV, Noh SY, Novak J, Nurushev SB, Odyniec G, Ogawa A, Oh K, Ohlson A, Okorokov V, Oldag EW, Olvitt DL, Pachr M, Page BS, Pal SK, Pan YX, Pandit Y, Panebratsev Y, Pawlak T, Pawlik B, Pei H, Perkins C, Peryt W, Pile P, Planinic M, Pluta J, Poljak N, Porter J, Poskanzer AM, Pruthi NK, Przybycien M, Pujahari PR, Putschke J, Qiu H, Quintero A, Ramachandran S, Raniwala R, Raniwala S, Ray RL, Riley CK, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Ross JF, Roy A, Ruan L, Rusnak J, Rusnakova O, Sahoo NR, Sahu PK, Sakrejda I, Salur S, Sandweiss J, Sangaline E, Sarkar A, Schambach J, Scharenberg RP, Schmah AM, Schmidke WB, Schmitz N, Seger J, Seyboth P, Shah N, Shahaliev E, Shanmuganathan PV, Shao M, Sharma B, Shen WQ, Shi SS, Shou QY, Sichtermann EP, Singaraju RN, Skoby MJ, Smirnov D, Smirnov N, Solanki D, Sorensen P, Spinka HM, Srivastava B, Stanislaus TDS, Stevens JR, Stock R, Strikhanov M, Stringfellow B, Sumbera M, Sun X, Sun XM, Sun Y, Sun Z, Surrow B, Svirida DN, Symons TJM, Szelezniak MA, Takahashi J, Tang AH, Tang Z, Tarnowsky T, Thomas JH, Timmins AR, Tlusty D, Tokarev M, Trentalange S, Tribble RE, Tribedy P, Trzeciak BA, Tsai OD, Turnau J, Ullrich T, Underwood DG, Van Buren G, van Nieuwenhuizen G, Vandenbroucke M, Vanfossen JA, Varma R, Vasconcelos GMS, Vasiliev AN, Vertesi R, Videbæk F, Viyogi YP, Vokal S, Vossen A, Wada M, Wang F, Wang G, Wang H, Wang JS, Wang XL, Wang Y, Wang Y, Webb G, Webb JC, Westfall GD, Wieman H, Wissink SW, Witt R, Wu YF, Xiao Z, Xie W, Xin K, Xu H, Xu J, Xu N, Xu QH, Xu Y, Xu Z, Yan W, Yang C, Yang Y, Yang Y, Ye Z, Yepes P, Yi L, Yip K, Yoo IK, Yu N, Zawisza Y, Zbroszczyk H, Zha W, Zhang JB, Zhang JL, Zhang S, Zhang XP, Zhang Y, Zhang ZP, Zhao F, Zhao J, Zhong C, Zhu X, Zhu YH, Zoulkarneeva Y, Zyzak M. Erratum: Observation of D^{0} Meson Nuclear Modifications in Au+Au Collisions at sqrt[s_{NN}]=200 GeV [Phys. Rev. Lett. 113, 142301 (2014)]. Phys Rev Lett 2018; 121:229901. [PMID: 30547623 DOI: 10.1103/physrevlett.121.229901] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/24/2018] [Indexed: 06/09/2023]
Abstract
This corrects the article DOI: 10.1103/PhysRevLett.113.142301.
Collapse
|
33
|
Lorscheider J, Kuhle J, Izquierdo G, Lugaresi A, Havrdova E, Horakova D, Hupperts R, Duquette P, Girard M, Prat A, Grand'Maison F, Grammond P, Sola P, Ferraro D, Trojano M, Ramo-Tello C, Lechner-Scott J, Pucci E, Solaro C, Slee M, Van Pesch V, Sanchez Menoyo JL, van der Walt A, Butzkueven H, Kappos L, Kalincik T. Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study. Eur J Neurol 2018; 26:363-370. [PMID: 30298572 DOI: 10.1111/ene.13824] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2018] [Accepted: 10/04/2018] [Indexed: 11/29/2022]
Abstract
BACKGROUND AND PURPOSE Treatment options in primary progressive multiple sclerosis (PPMS) are scarce and, with the exception of ocrelizumab, anti-inflammatory agents have failed to show efficacy in ameliorating disability progression. The aim of this study was to investigate a potential effect of anti-inflammatory disease-modifying treatment on disability outcomes in PPMS. METHODS Using MSBase, a large, international, observational database, we identified patients with PPMS who were either never treated or treated with a disease-modifying agent. Propensity score matching was used to select subpopulations with similar baseline characteristics. Expanded Disability Status Scale (EDSS) outcomes were compared with an intention-to-treat and an as-treated approach in paired, pairwise-censored analyses. RESULTS Of the 1284 included patients, 533 were matched (treated, n = 195; untreated n = 338). Median on-study pairwise-censored follow-up was 3.4 years (quartiles 1.2-5.5). No difference in the hazard of experiencing 3-month confirmed EDSS progression events was observed between the groups [hazard ratio (HR), 1.0; 95% confidence interval (CI), 0.6-1.7, P = 0.87]. We did not find significant differences in the hazards of confirmed EDSS improvement (HR, 1.0; 95% CI, 0.6-1.6, P = 0.91) or reaching a confirmed EDSS step ≥7 (HR, 1.1; 95% CI, 0.7-1.6, P = 0.69). CONCLUSION Our pooled analysis of disease-modifying agents suggests that these therapies have no substantial effect on short- to medium-term disability outcomes in PPMS.
Collapse
Affiliation(s)
- J Lorscheider
- Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, Neurologic Clinic and Policlinic, University Hospital and University of Basel, Basel, Switzerland
| | - J Kuhle
- Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, Neurologic Clinic and Policlinic, University Hospital and University of Basel, Basel, Switzerland
| | - G Izquierdo
- Hospital Universitario Virgen Macarena, Seville, Spain
| | - A Lugaresi
- Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio, Chieti, Italy
| | - E Havrdova
- Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
| | - D Horakova
- Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
| | - R Hupperts
- Orbis Medical Center, Sittard, The Netherlands
| | | | - M Girard
- Hôpital Notre Dame, Montreal, Quebec
| | - A Prat
- Hôpital Notre Dame, Montreal, Quebec
| | - F Grand'Maison
- Neuro Rive-Sud, Hôpital Charles LeMoyne, Greenfield Park, Quebec
| | - P Grammond
- Hôtel-Dieu de Lévis, Lévis, Quebec, Canada
| | - P Sola
- Nuovo Ospedale Civile S.Agostino/Estense, Modena
| | - D Ferraro
- Nuovo Ospedale Civile S.Agostino/Estense, Modena
| | - M Trojano
- Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy
| | | | - J Lechner-Scott
- Department of Neurology, John Hunter Hospital, Newcastle, NSW.,School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia
| | - E Pucci
- Neurology Unit, ASUR Marche, AV3, Macerata
| | - C Solaro
- Hospedale P. A. Micone, Genova, Italy
| | - M Slee
- Flinders Medical Centre, Flinders University, Adelaide, SA, Australia
| | - V Van Pesch
- Cliniques Universitaires Saint-Luc, Brussels, Belgium
| | | | - A van der Walt
- Department of Medicine, University of Melbourne, Melbourne, VIC.,Department of Neurology, Royal Melbourne Hospital, Melbourne, VIC.,Department of Neuroscience, Central Clinical School Alfred Hospital, Monash University, Melbourne, VIC
| | - H Butzkueven
- Department of Medicine, University of Melbourne, Melbourne, VIC.,Department of Neurology, Royal Melbourne Hospital, Melbourne, VIC.,Department of Neuroscience, Central Clinical School Alfred Hospital, Monash University, Melbourne, VIC.,Department of Neurology, Box Hill Hospital, Monash University, Melbourne, VIC
| | - L Kappos
- Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, Neurologic Clinic and Policlinic, University Hospital and University of Basel, Basel, Switzerland
| | - T Kalincik
- Department of Neurology, Royal Melbourne Hospital, Melbourne, VIC.,CORe, Department of Medicine, University of Melbourne, Melbourne, VIC, Australia
| | | |
Collapse
|
34
|
Ramasamy A, Ng J, Foin N, Girard M, Dijkstra J, Zanchin T, Crake T, Torii R, Rakhit R, Serruys PW, Raber L, Baumbach A, Mathur A, Bourantas CV. P6496Advantages and limitations of the attenuation-compensated technique in assessing plaque and neointima morphology in optical coherence tomography. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p6496] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- A Ramasamy
- Barts Health NHS Trust, Department of Cardiology, London, United Kingdom
| | - J Ng
- National University of Singapore, National Heart Centre and Department of Biomedical Engineering, Singapore, Singapore
| | - N Foin
- National University of Singapore, National Heart Centre and Duke-NUS Medical School, Singapore, Singapore
| | - M Girard
- National University of Singapore, National Heart Centre and Duke-NUS Medical School, Singapore, Singapore
| | - J Dijkstra
- Leiden University Medical Center, Department of Radiology, Leiden, Netherlands
| | - T Zanchin
- Bern University Hospital, Department of Cardiology, Bern, Switzerland
| | - T Crake
- University College London, Department of Cardiology, London, United Kingdom
| | - R Torii
- University College London, Department of Mechanical Engineering, London, United Kingdom
| | - R Rakhit
- Royal Free Hospital, UCL Institute of Cardiovascular Science, London, United Kingdom
| | - P W Serruys
- Imperial College London, International Centre for Circulatory Health, NHLI, London, United Kingdom
| | - L Raber
- Bern University Hospital, Department of Cardiology, Bern, Switzerland
| | - A Baumbach
- Barts Health NHS Trust, Department of Cardiology, London, United Kingdom
| | - A Mathur
- Barts Health NHS Trust, Department of Cardiology, London, United Kingdom
| | - C V Bourantas
- Barts Health NHS Trust, Department of Cardiology, London, United Kingdom
| |
Collapse
|
35
|
Adamczyk L, Adams JR, Adkins JK, Agakishiev G, Aggarwal MM, Ahammed Z, Ajitanand NN, Alekseev I, Anderson DM, Aoyama R, Aparin A, Arkhipkin D, Aschenauer EC, Ashraf MU, Attri A, Averichev GS, Bai X, Bairathi V, Barish K, Behera A, Bellwied R, Bhasin A, Bhati AK, Bhattarai P, Bielcik J, Bielcikova J, Bland LC, Bordyuzhin IG, Bouchet J, Brandenburg JD, Brandin AV, Brown D, Bunzarov I, Butterworth J, Caines H, Calderón de la Barca Sánchez M, Campbell JM, Cebra D, Chakaberia I, Chaloupka P, Chang Z, Chankova-Bunzarova N, Chatterjee A, Chattopadhyay S, Chen JH, Chen X, Chen X, Cheng J, Cherney M, Christie W, Contin G, Crawford HJ, Das S, De Silva LC, Debbe RR, Dedovich TG, Deng J, Derevschikov AA, Didenko L, Dilks C, Dong X, Drachenberg JL, Draper JE, Dunkelberger LE, Dunlop JC, Efimov LG, Elsey N, Engelage J, Eppley G, Esha R, Esumi S, Evdokimov O, Ewigleben J, Eyser O, Fatemi R, Fazio S, Federic P, Federicova P, Fedorisin J, Feng Z, Filip P, Finch E, Fisyak Y, Flores CE, Fujita J, Fulek L, Gagliardi CA, Garand D, Geurts F, Gibson A, Girard M, Grosnick D, Gunarathne DS, Guo Y, Gupta S, Gupta A, Guryn W, Hamad AI, Hamed A, Harlenderova A, Harris JW, He L, Heppelmann S, Heppelmann S, Hirsch A, Hoffmann GW, Horvat S, Huang X, Huang HZ, Huang T, Huang B, Humanic TJ, Huo P, Igo G, Jacobs WW, Jentsch A, Jia J, Jiang K, Jowzaee S, Judd EG, Kabana S, Kalinkin D, Kang K, Kapukchyan D, Kauder K, Ke HW, Keane D, Kechechyan A, Khan Z, Kikoła DP, Kim C, Kisel I, Kisiel A, Kochenda L, Kocmanek M, Kollegger T, Kosarzewski LK, Kraishan AF, Krauth L, Kravtsov P, Krueger K, Kulathunga N, Kumar L, Kvapil J, Kwasizur JH, Lacey R, Landgraf JM, Landry KD, Lauret J, Lebedev A, Lednicky R, Lee JH, Li C, Li W, Li Y, Li X, Lidrych J, Lin T, Lisa MA, Liu P, Liu F, Liu H, Liu Y, Ljubicic T, Llope WJ, Lomnitz M, Longacre RS, Luo X, Luo S, Ma GL, Ma L, Ma YG, Ma R, Magdy N, Majka R, Mallick D, Margetis S, Markert C, Matis HS, Meehan K, Mei JC, Miller ZW, Minaev NG, Mioduszewski S, Mishra D, Mizuno S, Mohanty B, Mondal MM, Morozov DA, Mustafa MK, Nasim M, Nayak TK, Nelson JM, Nie M, Nigmatkulov G, Niida T, Nogach LV, Nonaka T, Nurushev SB, Odyniec G, Ogawa A, Oh K, Okorokov VA, Olvitt D, Page BS, Pak R, Pandit Y, Panebratsev Y, Pawlik B, Pei H, Perkins C, Pile P, Pluta J, Poniatowska K, Porter J, Posik M, Pruthi NK, Przybycien M, Putschke J, Qiu H, Quintero A, Ramachandran S, Ray RL, Reed R, Rehbein MJ, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Roth JD, Ruan L, Rusnak J, Rusnakova O, Sahoo NR, Sahu PK, Salur S, Sandweiss J, Sangaline E, Saur M, Schambach J, Schmah AM, Schmidke WB, Schmitz N, Schweid BR, Seger J, Sergeeva M, Seto R, Seyboth P, Shah N, Shahaliev E, Shanmuganathan PV, Shao M, Sharma MK, Sharma A, Shen WQ, Shi Z, Shi SS, Shou QY, Sichtermann EP, Sikora R, Simko M, Singha S, Skoby MJ, Smirnov D, Smirnov N, Solyst W, Song L, Sorensen P, Spinka HM, Srivastava B, Stanislaus TDS, Strikhanov M, Stringfellow B, Sugiura T, Sumbera M, Summa B, Sun XM, Sun Y, Sun X, Surrow B, Svirida DN, Tang AH, Tang Z, Taranenko A, Tarnowsky T, Tawfik A, Thäder J, Thomas JH, Timmins AR, Tlusty D, Todoroki T, Tokarev M, Trentalange S, Tribble RE, Tribedy P, Tripathy SK, Trzeciak BA, Tsai OD, Ullrich T, Underwood DG, Upsal I, Van Buren G, van Nieuwenhuizen G, Vasiliev AN, Videbæk F, Vokal S, Voloshin SA, Vossen A, Wang F, Wang Y, Wang G, Wang Y, Webb JC, Webb G, Wen L, Westfall GD, Wieman H, Wissink SW, Witt R, Wu Y, Xiao ZG, Xie G, Xie W, Xu Z, Xu N, Xu YF, Xu QH, Xu J, Yang Q, Yang C, Yang S, Yang Y, Ye Z, Ye Z, Yi L, Yip K, Yoo IK, Yu N, Zbroszczyk H, Zha W, Zhang XP, Zhang S, Zhang JB, Zhang J, Zhang Z, Zhang S, Zhang J, Zhang Y, Zhao J, Zhong C, Zhou L, Zhou C, Zhu Z, Zhu X, Zyzak M. Beam Energy Dependence of Jet-Quenching Effects in Au+Au Collisions at sqrt[s_{NN}]=7.7, 11.5, 14.5, 19.6, 27, 39, and 62.4 GeV. Phys Rev Lett 2018; 121:032301. [PMID: 30085817 DOI: 10.1103/physrevlett.121.032301] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/11/2017] [Revised: 03/29/2018] [Indexed: 06/08/2023]
Abstract
We report measurements of the nuclear modification factor R_{CP} for charged hadrons as well as identified π^{+(-)}, K^{+(-)}, and p(p[over ¯]) for Au+Au collision energies of sqrt[s_{NN}]=7.7, 11.5, 14.5, 19.6, 27, 39, and 62.4 GeV. We observe a clear high-p_{T} net suppression in central collisions at 62.4 GeV for charged hadrons which evolves smoothly to a large net enhancement at lower energies. This trend is driven by the evolution of the pion spectra but is also very similar for the kaon spectra. While the magnitude of the proton R_{CP} at high p_{T} does depend on the collision energy, neither the proton nor the antiproton R_{CP} at high p_{T} exhibit net suppression at any energy. A study of how the binary collision-scaled high-p_{T} yield evolves with centrality reveals a nonmonotonic shape that is consistent with the idea that jet quenching is increasing faster than the combined phenomena that lead to enhancement.
Collapse
Affiliation(s)
- L Adamczyk
- AGH University of Science and Technology, FPACS, Cracow 30-059, Poland
| | - J R Adams
- Ohio State University, Columbus, Ohio 43210, USA
| | - J K Adkins
- University of Kentucky, Lexington, Kentucky 40506-0055, USA
| | - G Agakishiev
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | | | - Z Ahammed
- Variable Energy Cyclotron Centre, Kolkata 700064, India
| | - N N Ajitanand
- State University of New York, Stony Brook, New York 11794, USA
| | - I Alekseev
- Alikhanov Institute for Theoretical and Experimental Physics, Moscow 117218, Russia
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - D M Anderson
- Texas A&M University, College Station, Texas 77843, USA
| | - R Aoyama
- University of Tsukuba, Tsukuba, Ibaraki 305-8571, Japan
| | - A Aparin
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | - D Arkhipkin
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - E C Aschenauer
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - M U Ashraf
- Tsinghua University, Beijing 100084, China
| | - A Attri
- Panjab University, Chandigarh 160014, India
| | - G S Averichev
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | - X Bai
- Central China Normal University, Wuhan, Hubei 430079, China
| | - V Bairathi
- National Institute of Science Education and Research, HBNI, Jatni 752050, India
| | - K Barish
- University of California, Riverside, California 92521, USA
| | - A Behera
- State University of New York, Stony Brook, New York 11794, USA
| | - R Bellwied
- University of Houston, Houston, Texas 77204, USA
| | - A Bhasin
- University of Jammu, Jammu 180001, India
| | - A K Bhati
- Panjab University, Chandigarh 160014, India
| | - P Bhattarai
- University of Texas, Austin, Texas 78712, USA
| | - J Bielcik
- Czech Technical University in Prague, FNSPE, Prague, 115 19, Czech Republic
| | - J Bielcikova
- Nuclear Physics Institute AS CR, Prague, 250 68, Czech Republic
| | - L C Bland
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - I G Bordyuzhin
- Alikhanov Institute for Theoretical and Experimental Physics, Moscow 117218, Russia
| | - J Bouchet
- Kent State University, Kent, Ohio 44242, USA
| | | | - A V Brandin
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - D Brown
- Lehigh University, Bethlehem, Pennsylvania 18015, USA
| | - I Bunzarov
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | | | - H Caines
- Yale University, New Haven, Connecticut 06520, USA
| | | | - J M Campbell
- Ohio State University, Columbus, Ohio 43210, USA
| | - D Cebra
- University of California, Davis, California 95616, USA
| | - I Chakaberia
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - P Chaloupka
- Czech Technical University in Prague, FNSPE, Prague, 115 19, Czech Republic
| | - Z Chang
- Texas A&M University, College Station, Texas 77843, USA
| | | | - A Chatterjee
- Variable Energy Cyclotron Centre, Kolkata 700064, India
| | | | - J H Chen
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - X Chen
- Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 730000, China
| | - X Chen
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - J Cheng
- Tsinghua University, Beijing 100084, China
| | - M Cherney
- Creighton University, Omaha, Nebraska 68178, USA
| | - W Christie
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - G Contin
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - H J Crawford
- University of California, Berkeley, California 94720, USA
| | - S Das
- Central China Normal University, Wuhan, Hubei 430079, China
| | - L C De Silva
- Creighton University, Omaha, Nebraska 68178, USA
| | - R R Debbe
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - T G Dedovich
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | - J Deng
- Shandong University, Jinan, Shandong 250100, China
| | | | - L Didenko
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - C Dilks
- Pennsylvania State University, University Park, Pennsylvania 16802, USA
| | - X Dong
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - J L Drachenberg
- Lamar University, Physics Department, Beaumont, Texas 77710, USA
| | - J E Draper
- University of California, Davis, California 95616, USA
| | | | - J C Dunlop
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - L G Efimov
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | - N Elsey
- Wayne State University, Detroit, Michigan 48201, USA
| | - J Engelage
- University of California, Berkeley, California 94720, USA
| | - G Eppley
- Rice University, Houston, Texas 77251, USA
| | - R Esha
- University of California, Los Angeles, California 90095, USA
| | - S Esumi
- University of Tsukuba, Tsukuba, Ibaraki 305-8571, Japan
| | - O Evdokimov
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - J Ewigleben
- Lehigh University, Bethlehem, Pennsylvania 18015, USA
| | - O Eyser
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - R Fatemi
- University of Kentucky, Lexington, Kentucky 40506-0055, USA
| | - S Fazio
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - P Federic
- Nuclear Physics Institute AS CR, Prague, 250 68, Czech Republic
| | - P Federicova
- Czech Technical University in Prague, FNSPE, Prague, 115 19, Czech Republic
| | - J Fedorisin
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | - Z Feng
- Central China Normal University, Wuhan, Hubei 430079, China
| | - P Filip
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | - E Finch
- Southern Connecticut State University, New Haven, Connecticut 06515, USA
| | - Y Fisyak
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - C E Flores
- University of California, Davis, California 95616, USA
| | - J Fujita
- Creighton University, Omaha, Nebraska 68178, USA
| | - L Fulek
- AGH University of Science and Technology, FPACS, Cracow 30-059, Poland
| | - C A Gagliardi
- Texas A&M University, College Station, Texas 77843, USA
| | - D Garand
- Purdue University, West Lafayette, Indiana 47907, USA
| | - F Geurts
- Rice University, Houston, Texas 77251, USA
| | - A Gibson
- Valparaiso University, Valparaiso, Indiana 46383, USA
| | - M Girard
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - D Grosnick
- Valparaiso University, Valparaiso, Indiana 46383, USA
| | - D S Gunarathne
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - Y Guo
- Kent State University, Kent, Ohio 44242, USA
| | - S Gupta
- University of Jammu, Jammu 180001, India
| | - A Gupta
- University of Jammu, Jammu 180001, India
| | - W Guryn
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - A I Hamad
- Kent State University, Kent, Ohio 44242, USA
| | - A Hamed
- Texas A&M University, College Station, Texas 77843, USA
| | - A Harlenderova
- Czech Technical University in Prague, FNSPE, Prague, 115 19, Czech Republic
| | - J W Harris
- Yale University, New Haven, Connecticut 06520, USA
| | - L He
- Purdue University, West Lafayette, Indiana 47907, USA
| | - S Heppelmann
- University of California, Davis, California 95616, USA
| | - S Heppelmann
- Pennsylvania State University, University Park, Pennsylvania 16802, USA
| | - A Hirsch
- Purdue University, West Lafayette, Indiana 47907, USA
| | | | - S Horvat
- Yale University, New Haven, Connecticut 06520, USA
| | - X Huang
- Tsinghua University, Beijing 100084, China
| | - H Z Huang
- University of California, Los Angeles, California 90095, USA
| | - T Huang
- National Cheng Kung University, Tainan 70101, Taiwan
| | - B Huang
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - T J Humanic
- Ohio State University, Columbus, Ohio 43210, USA
| | - P Huo
- State University of New York, Stony Brook, New York 11794, USA
| | - G Igo
- University of California, Los Angeles, California 90095, USA
| | - W W Jacobs
- Indiana University, Bloomington, Indiana 47408, USA
| | - A Jentsch
- University of Texas, Austin, Texas 78712, USA
| | - J Jia
- Brookhaven National Laboratory, Upton, New York 11973, USA
- State University of New York, Stony Brook, New York 11794, USA
| | - K Jiang
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - S Jowzaee
- Wayne State University, Detroit, Michigan 48201, USA
| | - E G Judd
- University of California, Berkeley, California 94720, USA
| | - S Kabana
- Kent State University, Kent, Ohio 44242, USA
| | - D Kalinkin
- Indiana University, Bloomington, Indiana 47408, USA
| | - K Kang
- Tsinghua University, Beijing 100084, China
| | - D Kapukchyan
- University of California, Riverside, California 92521, USA
| | - K Kauder
- Wayne State University, Detroit, Michigan 48201, USA
| | - H W Ke
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - D Keane
- Kent State University, Kent, Ohio 44242, USA
| | - A Kechechyan
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | - Z Khan
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - D P Kikoła
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - C Kim
- University of California, Riverside, California 92521, USA
| | - I Kisel
- Frankfurt Institute for Advanced Studies FIAS, Frankfurt 60438, Germany
| | - A Kisiel
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - L Kochenda
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - M Kocmanek
- Nuclear Physics Institute AS CR, Prague, 250 68, Czech Republic
| | - T Kollegger
- Frankfurt Institute for Advanced Studies FIAS, Frankfurt 60438, Germany
| | | | - A F Kraishan
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - L Krauth
- University of California, Riverside, California 92521, USA
| | - P Kravtsov
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - K Krueger
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - N Kulathunga
- University of Houston, Houston, Texas 77204, USA
| | - L Kumar
- Panjab University, Chandigarh 160014, India
| | - J Kvapil
- Czech Technical University in Prague, FNSPE, Prague, 115 19, Czech Republic
| | - J H Kwasizur
- Indiana University, Bloomington, Indiana 47408, USA
| | - R Lacey
- State University of New York, Stony Brook, New York 11794, USA
| | - J M Landgraf
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - K D Landry
- University of California, Los Angeles, California 90095, USA
| | - J Lauret
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - A Lebedev
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - R Lednicky
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | - J H Lee
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - C Li
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - W Li
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - Y Li
- Tsinghua University, Beijing 100084, China
| | - X Li
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - J Lidrych
- Czech Technical University in Prague, FNSPE, Prague, 115 19, Czech Republic
| | - T Lin
- Indiana University, Bloomington, Indiana 47408, USA
| | - M A Lisa
- Ohio State University, Columbus, Ohio 43210, USA
| | - P Liu
- State University of New York, Stony Brook, New York 11794, USA
| | - F Liu
- Central China Normal University, Wuhan, Hubei 430079, China
| | - H Liu
- Indiana University, Bloomington, Indiana 47408, USA
| | - Y Liu
- Texas A&M University, College Station, Texas 77843, USA
| | - T Ljubicic
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - W J Llope
- Wayne State University, Detroit, Michigan 48201, USA
| | - M Lomnitz
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - R S Longacre
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - X Luo
- Central China Normal University, Wuhan, Hubei 430079, China
| | - S Luo
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - G L Ma
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - L Ma
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - Y G Ma
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - R Ma
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - N Magdy
- State University of New York, Stony Brook, New York 11794, USA
| | - R Majka
- Yale University, New Haven, Connecticut 06520, USA
| | - D Mallick
- National Institute of Science Education and Research, HBNI, Jatni 752050, India
| | - S Margetis
- Kent State University, Kent, Ohio 44242, USA
| | - C Markert
- University of Texas, Austin, Texas 78712, USA
| | - H S Matis
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - K Meehan
- University of California, Davis, California 95616, USA
| | - J C Mei
- Shandong University, Jinan, Shandong 250100, China
| | - Z W Miller
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - N G Minaev
- Institute of High Energy Physics, Protvino 142281, Russia
| | | | - D Mishra
- National Institute of Science Education and Research, HBNI, Jatni 752050, India
| | - S Mizuno
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - B Mohanty
- National Institute of Science Education and Research, HBNI, Jatni 752050, India
| | - M M Mondal
- Institute of Physics, Bhubaneswar 751005, India
| | - D A Morozov
- Institute of High Energy Physics, Protvino 142281, Russia
| | - M K Mustafa
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - Md Nasim
- University of California, Los Angeles, California 90095, USA
| | - T K Nayak
- Variable Energy Cyclotron Centre, Kolkata 700064, India
| | - J M Nelson
- University of California, Berkeley, California 94720, USA
| | - M Nie
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - G Nigmatkulov
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - T Niida
- Wayne State University, Detroit, Michigan 48201, USA
| | - L V Nogach
- Institute of High Energy Physics, Protvino 142281, Russia
| | - T Nonaka
- University of Tsukuba, Tsukuba, Ibaraki 305-8571, Japan
| | - S B Nurushev
- Institute of High Energy Physics, Protvino 142281, Russia
| | - G Odyniec
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - A Ogawa
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - K Oh
- Pusan National University, Pusan 46241, Korea
| | - V A Okorokov
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - D Olvitt
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - B S Page
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - R Pak
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - Y Pandit
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - Y Panebratsev
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | - B Pawlik
- Institute of Nuclear Physics PAN, Cracow 31-342, Poland
| | - H Pei
- Central China Normal University, Wuhan, Hubei 430079, China
| | - C Perkins
- University of California, Berkeley, California 94720, USA
| | - P Pile
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - J Pluta
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - K Poniatowska
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - J Porter
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - M Posik
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - N K Pruthi
- Panjab University, Chandigarh 160014, India
| | - M Przybycien
- AGH University of Science and Technology, FPACS, Cracow 30-059, Poland
| | - J Putschke
- Wayne State University, Detroit, Michigan 48201, USA
| | - H Qiu
- Purdue University, West Lafayette, Indiana 47907, USA
| | - A Quintero
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - S Ramachandran
- University of Kentucky, Lexington, Kentucky 40506-0055, USA
| | - R L Ray
- University of Texas, Austin, Texas 78712, USA
| | - R Reed
- Lehigh University, Bethlehem, Pennsylvania 18015, USA
| | - M J Rehbein
- Creighton University, Omaha, Nebraska 68178, USA
| | - H G Ritter
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | | | | | - J L Romero
- University of California, Davis, California 95616, USA
| | - J D Roth
- Creighton University, Omaha, Nebraska 68178, USA
| | - L Ruan
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - J Rusnak
- Nuclear Physics Institute AS CR, Prague, 250 68, Czech Republic
| | - O Rusnakova
- Czech Technical University in Prague, FNSPE, Prague, 115 19, Czech Republic
| | - N R Sahoo
- Texas A&M University, College Station, Texas 77843, USA
| | - P K Sahu
- Institute of Physics, Bhubaneswar 751005, India
| | - S Salur
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - J Sandweiss
- Yale University, New Haven, Connecticut 06520, USA
| | - E Sangaline
- University of California, Davis, California 95616, USA
| | - M Saur
- Nuclear Physics Institute AS CR, Prague, 250 68, Czech Republic
| | - J Schambach
- University of Texas, Austin, Texas 78712, USA
| | - A M Schmah
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - W B Schmidke
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - N Schmitz
- Max-Planck-Institut fur Physik, Munich 80805, Germany
| | - B R Schweid
- State University of New York, Stony Brook, New York 11794, USA
| | - J Seger
- Creighton University, Omaha, Nebraska 68178, USA
| | - M Sergeeva
- University of California, Los Angeles, California 90095, USA
| | - R Seto
- University of California, Riverside, California 92521, USA
| | - P Seyboth
- Max-Planck-Institut fur Physik, Munich 80805, Germany
| | - N Shah
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - E Shahaliev
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | | | - M Shao
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - M K Sharma
- University of Jammu, Jammu 180001, India
| | - A Sharma
- University of Jammu, Jammu 180001, India
| | - W Q Shen
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - Z Shi
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - S S Shi
- Central China Normal University, Wuhan, Hubei 430079, China
| | - Q Y Shou
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - E P Sichtermann
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - R Sikora
- AGH University of Science and Technology, FPACS, Cracow 30-059, Poland
| | - M Simko
- Nuclear Physics Institute AS CR, Prague, 250 68, Czech Republic
| | - S Singha
- Kent State University, Kent, Ohio 44242, USA
| | - M J Skoby
- Indiana University, Bloomington, Indiana 47408, USA
| | - D Smirnov
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - N Smirnov
- Yale University, New Haven, Connecticut 06520, USA
| | - W Solyst
- Indiana University, Bloomington, Indiana 47408, USA
| | - L Song
- University of Houston, Houston, Texas 77204, USA
| | - P Sorensen
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - H M Spinka
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - B Srivastava
- Purdue University, West Lafayette, Indiana 47907, USA
| | | | - M Strikhanov
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | | | - T Sugiura
- University of Tsukuba, Tsukuba, Ibaraki 305-8571, Japan
| | - M Sumbera
- Nuclear Physics Institute AS CR, Prague, 250 68, Czech Republic
| | - B Summa
- Pennsylvania State University, University Park, Pennsylvania 16802, USA
| | - X M Sun
- Central China Normal University, Wuhan, Hubei 430079, China
| | - Y Sun
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - X Sun
- Central China Normal University, Wuhan, Hubei 430079, China
| | - B Surrow
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - D N Svirida
- Alikhanov Institute for Theoretical and Experimental Physics, Moscow 117218, Russia
| | - A H Tang
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - Z Tang
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - A Taranenko
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - T Tarnowsky
- Michigan State University, East Lansing, Michigan 48824, USA
| | - A Tawfik
- World Laboratory for Cosmology and Particle Physics (WLCAPP), Cairo 11571, Egypt
| | - J Thäder
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - J H Thomas
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - A R Timmins
- University of Houston, Houston, Texas 77204, USA
| | - D Tlusty
- Rice University, Houston, Texas 77251, USA
| | - T Todoroki
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - M Tokarev
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | - S Trentalange
- University of California, Los Angeles, California 90095, USA
| | - R E Tribble
- Texas A&M University, College Station, Texas 77843, USA
| | - P Tribedy
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | | | - B A Trzeciak
- Czech Technical University in Prague, FNSPE, Prague, 115 19, Czech Republic
| | - O D Tsai
- University of California, Los Angeles, California 90095, USA
| | - T Ullrich
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - D G Underwood
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - I Upsal
- Ohio State University, Columbus, Ohio 43210, USA
| | - G Van Buren
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | | | - A N Vasiliev
- Institute of High Energy Physics, Protvino 142281, Russia
| | - F Videbæk
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - S Vokal
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | - S A Voloshin
- Wayne State University, Detroit, Michigan 48201, USA
| | - A Vossen
- Indiana University, Bloomington, Indiana 47408, USA
| | - F Wang
- Purdue University, West Lafayette, Indiana 47907, USA
| | - Y Wang
- Central China Normal University, Wuhan, Hubei 430079, China
| | - G Wang
- University of California, Los Angeles, California 90095, USA
| | - Y Wang
- Tsinghua University, Beijing 100084, China
| | - J C Webb
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - G Webb
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - L Wen
- University of California, Los Angeles, California 90095, USA
| | - G D Westfall
- Michigan State University, East Lansing, Michigan 48824, USA
| | - H Wieman
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - S W Wissink
- Indiana University, Bloomington, Indiana 47408, USA
| | - R Witt
- United States Naval Academy, Annapolis, Maryland 21402, USA
| | - Y Wu
- Kent State University, Kent, Ohio 44242, USA
| | - Z G Xiao
- Tsinghua University, Beijing 100084, China
| | - G Xie
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - W Xie
- Purdue University, West Lafayette, Indiana 47907, USA
| | - Z Xu
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - N Xu
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - Y F Xu
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - Q H Xu
- Shandong University, Jinan, Shandong 250100, China
| | - J Xu
- Central China Normal University, Wuhan, Hubei 430079, China
| | - Q Yang
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - C Yang
- Shandong University, Jinan, Shandong 250100, China
| | - S Yang
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - Y Yang
- National Cheng Kung University, Tainan 70101, Taiwan
| | - Z Ye
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - Z Ye
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - L Yi
- Yale University, New Haven, Connecticut 06520, USA
| | - K Yip
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - I-K Yoo
- Pusan National University, Pusan 46241, Korea
| | - N Yu
- Central China Normal University, Wuhan, Hubei 430079, China
| | - H Zbroszczyk
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - W Zha
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - X P Zhang
- Tsinghua University, Beijing 100084, China
| | - S Zhang
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - J B Zhang
- Central China Normal University, Wuhan, Hubei 430079, China
| | - J Zhang
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - Z Zhang
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - S Zhang
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - J Zhang
- Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 730000, China
| | - Y Zhang
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - J Zhao
- Purdue University, West Lafayette, Indiana 47907, USA
| | - C Zhong
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - L Zhou
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - C Zhou
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - Z Zhu
- Shandong University, Jinan, Shandong 250100, China
| | - X Zhu
- Tsinghua University, Beijing 100084, China
| | - M Zyzak
- Frankfurt Institute for Advanced Studies FIAS, Frankfurt 60438, Germany
| |
Collapse
|
36
|
Girard M, Poujois A, Fabre M, Lacaille F, Debray D, Rio M, Fenaille F, Cholet S, Ruel C, Caussé E, Selves J, Bridoux-Henno L, Woimant F, Dupré T, Vuillaumier-Barrot S, Seta N, Alric L, de Lonlay P, Bruneel A. CCDC115-CDG: A new rare and misleading inherited cause of liver disease. Mol Genet Metab 2018; 124:228-235. [PMID: 29759592 DOI: 10.1016/j.ymgme.2018.05.002] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/19/2018] [Revised: 05/07/2018] [Accepted: 05/07/2018] [Indexed: 01/06/2023]
Abstract
Congenital disorders of glycosylation (CDG) linked to defects in Golgi apparatus homeostasis constitute an increasing part of these rare inherited diseases. Among them, COG-CDG, ATP6V0A2-CDG, TMEM199-CDG and CCDC115-CDG have been shown to disturb Golgi vesicular trafficking and/or lumen pH acidification. Here, we report 3 new unrelated cases of CCDC115-CDG with emphasis on diagnosis difficulties related to strong phenotypic similarities with mitochondriopathies, Niemann-Pick disease C and Wilson Disease. Indeed, while two individuals clinically presented with early and severe liver fibrosis and cirrhosis associated with neurological symptoms, the other one "only" showed isolated and late severe liver involvement. Biological results were similar to previously described patients, including hypercholesterolemia, elevated alkaline phosphatases and defects in copper metabolism. CDG screening and glycosylation study finally led to the molecular diagnosis of CCDC115-CDG. Besides pointing to the importance of CDG screening in patients with unexplained and severe liver disease, these reports expand the clinical and molecular phenotypes of CCDC115-CDG. The hepatic involvement is particularly addressed. Furthermore, hypothesis concerning the pathogenesis of the liver disease and of major biological abnormalities are proposed.
Collapse
Affiliation(s)
- Muriel Girard
- AP-HP, Necker University Hospital, Hepatology and Gastroenterology Unit, French National Reference Centre for Biliary Atresia and Genetic Cholestasis, France; Paris Descartes University, France
| | - Aurélia Poujois
- AP-HP, French National Reference Centre for Wilson Disease, Neurology Department, Lariboisière Hospital, Paris, France
| | - Monique Fabre
- AP-HP, Necker University Hospital, Department of Pathology, Paris, France
| | - Florence Lacaille
- AP-HP, Necker University Hospital, Hepatology and Gastroenterology Unit, French National Reference Centre for Biliary Atresia and Genetic Cholestasis, France
| | - Dominique Debray
- AP-HP, Necker University Hospital, Hepatology and Gastroenterology Unit, French National Reference Centre for Biliary Atresia and Genetic Cholestasis, France
| | - Marlène Rio
- AP-HP, Necker University Hospital, Department of Genetics, Paris, France
| | - François Fenaille
- Service de Pharmacologie et d'Immunoanalyse (SPI), Laboratoire d'Etude du Métabolisme des Médicaments, CEA, INRA, Université Paris Saclay, MetaboHUB, F-91191 Gif-sur-Yvette, France
| | - Sophie Cholet
- Service de Pharmacologie et d'Immunoanalyse (SPI), Laboratoire d'Etude du Métabolisme des Médicaments, CEA, INRA, Université Paris Saclay, MetaboHUB, F-91191 Gif-sur-Yvette, France
| | - Coralie Ruel
- Service de Pharmacologie et d'Immunoanalyse (SPI), Laboratoire d'Etude du Métabolisme des Médicaments, CEA, INRA, Université Paris Saclay, MetaboHUB, F-91191 Gif-sur-Yvette, France; Institut Galien Paris-Sud, UMR CNRS 8612, Proteins and Nanotechnology in Analytical Science (PNAS), Université Paris-Sud, Châtenay-Malabry, France
| | | | - Janick Selves
- Department of Pathology, University Hospital Toulouse, Paul Sabatier University, Toulouse, France
| | | | - France Woimant
- AP-HP, French National Reference Centre for Wilson Disease, Neurology Department, Lariboisière Hospital, Paris, France
| | - Thierry Dupré
- AP-HP, Bichat University Hospital, Biochemistry, Paris, France
| | | | - Nathalie Seta
- AP-HP, Bichat University Hospital, Biochemistry, Paris, France; Paris Descartes University, France
| | - Laurent Alric
- Internal Medicine-Digestive Department CHU Purpan, UMR152 IRD Toulouse 3 University, France
| | - Pascale de Lonlay
- AP-HP, Necker University Hospital, French National Reference Centre for Inborn Errors of Metabolism, Paris, France
| | - Arnaud Bruneel
- AP-HP, Bichat University Hospital, Biochemistry, Paris, France; INSERM UMR-1193 "Mécanismes cellulaires et moléculaires de l'adaptation au stress et cancérogenèse", Université Paris-Sud, Châtenay-Malabry, France.
| |
Collapse
|
37
|
Bartsch N, Girard M, Schneider L, Weijgert VVD, Wilde A, Kappenstein O, Vieth B, Hutzler C, Luch A. Chemical stabilization of polymers: Implications for dermal exposure to additives. J Environ Sci Health A Tox Hazard Subst Environ Eng 2018; 53:405-420. [PMID: 29334019 DOI: 10.1080/10934529.2017.1412192] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Technical benefits of additives in polymers stand in marked contrast to their associated health risks. Here, a multi-analyte method based on gas chromatography coupled to tandem mass spectrometry (GC-MS/MS) was developed to quantify polymer additives in complex matrices such as low-density polyethylene (LDPE) and isolated human skin layers after dermal exposure ex vivo. That way both technical aspects and dermal exposure were investigated. The effects of polymer additivation on the material were studied using the example of LDPE. To this end, a tailor-made polymer was applied in aging studies that had been furnished with two different mixtures of phenol- and diarylamine-based antioxidants, plasticizers and processing aids. Upon accelerated thermo-oxidative aging of the material, the formation of LDPE degradation products was monitored with attenuated total reflectance-Fourier transformed infrared (ATR-FTIR) spectroscopy. Compared to pure LDPE, a protective effect of added antioxidants could be observed on the integrity of the polymer. Further, thermo-oxidative degradation of the additives and its kinetics were investigated using LDPE or squalane as matrix. The half-lives of additives in both matrices revealed significant differences between the tested additives as well as between LDPE and squalane. For instance, 2-tert-butyl-6-[(3-tert-butyl-2-hydroxy-5-methylphenyl)methyl]-4-methylphenol (Antioxidant 2246) showed a half-life 12 times lower when incorporated in LDPE as compared to squalane. As a model for dermal exposure of consumers, human skin was brought into contact with the tailor-made LDPE containing additives ex vivo in static Franz diffusion cells. The skin was then analyzed for additives and decomposition products. This study proved 10 polymer additives of diverse pysicochemical properties and functionalities to migrate out of the polymer and eventually overcome the intact human skin barrier during contact. Moreover, their individual distribution within distinct skin layers was demonstrated. This is exemplified by the penetration of the procarcinogenic antioxidant N-phenylnaphthalen-2-amine (Neozon D) into the viable epidermis and the permeation through the skin of the neurotoxic plasticizer N-butylbenzenesulfonamide (NBBS). In addition, the analyses of additive degradation products in the isolated skin layers revealed the presence of 2-tert-butyl-4-methylphenol in all layers after contact to a polymer with substances of origin like Antioxidant 2246. Thus, attention needs to be paid to absorption of polymer additives together with their degradation products when it comes to dermal exposure assessment.
Collapse
Affiliation(s)
- N Bartsch
- a Department of Chemical and Product Safety , German Federal Institute for Risk Assessment (BfR) , Berlin , Germany
| | - M Girard
- a Department of Chemical and Product Safety , German Federal Institute for Risk Assessment (BfR) , Berlin , Germany
| | - L Schneider
- a Department of Chemical and Product Safety , German Federal Institute for Risk Assessment (BfR) , Berlin , Germany
| | - V Van De Weijgert
- a Department of Chemical and Product Safety , German Federal Institute for Risk Assessment (BfR) , Berlin , Germany
| | - A Wilde
- a Department of Chemical and Product Safety , German Federal Institute for Risk Assessment (BfR) , Berlin , Germany
| | - O Kappenstein
- a Department of Chemical and Product Safety , German Federal Institute for Risk Assessment (BfR) , Berlin , Germany
| | - B Vieth
- a Department of Chemical and Product Safety , German Federal Institute for Risk Assessment (BfR) , Berlin , Germany
| | - C Hutzler
- a Department of Chemical and Product Safety , German Federal Institute for Risk Assessment (BfR) , Berlin , Germany
| | - A Luch
- a Department of Chemical and Product Safety , German Federal Institute for Risk Assessment (BfR) , Berlin , Germany
| |
Collapse
|
38
|
Girard M, Delanghe M, Domingo-Levy L, Zamith-Chavant M. Cas pratique de communication institutionnelle : la sollicitation des psychologues par les soignants de l’IUCT-O. PSYCHO-ONCOLOGIE 2018. [DOI: 10.3166/pson-2018-0028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
39
|
Girard M. Management of Hypertension. J R Soc Med 2018; 84:572. [PMID: 1941869 PMCID: PMC1293440 DOI: 10.1177/014107689108400936] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
40
|
Adamczyk L, Adams JR, Adkins JK, Agakishiev G, Aggarwal MM, Ahammed Z, Ajitanand NN, Alekseev I, Anderson DM, Aoyama R, Aparin A, Arkhipkin D, Aschenauer EC, Ashraf MU, Attri A, Averichev GS, Bai X, Bairathi V, Barish K, Behera A, Bellwied R, Bhasin A, Bhati AK, Bhattarai P, Bielcik J, Bielcikova J, Bland LC, Bordyuzhin IG, Bouchet J, Brandenburg JD, Brandin AV, Brown D, Bunzarov I, Butterworth J, Caines H, Calderón de la Barca Sánchez M, Campbell JM, Cebra D, Chakaberia I, Chaloupka P, Chang Z, Chankova-Bunzarova N, Chatterjee A, Chattopadhyay S, Chen X, Chen JH, Chen X, Cheng J, Cherney M, Christie W, Contin G, Crawford HJ, Das S, De Silva LC, Dedovich TG, Deng J, Derevschikov AA, Didenko L, Dilks C, Dong X, Drachenberg JL, Draper JE, Dunkelberger LE, Dunlop JC, Efimov LG, Elsey N, Engelage J, Eppley G, Esha R, Esumi S, Evdokimov O, Ewigleben J, Eyser O, Fatemi R, Fazio S, Federic P, Federicova P, Fedorisin J, Feng Z, Filip P, Finch E, Fisyak Y, Flores CE, Fujita J, Fulek L, Gagliardi CA, Garand D, Geurts F, Gibson A, Girard M, Grosnick D, Gunarathne DS, Guo Y, Gupta A, Gupta S, Guryn W, Hamad AI, Hamed A, Harlenderova A, Harris JW, He L, Heppelmann S, Heppelmann S, Hirsch A, Horvat S, Huang X, Huang B, Huang T, Huang HZ, Humanic TJ, Huo P, Igo G, Jacobs WW, Jentsch A, Jia J, Jiang K, Jowzaee S, Judd EG, Kabana S, Kalinkin D, Kang K, Kapukchyan D, Kauder K, Ke HW, Keane D, Kechechyan A, Khan Z, Kikoła DP, Kim C, Kisel I, Kisiel A, Kochenda L, Kocmanek M, Kollegger T, Kosarzewski LK, Kraishan AF, Krauth L, Kravtsov P, Krueger K, Kulathunga N, Kumar L, Kvapil J, Kwasizur JH, Lacey R, Landgraf JM, Landry KD, Lauret J, Lebedev A, Lednicky R, Lee JH, Li C, Li X, Li Y, Li W, Lidrych J, Lin T, Lisa MA, Liu P, Liu H, Liu Y, Liu F, Ljubicic T, Llope WJ, Lomnitz M, Longacre RS, Luo S, Luo X, Ma YG, Ma L, Ma R, Ma GL, Magdy N, Majka R, Mallick D, Margetis S, Markert C, Matis HS, Meehan K, Mei JC, Miller ZW, Minaev NG, Mioduszewski S, Mishra D, Mizuno S, Mohanty B, Mondal MM, Morozov DA, Mustafa MK, Nasim M, Nayak TK, Nelson JM, Nie M, Nigmatkulov G, Niida T, Nogach LV, Nonaka T, Nurushev SB, Odyniec G, Ogawa A, Oh K, Okorokov VA, Olvitt D, Page BS, Pak R, Pandit Y, Panebratsev Y, Pawlik B, Pei H, Perkins C, Pile P, Pluta J, Poniatowska K, Porter J, Posik M, Pruthi NK, Przybycien M, Putschke J, Qiu H, Quintero A, Ramachandran S, Ray RL, Reed R, Rehbein MJ, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Roth JD, Ruan L, Rusnak J, Rusnakova O, Sahoo NR, Sahu PK, Salur S, Sandweiss J, Saur M, Schambach J, Schmah AM, Schmidke WB, Schmitz N, Schweid BR, Seger J, Sergeeva M, Seto R, Seyboth P, Shah N, Shahaliev E, Shanmuganathan PV, Shao M, Sharma A, Sharma MK, Shen WQ, Shi SS, Shi Z, Shou QY, Sichtermann EP, Sikora R, Simko M, Singha S, Skoby MJ, Smirnov N, Smirnov D, Solyst W, Song L, Sorensen P, Spinka HM, Srivastava B, Stanislaus TDS, Strikhanov M, Stringfellow B, Suaide AAP, Sugiura T, Sumbera M, Summa B, Sun Y, Sun XM, Sun X, Surrow B, Svirida DN, Tang Z, Tang AH, Taranenko A, Tarnowsky T, Tawfik A, Thäder J, Thomas JH, Timmins AR, Tlusty D, Todoroki T, Tokarev M, Trentalange S, Tribble RE, Tribedy P, Tripathy SK, Trzeciak BA, Tsai OD, Ullrich T, Underwood DG, Upsal I, Van Buren G, van Nieuwenhuizen G, Vasiliev AN, Videbæk F, Vokal S, Voloshin SA, Vossen A, Wang G, Wang Y, Wang F, Wang Y, Webb JC, Webb G, Wen L, Westfall GD, Wieman H, Wissink SW, Witt R, Wu Y, Xiao ZG, Xie G, Xie W, Xu J, Xu Z, Xu QH, Xu YF, Xu N, Yang S, Yang Y, Yang C, Yang Q, Ye Z, Ye Z, Yi L, Yip K, Yoo IK, Yu N, Zbroszczyk H, Zha W, Zhang Z, Zhang JB, Zhang J, Zhang S, Zhang Y, Zhang XP, Zhang J, Zhang S, Zhao J, Zhong C, Zhou C, Zhou L, Zhu X, Zhu Z, Zyzak M. Beam-Energy Dependence of Directed Flow of Λ, Λ[over ¯], K^{±}, K_{s}^{0}, and ϕ in Au+Au Collisions. Phys Rev Lett 2018; 120:062301. [PMID: 29481217 DOI: 10.1103/physrevlett.120.062301] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/24/2017] [Indexed: 06/08/2023]
Abstract
Rapidity-odd directed-flow measurements at midrapidity are presented for Λ, Λ[over ¯], K^{±}, K_{s}^{0}, and ϕ at sqrt[s_{NN}]=7.7, 11.5, 14.5, 19.6, 27, 39, 62.4, and 200 GeV in Au+Au collisions recorded by the Solenoidal Tracker detector at the Relativistic Heavy Ion Collider. These measurements greatly expand the scope of data available to constrain models with differing prescriptions for the equation of state of quantum chromodynamics. Results show good sensitivity for testing a picture where flow is assumed to be imposed before hadron formation and the observed particles are assumed to form via coalescence of constituent quarks. The pattern of departure from a coalescence-inspired sum rule can be a valuable new tool for probing the collision dynamics.
Collapse
Affiliation(s)
- L Adamczyk
- AGH University of Science and Technology, FPACS, Cracow 30-059, Poland
| | - J R Adams
- Ohio State University, Columbus, Ohio 43210
| | - J K Adkins
- University of Kentucky, Lexington, Kentucky 40506-0055
| | - G Agakishiev
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | | | - Z Ahammed
- Variable Energy Cyclotron Centre, Kolkata 700064, India
| | - N N Ajitanand
- State University of New York, Stony Brook, New York 11794
| | - I Alekseev
- Alikhanov Institute for Theoretical and Experimental Physics, Moscow 117218, Russia
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - D M Anderson
- Texas A&M University, College Station, Texas 77843
| | - R Aoyama
- University of Tsukuba, Tsukuba, Ibaraki 305-8571, Japan
| | - A Aparin
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | - D Arkhipkin
- Brookhaven National Laboratory, Upton, New York 11973
| | | | | | - A Attri
- Panjab University, Chandigarh 160014, India
| | - G S Averichev
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | - X Bai
- Central China Normal University, Wuhan, Hubei 430079
| | - V Bairathi
- National Institute of Science Education and Research, HBNI, Jatni 752050, India
| | - K Barish
- University of California, Riverside, California 92521
| | - A Behera
- State University of New York, Stony Brook, New York 11794
| | - R Bellwied
- University of Houston, Houston, Texas 77204
| | - A Bhasin
- University of Jammu, Jammu 180001, India
| | - A K Bhati
- Panjab University, Chandigarh 160014, India
| | | | - J Bielcik
- Czech Technical University in Prague, FNSPE, Prague, 115 19, Czech Republic
| | - J Bielcikova
- Nuclear Physics Institute AS CR, 250 68 Prague, Czech Republic
| | - L C Bland
- Brookhaven National Laboratory, Upton, New York 11973
| | - I G Bordyuzhin
- Alikhanov Institute for Theoretical and Experimental Physics, Moscow 117218, Russia
| | - J Bouchet
- Kent State University, Kent, Ohio 44242
| | | | - A V Brandin
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - D Brown
- Lehigh University, Bethlehem, Pennsylvania 18015
| | - I Bunzarov
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | | | - H Caines
- Yale University, New Haven, Connecticut 06520
| | | | | | - D Cebra
- University of California, Davis, California 95616
| | - I Chakaberia
- Brookhaven National Laboratory, Upton, New York 11973
- Kent State University, Kent, Ohio 44242
- Shandong University, Jinan, Shandong 250100
| | - P Chaloupka
- Czech Technical University in Prague, FNSPE, Prague, 115 19, Czech Republic
| | - Z Chang
- Texas A&M University, College Station, Texas 77843
| | | | - A Chatterjee
- Variable Energy Cyclotron Centre, Kolkata 700064, India
| | | | - X Chen
- University of Science and Technology of China, Hefei, Anhui 230026
| | - J H Chen
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - X Chen
- Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 730000
| | - J Cheng
- Tsinghua University, Beijing 100084
| | - M Cherney
- Creighton University, Omaha, Nebraska 68178
| | - W Christie
- Brookhaven National Laboratory, Upton, New York 11973
| | - G Contin
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - H J Crawford
- University of California, Berkeley, California 94720
| | - S Das
- Central China Normal University, Wuhan, Hubei 430079
| | | | - T G Dedovich
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | - J Deng
- Shandong University, Jinan, Shandong 250100
| | | | - L Didenko
- Brookhaven National Laboratory, Upton, New York 11973
| | - C Dilks
- Pennsylvania State University, University Park, Pennsylvania 16802
| | - X Dong
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | | | - J E Draper
- University of California, Davis, California 95616
| | | | - J C Dunlop
- Brookhaven National Laboratory, Upton, New York 11973
| | - L G Efimov
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | - N Elsey
- Wayne State University, Detroit, Michigan 48201
| | - J Engelage
- University of California, Berkeley, California 94720
| | - G Eppley
- Rice University, Houston, Texas 77251
| | - R Esha
- University of California, Los Angeles, California 90095
| | - S Esumi
- University of Tsukuba, Tsukuba, Ibaraki 305-8571, Japan
| | - O Evdokimov
- University of Illinois at Chicago, Chicago, Illinois 60607
| | - J Ewigleben
- Lehigh University, Bethlehem, Pennsylvania 18015
| | - O Eyser
- Brookhaven National Laboratory, Upton, New York 11973
| | - R Fatemi
- University of Kentucky, Lexington, Kentucky 40506-0055
| | - S Fazio
- Brookhaven National Laboratory, Upton, New York 11973
| | - P Federic
- Nuclear Physics Institute AS CR, 250 68 Prague, Czech Republic
| | - P Federicova
- Czech Technical University in Prague, FNSPE, Prague, 115 19, Czech Republic
| | - J Fedorisin
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | - Z Feng
- Central China Normal University, Wuhan, Hubei 430079
| | - P Filip
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | - E Finch
- Southern Connecticut State University, New Haven, Connecticut 06515
| | - Y Fisyak
- Brookhaven National Laboratory, Upton, New York 11973
| | - C E Flores
- University of California, Davis, California 95616
| | - J Fujita
- Creighton University, Omaha, Nebraska 68178
| | - L Fulek
- AGH University of Science and Technology, FPACS, Cracow 30-059, Poland
| | | | - D Garand
- Purdue University, West Lafayette, Indiana 47907
| | - F Geurts
- Rice University, Houston, Texas 77251
| | - A Gibson
- Valparaiso University, Valparaiso, Indiana 46383
| | - M Girard
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - D Grosnick
- Valparaiso University, Valparaiso, Indiana 46383
| | | | - Y Guo
- Kent State University, Kent, Ohio 44242
| | - A Gupta
- University of Jammu, Jammu 180001, India
| | - S Gupta
- University of Jammu, Jammu 180001, India
| | - W Guryn
- Brookhaven National Laboratory, Upton, New York 11973
| | - A I Hamad
- Kent State University, Kent, Ohio 44242
| | - A Hamed
- Texas A&M University, College Station, Texas 77843
| | - A Harlenderova
- Czech Technical University in Prague, FNSPE, Prague, 115 19, Czech Republic
| | - J W Harris
- Yale University, New Haven, Connecticut 06520
| | - L He
- Purdue University, West Lafayette, Indiana 47907
| | - S Heppelmann
- Pennsylvania State University, University Park, Pennsylvania 16802
| | - S Heppelmann
- University of California, Davis, California 95616
| | - A Hirsch
- Purdue University, West Lafayette, Indiana 47907
| | - S Horvat
- Yale University, New Haven, Connecticut 06520
| | - X Huang
- Tsinghua University, Beijing 100084
| | - B Huang
- University of Illinois at Chicago, Chicago, Illinois 60607
| | - T Huang
- National Cheng Kung University, Tainan 70101
| | - H Z Huang
- University of California, Los Angeles, California 90095
| | | | - P Huo
- State University of New York, Stony Brook, New York 11794
| | - G Igo
- University of California, Los Angeles, California 90095
| | - W W Jacobs
- Indiana University, Bloomington, Indiana 47408
| | - A Jentsch
- University of Texas, Austin, Texas 78712
| | - J Jia
- Brookhaven National Laboratory, Upton, New York 11973
- State University of New York, Stony Brook, New York 11794
| | - K Jiang
- University of Science and Technology of China, Hefei, Anhui 230026
| | - S Jowzaee
- Wayne State University, Detroit, Michigan 48201
| | - E G Judd
- University of California, Berkeley, California 94720
| | - S Kabana
- Kent State University, Kent, Ohio 44242
| | - D Kalinkin
- Indiana University, Bloomington, Indiana 47408
| | - K Kang
- Tsinghua University, Beijing 100084
| | - D Kapukchyan
- University of California, Riverside, California 92521
| | - K Kauder
- Wayne State University, Detroit, Michigan 48201
| | - H W Ke
- Brookhaven National Laboratory, Upton, New York 11973
| | - D Keane
- Kent State University, Kent, Ohio 44242
| | - A Kechechyan
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | - Z Khan
- University of Illinois at Chicago, Chicago, Illinois 60607
| | - D P Kikoła
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - C Kim
- University of California, Riverside, California 92521
| | - I Kisel
- Frankfurt Institute for Advanced Studies FIAS, Frankfurt 60438, Germany
| | - A Kisiel
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - L Kochenda
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - M Kocmanek
- Nuclear Physics Institute AS CR, 250 68 Prague, Czech Republic
| | - T Kollegger
- Frankfurt Institute for Advanced Studies FIAS, Frankfurt 60438, Germany
| | | | - A F Kraishan
- Temple University, Philadelphia, Pennsylvania 19122
| | - L Krauth
- University of California, Riverside, California 92521
| | - P Kravtsov
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - K Krueger
- Argonne National Laboratory, Argonne, Illinois 60439
| | | | - L Kumar
- Panjab University, Chandigarh 160014, India
| | - J Kvapil
- Czech Technical University in Prague, FNSPE, Prague, 115 19, Czech Republic
| | | | - R Lacey
- State University of New York, Stony Brook, New York 11794
| | - J M Landgraf
- Brookhaven National Laboratory, Upton, New York 11973
| | - K D Landry
- University of California, Los Angeles, California 90095
| | - J Lauret
- Brookhaven National Laboratory, Upton, New York 11973
| | - A Lebedev
- Brookhaven National Laboratory, Upton, New York 11973
| | - R Lednicky
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | - J H Lee
- Brookhaven National Laboratory, Upton, New York 11973
| | - C Li
- University of Science and Technology of China, Hefei, Anhui 230026
| | - X Li
- University of Science and Technology of China, Hefei, Anhui 230026
| | - Y Li
- Tsinghua University, Beijing 100084
| | - W Li
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - J Lidrych
- Czech Technical University in Prague, FNSPE, Prague, 115 19, Czech Republic
| | - T Lin
- Indiana University, Bloomington, Indiana 47408
| | - M A Lisa
- Ohio State University, Columbus, Ohio 43210
| | - P Liu
- State University of New York, Stony Brook, New York 11794
| | - H Liu
- Indiana University, Bloomington, Indiana 47408
| | - Y Liu
- Texas A&M University, College Station, Texas 77843
| | - F Liu
- Central China Normal University, Wuhan, Hubei 430079
| | - T Ljubicic
- Brookhaven National Laboratory, Upton, New York 11973
| | - W J Llope
- Wayne State University, Detroit, Michigan 48201
| | - M Lomnitz
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - R S Longacre
- Brookhaven National Laboratory, Upton, New York 11973
| | - S Luo
- University of Illinois at Chicago, Chicago, Illinois 60607
| | - X Luo
- Central China Normal University, Wuhan, Hubei 430079
| | - Y G Ma
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - L Ma
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - R Ma
- Brookhaven National Laboratory, Upton, New York 11973
| | - G L Ma
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - N Magdy
- State University of New York, Stony Brook, New York 11794
| | - R Majka
- Yale University, New Haven, Connecticut 06520
| | - D Mallick
- National Institute of Science Education and Research, HBNI, Jatni 752050, India
| | | | - C Markert
- University of Texas, Austin, Texas 78712
| | - H S Matis
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - K Meehan
- University of California, Davis, California 95616
| | - J C Mei
- Shandong University, Jinan, Shandong 250100
| | - Z W Miller
- University of Illinois at Chicago, Chicago, Illinois 60607
| | - N G Minaev
- Institute of High Energy Physics, Protvino 142281, Russia
| | | | - D Mishra
- National Institute of Science Education and Research, HBNI, Jatni 752050, India
| | - S Mizuno
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - B Mohanty
- National Institute of Science Education and Research, HBNI, Jatni 752050, India
| | - M M Mondal
- Institute of Physics, Bhubaneswar 751005, India
| | - D A Morozov
- Institute of High Energy Physics, Protvino 142281, Russia
| | - M K Mustafa
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - Md Nasim
- University of California, Los Angeles, California 90095
| | - T K Nayak
- Variable Energy Cyclotron Centre, Kolkata 700064, India
| | - J M Nelson
- University of California, Berkeley, California 94720
| | - M Nie
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - G Nigmatkulov
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - T Niida
- Wayne State University, Detroit, Michigan 48201
| | - L V Nogach
- Institute of High Energy Physics, Protvino 142281, Russia
| | - T Nonaka
- University of Tsukuba, Tsukuba, Ibaraki 305-8571, Japan
| | - S B Nurushev
- Institute of High Energy Physics, Protvino 142281, Russia
| | - G Odyniec
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - A Ogawa
- Brookhaven National Laboratory, Upton, New York 11973
| | - K Oh
- Pusan National University, Pusan 46241, Korea
| | - V A Okorokov
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - D Olvitt
- Temple University, Philadelphia, Pennsylvania 19122
| | - B S Page
- Brookhaven National Laboratory, Upton, New York 11973
| | - R Pak
- Brookhaven National Laboratory, Upton, New York 11973
| | - Y Pandit
- University of Illinois at Chicago, Chicago, Illinois 60607
| | - Y Panebratsev
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | - B Pawlik
- Institute of Nuclear Physics PAN, Cracow 31-342, Poland
| | - H Pei
- Central China Normal University, Wuhan, Hubei 430079
| | - C Perkins
- University of California, Berkeley, California 94720
| | - P Pile
- Brookhaven National Laboratory, Upton, New York 11973
| | - J Pluta
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - K Poniatowska
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - J Porter
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - M Posik
- Temple University, Philadelphia, Pennsylvania 19122
| | - N K Pruthi
- Panjab University, Chandigarh 160014, India
| | - M Przybycien
- AGH University of Science and Technology, FPACS, Cracow 30-059, Poland
| | - J Putschke
- Wayne State University, Detroit, Michigan 48201
| | - H Qiu
- Purdue University, West Lafayette, Indiana 47907
| | - A Quintero
- Temple University, Philadelphia, Pennsylvania 19122
| | | | - R L Ray
- University of Texas, Austin, Texas 78712
| | - R Reed
- Lehigh University, Bethlehem, Pennsylvania 18015
| | | | - H G Ritter
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | | | | | - J L Romero
- University of California, Davis, California 95616
| | - J D Roth
- Creighton University, Omaha, Nebraska 68178
| | - L Ruan
- Brookhaven National Laboratory, Upton, New York 11973
| | - J Rusnak
- Nuclear Physics Institute AS CR, 250 68 Prague, Czech Republic
| | - O Rusnakova
- Czech Technical University in Prague, FNSPE, Prague, 115 19, Czech Republic
| | - N R Sahoo
- Texas A&M University, College Station, Texas 77843
| | - P K Sahu
- Institute of Physics, Bhubaneswar 751005, India
| | - S Salur
- Rutgers University, Piscataway, New Jersey 08854
| | - J Sandweiss
- Yale University, New Haven, Connecticut 06520
| | - M Saur
- Nuclear Physics Institute AS CR, 250 68 Prague, Czech Republic
| | | | - A M Schmah
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - W B Schmidke
- Brookhaven National Laboratory, Upton, New York 11973
| | - N Schmitz
- Max-Planck-Institut fur Physik, Munich 80805, Germany
| | - B R Schweid
- State University of New York, Stony Brook, New York 11794
| | - J Seger
- Creighton University, Omaha, Nebraska 68178
| | - M Sergeeva
- University of California, Los Angeles, California 90095
| | - R Seto
- University of California, Riverside, California 92521
| | - P Seyboth
- Max-Planck-Institut fur Physik, Munich 80805, Germany
| | - N Shah
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - E Shahaliev
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | | | - M Shao
- University of Science and Technology of China, Hefei, Anhui 230026
| | - A Sharma
- University of Jammu, Jammu 180001, India
| | - M K Sharma
- University of Jammu, Jammu 180001, India
| | - W Q Shen
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - S S Shi
- Central China Normal University, Wuhan, Hubei 430079
| | - Z Shi
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - Q Y Shou
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - E P Sichtermann
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - R Sikora
- AGH University of Science and Technology, FPACS, Cracow 30-059, Poland
| | - M Simko
- Nuclear Physics Institute AS CR, 250 68 Prague, Czech Republic
| | - S Singha
- Kent State University, Kent, Ohio 44242
| | - M J Skoby
- Indiana University, Bloomington, Indiana 47408
| | - N Smirnov
- Yale University, New Haven, Connecticut 06520
| | - D Smirnov
- Brookhaven National Laboratory, Upton, New York 11973
| | - W Solyst
- Indiana University, Bloomington, Indiana 47408
| | - L Song
- University of Houston, Houston, Texas 77204
| | - P Sorensen
- Brookhaven National Laboratory, Upton, New York 11973
| | - H M Spinka
- Argonne National Laboratory, Argonne, Illinois 60439
| | - B Srivastava
- Purdue University, West Lafayette, Indiana 47907
| | | | - M Strikhanov
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | | | - A A P Suaide
- Universidade de Sao Paulo, Sao Paulo, Brazil, 05314-970
| | - T Sugiura
- University of Tsukuba, Tsukuba, Ibaraki 305-8571, Japan
| | - M Sumbera
- Nuclear Physics Institute AS CR, 250 68 Prague, Czech Republic
| | - B Summa
- Pennsylvania State University, University Park, Pennsylvania 16802
| | - Y Sun
- University of Science and Technology of China, Hefei, Anhui 230026
| | - X M Sun
- Central China Normal University, Wuhan, Hubei 430079
| | - X Sun
- Central China Normal University, Wuhan, Hubei 430079
| | - B Surrow
- Temple University, Philadelphia, Pennsylvania 19122
| | - D N Svirida
- Alikhanov Institute for Theoretical and Experimental Physics, Moscow 117218, Russia
| | - Z Tang
- University of Science and Technology of China, Hefei, Anhui 230026
| | - A H Tang
- Brookhaven National Laboratory, Upton, New York 11973
| | - A Taranenko
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - T Tarnowsky
- Michigan State University, East Lansing, Michigan 48824
| | - A Tawfik
- World Laboratory for Cosmology and Particle Physics (WLCAPP), Cairo 11571, Egypt
| | - J Thäder
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - J H Thomas
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | | | - D Tlusty
- Rice University, Houston, Texas 77251
| | - T Todoroki
- Brookhaven National Laboratory, Upton, New York 11973
| | - M Tokarev
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | - S Trentalange
- University of California, Los Angeles, California 90095
| | - R E Tribble
- Texas A&M University, College Station, Texas 77843
| | - P Tribedy
- Brookhaven National Laboratory, Upton, New York 11973
| | | | - B A Trzeciak
- Czech Technical University in Prague, FNSPE, Prague, 115 19, Czech Republic
| | - O D Tsai
- University of California, Los Angeles, California 90095
| | - T Ullrich
- Brookhaven National Laboratory, Upton, New York 11973
| | - D G Underwood
- Argonne National Laboratory, Argonne, Illinois 60439
| | - I Upsal
- Ohio State University, Columbus, Ohio 43210
| | - G Van Buren
- Brookhaven National Laboratory, Upton, New York 11973
| | | | - A N Vasiliev
- Institute of High Energy Physics, Protvino 142281, Russia
| | - F Videbæk
- Brookhaven National Laboratory, Upton, New York 11973
| | - S Vokal
- Joint Institute for Nuclear Research, Dubna, 141 980, Russia
| | | | - A Vossen
- Indiana University, Bloomington, Indiana 47408
| | - G Wang
- University of California, Los Angeles, California 90095
| | - Y Wang
- Central China Normal University, Wuhan, Hubei 430079
| | - F Wang
- Purdue University, West Lafayette, Indiana 47907
| | - Y Wang
- Tsinghua University, Beijing 100084
| | - J C Webb
- Brookhaven National Laboratory, Upton, New York 11973
| | - G Webb
- Brookhaven National Laboratory, Upton, New York 11973
| | - L Wen
- University of California, Los Angeles, California 90095
| | - G D Westfall
- Michigan State University, East Lansing, Michigan 48824
| | - H Wieman
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - S W Wissink
- Indiana University, Bloomington, Indiana 47408
| | - R Witt
- United States Naval Academy, Annapolis, Maryland 21402
| | - Y Wu
- Kent State University, Kent, Ohio 44242
| | - Z G Xiao
- Tsinghua University, Beijing 100084
| | - G Xie
- University of Science and Technology of China, Hefei, Anhui 230026
| | - W Xie
- Purdue University, West Lafayette, Indiana 47907
| | - J Xu
- Central China Normal University, Wuhan, Hubei 430079
| | - Z Xu
- Brookhaven National Laboratory, Upton, New York 11973
| | - Q H Xu
- Shandong University, Jinan, Shandong 250100
| | - Y F Xu
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - N Xu
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - S Yang
- Brookhaven National Laboratory, Upton, New York 11973
| | - Y Yang
- National Cheng Kung University, Tainan 70101
| | - C Yang
- Shandong University, Jinan, Shandong 250100
| | - Q Yang
- University of Science and Technology of China, Hefei, Anhui 230026
| | - Z Ye
- University of Illinois at Chicago, Chicago, Illinois 60607
| | - Z Ye
- University of Illinois at Chicago, Chicago, Illinois 60607
| | - L Yi
- Yale University, New Haven, Connecticut 06520
| | - K Yip
- Brookhaven National Laboratory, Upton, New York 11973
| | - I-K Yoo
- Pusan National University, Pusan 46241, Korea
| | - N Yu
- Central China Normal University, Wuhan, Hubei 430079
| | - H Zbroszczyk
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - W Zha
- University of Science and Technology of China, Hefei, Anhui 230026
| | - Z Zhang
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - J B Zhang
- Central China Normal University, Wuhan, Hubei 430079
| | - J Zhang
- Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 730000
| | - S Zhang
- University of Science and Technology of China, Hefei, Anhui 230026
| | - Y Zhang
- University of Science and Technology of China, Hefei, Anhui 230026
| | | | - J Zhang
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - S Zhang
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - J Zhao
- Purdue University, West Lafayette, Indiana 47907
| | - C Zhong
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - C Zhou
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - L Zhou
- University of Science and Technology of China, Hefei, Anhui 230026
| | - X Zhu
- Tsinghua University, Beijing 100084
| | - Z Zhu
- Shandong University, Jinan, Shandong 250100
| | - M Zyzak
- Frankfurt Institute for Advanced Studies FIAS, Frankfurt 60438, Germany
| |
Collapse
|
41
|
Armiroli S, Cotillard R, Laffont G, Girard M, Cambet D, Jeannot JP, Charvet P, Albaladéjo S, Lusso S. Optical fiber distributed sensing based on Rayleigh scatter frequency domain reflectometry for Sodium leakage detection within SFR reactors. EPJ Web Conf 2018. [DOI: 10.1051/epjconf/201817003001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
42
|
Rodero MP, Tesser A, Bartok E, Rice GI, Della Mina E, Depp M, Beitz B, Bondet V, Cagnard N, Duffy D, Dussiot M, Frémond ML, Gattorno M, Guillem F, Kitabayashi N, Porcheray F, Rieux-Laucat F, Seabra L, Uggenti C, Volpi S, Zeef LAH, Alyanakian MA, Beltrand J, Bianco AM, Boddaert N, Brouzes C, Candon S, Caorsi R, Charbit M, Fabre M, Faletra F, Girard M, Harroche A, Hartmann E, Lasne D, Marcuzzi A, Neven B, Nitschke P, Pascreau T, Pastore S, Picard C, Picco P, Piscianz E, Polak M, Quartier P, Rabant M, Stocco G, Taddio A, Uettwiller F, Valencic E, Vozzi D, Hartmann G, Barchet W, Hermine O, Bader-Meunier B, Tommasini A, Crow YJ. Type I interferon-mediated autoinflammation due to DNase II deficiency. Nat Commun 2017; 8:2176. [PMID: 29259162 PMCID: PMC5736616 DOI: 10.1038/s41467-017-01932-3] [Citation(s) in RCA: 143] [Impact Index Per Article: 20.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2017] [Accepted: 10/25/2017] [Indexed: 12/24/2022] Open
Abstract
Microbial nucleic acid recognition serves as the major stimulus to an antiviral response, implying a requirement to limit the misrepresentation of self nucleic acids as non-self and the induction of autoinflammation. By systematic screening using a panel of interferon-stimulated genes we identify two siblings and a singleton variably demonstrating severe neonatal anemia, membranoproliferative glomerulonephritis, liver fibrosis, deforming arthropathy and increased anti-DNA antibodies. In both families we identify biallelic mutations in DNASE2, associated with a loss of DNase II endonuclease activity. We record increased interferon alpha protein levels using digital ELISA, enhanced interferon signaling by RNA-Seq analysis and constitutive upregulation of phosphorylated STAT1 and STAT3 in patient lymphocytes and monocytes. A hematological disease transcriptomic signature and increased numbers of erythroblasts are recorded in patient peripheral blood, suggesting that interferon might have a particular effect on hematopoiesis. These data define a type I interferonopathy due to DNase II deficiency in humans. Nucleic acid sensing is important to ensure that an innate immune response is only mounted against microbial nucleic acid. Here, the authors identify loss-of-function mutations in the DNASE2 gene that cause type I interferon-mediated autoinflammation due to enhanced systemic interferon signaling.
Collapse
Affiliation(s)
- Mathieu P Rodero
- INSERM UMR1163, Laboratory of Neurogenetics and Neuroinflammation, Paris, 75015, France
| | - Alessandra Tesser
- Department of Medicine, Surgery, and Health Sciences, University of Trieste, Trieste, 34149, Italy
| | - Eva Bartok
- Institute for Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, 53127, Germany
| | - Gillian I Rice
- Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
| | - Erika Della Mina
- INSERM UMR1163, Laboratory of Neurogenetics and Neuroinflammation, Paris, 75015, France
| | - Marine Depp
- INSERM UMR1163, Laboratory of Neurogenetics and Neuroinflammation, Paris, 75015, France
| | - Benoit Beitz
- Bioaster, Immunomonitoring Unit, Paris, 75015, France
| | - Vincent Bondet
- Immunobiology of Dendritic Cells, Institut Pasteur, Paris, 75015, France.,INSERM U1223, Paris, 75015, France
| | - Nicolas Cagnard
- Plateforme Bio-informatique, Université Paris Descartes-Structure, Fédérative de Recherche Necker, INSERM US24/CNRS, UMS 3633, Paris, 75015, France
| | - Darragh Duffy
- Immunobiology of Dendritic Cells, Institut Pasteur, Paris, 75015, France.,INSERM U1223, Paris, 75015, France.,Centre for Translational Research, Institut Pasteur, Paris, 75015, France
| | - Michael Dussiot
- INSERM UMR 1163, CNRS ERL 8254, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Imagine Institute, Université Paris Descartes, Sorbonne Paris-Cité et Assistance publique-Hôpitaux de Paris, Hôpital Necker, Paris, France, Laboratory of Excellence GR-ex, Paris, 75015, France
| | - Marie-Louise Frémond
- INSERM UMR1163, Laboratory of Neurogenetics and Neuroinflammation, Paris, 75015, France
| | - Marco Gattorno
- Unita' Operativa Pediatria 2, Istituto Giannina Gaslini, Genova, 16147, Italy
| | - Flavia Guillem
- INSERM UMR 1163, CNRS ERL 8254, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Imagine Institute, Université Paris Descartes, Sorbonne Paris-Cité et Assistance publique-Hôpitaux de Paris, Hôpital Necker, Paris, France, Laboratory of Excellence GR-ex, Paris, 75015, France
| | - Naoki Kitabayashi
- INSERM UMR1163, Laboratory of Neurogenetics and Neuroinflammation, Paris, 75015, France
| | | | - Frederic Rieux-Laucat
- Paris Descartes University, Sorbonne-Paris-Cité, Institut Imagine, Paris, 75015, France.,Laboratory of Immunogenetics of Pediatric Autoimmunity, INSERM UMR 1163, Paris, 75015, France
| | - Luis Seabra
- INSERM UMR1163, Laboratory of Neurogenetics and Neuroinflammation, Paris, 75015, France
| | - Carolina Uggenti
- INSERM UMR1163, Laboratory of Neurogenetics and Neuroinflammation, Paris, 75015, France
| | - Stefano Volpi
- Unita' Operativa Pediatria 2, Istituto Giannina Gaslini, Genova, 16147, Italy
| | - Leo A H Zeef
- Bioinformatics Core Facility, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK
| | - Marie-Alexandra Alyanakian
- Laboratoire d'Immunologie Biologique, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France
| | - Jacques Beltrand
- Service d'endocrinologie, Gynécologie et Diabétologie Pédiatriques, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France.,INSERM U1016, Institut IMAGINE, Université Paris Descartes, Paris, 75015, France
| | - Anna Monica Bianco
- Institute for Maternal and Child Health-IRCCS "Burlo Garofolo"- Trieste, Trieste, 34137, Italy
| | - Nathalie Boddaert
- Pediatric Radiology Department, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France.,INSERM UMR1163, Imagine Institute, Paris Descartes University, Paris, 75015, France
| | - Chantal Brouzes
- Department of Biological Haematology, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France
| | - Sophie Candon
- Laboratoire d'Immunologie Biologique, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France.,Institut Necker-Enfants Malades, INSERM U1151-CNRS UMR 8253, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France
| | - Roberta Caorsi
- Unita' Operativa Pediatria 2, Istituto Giannina Gaslini, Genova, 16147, Italy
| | - Marina Charbit
- Pediatric Nephrology Department, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France
| | - Monique Fabre
- Pathology Department, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France
| | - Flavio Faletra
- Department of Advanced Diagnostic and Clinical Trials, Institute for Maternal and Child Health-IRCCS "Burlo Garofolo", Trieste, 34137, Italy
| | - Muriel Girard
- INSERM UMR1163, Imagine Institute, Paris Descartes University, Paris, 75015, France.,Pediatric Hepatology Unit, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France
| | - Annie Harroche
- Service d'hématologie-Centre de Traitement de l'Hémophilie, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France
| | - Evelyn Hartmann
- Institute for Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, 53127, Germany.,Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Bonn, Bonn, 53105, Germany
| | - Dominique Lasne
- INSERM UMR_S1176, Univ. Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, Paris, 94276, France.,Laboratoire d'Hématologie, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France
| | - Annalisa Marcuzzi
- Department of Medicine, Surgery, and Health Sciences, University of Trieste, Trieste, 34149, Italy
| | - Bénédicte Neven
- Paris Descartes University, Sorbonne-Paris-Cité, Institut Imagine, Paris, 75015, France.,Laboratory of Immunogenetics of Pediatric Autoimmunity, INSERM UMR 1163, Paris, 75015, France.,Pediatric Immunology-Hematology and Rheumatology Unit, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France
| | - Patrick Nitschke
- Plateforme Bio-informatique, Université Paris Descartes-Structure, Fédérative de Recherche Necker, INSERM US24/CNRS, UMS 3633, Paris, 75015, France.,INSERM UMR1163, Imagine Institute, Paris Descartes University, Paris, 75015, France
| | - Tiffany Pascreau
- INSERM UMR_S1176, Univ. Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, Paris, 94276, France.,Laboratoire d'Hématologie, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France
| | - Serena Pastore
- Institute for Maternal and Child Health-IRCCS "Burlo Garofolo"- Trieste, Trieste, 34137, Italy
| | - Capucine Picard
- Pediatric Immunology-Hematology and Rheumatology Unit, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France.,Study Center for Primary Immunodeficiencies, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France.,Necker Medical School, Paris, 75015, France.,INSERM UMR1163, Laboratory of Lymphocyte Activation and Susceptibility to EBV, Imagine Institute, Paris Descartes University, Paris, 75015, France
| | - Paolo Picco
- Unita' Operativa Pediatria 2, Istituto Giannina Gaslini, Genova, 16147, Italy
| | - Elisa Piscianz
- Department of Medicine, Surgery, and Health Sciences, University of Trieste, Trieste, 34149, Italy
| | - Michel Polak
- Service d'endocrinologie, Gynécologie et Diabétologie Pédiatriques, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France.,INSERM U1016, Institut IMAGINE, Université Paris Descartes, Paris, 75015, France
| | - Pierre Quartier
- Paris Descartes University, Sorbonne-Paris-Cité, Institut Imagine, Paris, 75015, France.,Laboratory of Immunogenetics of Pediatric Autoimmunity, INSERM UMR 1163, Paris, 75015, France.,Pediatric Immunology-Hematology and Rheumatology Unit, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France
| | - Marion Rabant
- Pathology Department, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France
| | - Gabriele Stocco
- Department of Life Sciences, University of Trieste, Trieste, 34128, Italy
| | - Andrea Taddio
- Department of Medicine, Surgery, and Health Sciences, University of Trieste, Trieste, 34149, Italy.,Institute for Maternal and Child Health-IRCCS "Burlo Garofolo"- Trieste, Trieste, 34137, Italy
| | - Florence Uettwiller
- Paris Descartes University, Sorbonne-Paris-Cité, Institut Imagine, Paris, 75015, France.,Laboratory of Immunogenetics of Pediatric Autoimmunity, INSERM UMR 1163, Paris, 75015, France.,Pediatric Immunology-Hematology and Rheumatology Unit, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France
| | - Erica Valencic
- Institute for Maternal and Child Health-IRCCS "Burlo Garofolo"- Trieste, Trieste, 34137, Italy
| | - Diego Vozzi
- Department of Advanced Diagnostic and Clinical Trials, Institute for Maternal and Child Health-IRCCS "Burlo Garofolo", Trieste, 34137, Italy
| | - Gunther Hartmann
- Institute for Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, 53127, Germany
| | - Winfried Barchet
- Institute for Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, 53127, Germany.,German Center for Infection Research (DZIF), Cologne-Bonn, Bonn, 53127, Germany
| | - Olivier Hermine
- INSERM UMR 1163, CNRS ERL 8254, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Imagine Institute, Université Paris Descartes, Sorbonne Paris-Cité et Assistance publique-Hôpitaux de Paris, Hôpital Necker, Paris, France, Laboratory of Excellence GR-ex, Paris, 75015, France.,Service d'hématologie, Faculté de Médecine Paris Descartes, Sorbonne Paris-Cité et Assistance Publique-Hôpitaux de Paris Hôpital Necker, Paris, 75015, France
| | - Brigitte Bader-Meunier
- Laboratory of Immunogenetics of Pediatric Autoimmunity, INSERM UMR 1163, Paris, 75015, France.,Pediatric Immunology-Hematology and Rheumatology Unit, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France
| | - Alberto Tommasini
- Institute for Maternal and Child Health-IRCCS "Burlo Garofolo"- Trieste, Trieste, 34137, Italy
| | - Yanick J Crow
- INSERM UMR1163, Laboratory of Neurogenetics and Neuroinflammation, Paris, 75015, France. .,Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK. .,Paris Descartes University, Sorbonne-Paris-Cité, Institut Imagine, Paris, 75015, France. .,Department of Genetics, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France.
| |
Collapse
|
43
|
Ruppé E, Cherkaoui A, Wagner N, La Scala GC, Beaulieu JY, Girard M, Frey J, Lazarevic V, Schrenzel J. In vivo selection of a multidrug-resistant Aeromonas salmonicida during medicinal leech therapy. New Microbes New Infect 2017; 21:23-27. [PMID: 29204282 PMCID: PMC5709350 DOI: 10.1016/j.nmni.2017.10.005] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2017] [Revised: 09/15/2017] [Accepted: 10/04/2017] [Indexed: 12/18/2022] Open
Abstract
We report the selection in a 15-year-old boy of a multidrug-resistant, extended-spectrum β-lactamase (ESBL)-producing Aeromonas salmonicida after medicinal leech therapy that required an antibiotic prophylaxis based on piperacillin/tazobactam and cotrimoxazole. Whole genome sequencing of the strain indeed revealed 13 antibiotic resistance genes, including the ESBL CTX-M-3 and the unusual β-lactamase SCO-1.
Collapse
Affiliation(s)
- E Ruppé
- Genomic Research Laboratory, Division of Infectious Diseases, Switzerland
| | - A Cherkaoui
- Bacteriology Laboratory, Division of Laboratory Medicine, Department of Genetics and Laboratory Medicine, Switzerland
| | - N Wagner
- Pediatric Infectious Diseases, Department of Pediatrics, Switzerland
| | - G C La Scala
- Division of Pediatric Surgery, Department of Pediatrics, Switzerland
| | - J-Y Beaulieu
- Hand Surgery Unit, Division of Orthopedic Surgery, Department of Surgery, Geneva University Hospitals, Geneva, Switzerland
| | - M Girard
- Genomic Research Laboratory, Division of Infectious Diseases, Switzerland
| | - J Frey
- Institute of Veterinary Bacteriology, University of Bern, Bern, Switzerland
| | - V Lazarevic
- Genomic Research Laboratory, Division of Infectious Diseases, Switzerland
| | - J Schrenzel
- Genomic Research Laboratory, Division of Infectious Diseases, Switzerland.,Bacteriology Laboratory, Division of Laboratory Medicine, Department of Genetics and Laboratory Medicine, Switzerland
| |
Collapse
|
44
|
Girard M, Marchand F, Uch R, Bretelle F. [Trauma and pregnancy: Is the Kleihauer-Betke test really useful?]. ACTA ACUST UNITED AC 2017; 45:584-589. [PMID: 28967599 DOI: 10.1016/j.gofs.2017.08.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2017] [Accepted: 08/29/2017] [Indexed: 10/18/2022]
Abstract
OBJECTIVE To evaluate the pertinence of Kleihauer-Betke (KB) test, in case of abdominal trauma during pregnancy in forecast of fetal outcomes, according to trauma severity. METHODS A single-center retrospective study conducted between January 2014 and April 2016 in a maternity type III and a trauma center, which included the pregnant women admitted for abdominal trauma. The trauma's severity was assessed using the guidelines of the Society of Obstetricians and Gynaecologists of Canada. The impact of a positive KB test, defined as>0.1%, was analyzed. Adverse outcome was defined as one or more of the following complications: intrauterine fetal death, placental abruption, pre-term birth<37 weeks of gestation, and fetal or neonatal anemia. RESULTS During the study period, 265 pregnancies involved into an abdominal trauma were included: 69% with a minor trauma and 31% with a severe trauma. Of all patients, 5.6% presented a positive KB test, among then 15.4% had an adverse outcome. There was no significant difference in the rate of adverse outcomes in the positive KB group and the KB negative group either in the overall population (P=0.16), in the minor trauma population (P=1) or in the major trauma population (P=0.14). The predictive positive values were respectively in the global population, in the minor trauma group and in the severe trauma group 15.4%, 0% and 25%. CONCLUSIONS The KB test does not seem to be useful in case of trauma during pregnancy to define adverse outcome.
Collapse
Affiliation(s)
- M Girard
- Pôle femme-enfant, Department of gynecology and obstetrics, hôpital Nord, Aix-Marseille université (AMU), Assistance publique-Hôpitaux de Marseille, 13015 Marseille, France.
| | - F Marchand
- Pôle femme-enfant, Department of gynecology and obstetrics, hôpital Nord, Aix-Marseille université (AMU), Assistance publique-Hôpitaux de Marseille, 13015 Marseille, France
| | - R Uch
- Établissement français du sang, Alpes-Méditerranée, Marseille Nord, chemin des Bourrely, 13015 Marseille, France
| | - F Bretelle
- Pôle femme-enfant, Department of gynecology and obstetrics, hôpital Nord, Aix-Marseille université (AMU), Assistance publique-Hôpitaux de Marseille, 13015 Marseille, France; A*MIDEX « CREER », unité de recherche sur les maladies infectieuses tropicales et émergentes, UM63, CNRS 7278, IRD 198, Inserm 1095, Aix-Marseille université, 13015 Marseille, France
| |
Collapse
|
45
|
Traboulsee A, Machan L, Girard M, Raymond J, Vosoughi R, Hardy B, Edmond F, Bone J, Gariepy J, Tam R, Klass D, Isserow S, Rauscher A, Sadovnick A, Li D, Illes J, Siskin G. Venoplasty of chronic cerebral spinal venous insufficiency to improve MS patient reported outcomes is not superior to sham treatment at week 2 or week 12. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.3012] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
46
|
Brisson H, Arbelot C, Monsel A, Parisot C, Girard M, Savier E, Vezinet C, Lu Q, Vaillant JC, Golmard JL, Gorochov G, Langeron O, Rouby JJ. Impact of graft preservation solutions for liver transplantation on early cytokine release and postoperative organ dysfunctions. A pilot study. Clin Res Hepatol Gastroenterol 2017; 41:564-574. [PMID: 28330599 DOI: 10.1016/j.clinre.2016.12.011] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/03/2016] [Revised: 12/23/2016] [Accepted: 12/28/2016] [Indexed: 02/06/2023]
Abstract
INTRODUCTION During liver transplantation, graft ischemia-reperfusion injury leads to a systemic inflammatory response producing postoperative organ dysfunctions. The aim of this observational and prospective study was to compare the impact of Solution de conservation des organes et tissus (SCOT) 15 and University of Wisconsin (UW) preservation solutions on early cytokine release, postreperfusion syndrome and postoperative organ dysfunctions. METHODS Thirty-seven liver transplantations were included: 21 in UW Group and 16 in SCOT 15 group. Five cytokines were measured in systemic blood after anesthetic induction, 30minutes after unclamping portal vein and on postoperative day 1. RESULTS Following unclamping portal vein, cytokines were released in systemic circulation. Systemic cytokine concentrations were higher in UW than in SCOT 15 group: Interleukin-10, Interleukine-6. In SCOT 15 group, significant reduction of postreperfusion syndrome incidence and acute kidney injury were observed. Alanine and aspartate aminotransferase peak concentrations were higher in SCOT 15 group than in UW group. However, from postoperative day 1 to day 10, aminotransferase returned to normal values and did not differ between groups. CONCLUSIONS Compared to UW, SCOT 15 decreases systemic cytokine release resulting from graft ischemia-reperfusion injury and reduces incidence of postreperfusion syndrome and postoperative renal failure.
Collapse
Affiliation(s)
- H Brisson
- Department of Anesthesiology and Critical Care Medicine, Multidisciplinary Intensive Care Unit, AP-HP, La Pitié-Salpêtrière Hospital, université Paris 06, université Pierre-et-Marie-Curie, 75013 Paris, France(1); UMR-S 945, La Pitié-Salpêtrière Hospital, Institut national de la santé et de la recherche médicale, AP-HP, université Paris 06, université Pierre-et-Marie-Curie, 75013 Paris, France.
| | - C Arbelot
- Department of Anesthesiology and Critical Care Medicine, Multidisciplinary Intensive Care Unit, AP-HP, La Pitié-Salpêtrière Hospital, université Paris 06, université Pierre-et-Marie-Curie, 75013 Paris, France(1)
| | - A Monsel
- Department of Anesthesiology and Critical Care Medicine, Multidisciplinary Intensive Care Unit, AP-HP, La Pitié-Salpêtrière Hospital, université Paris 06, université Pierre-et-Marie-Curie, 75013 Paris, France(1)
| | - C Parisot
- UMR-S 945, La Pitié-Salpêtrière Hospital, Institut national de la santé et de la recherche médicale, AP-HP, université Paris 06, université Pierre-et-Marie-Curie, 75013 Paris, France
| | - M Girard
- Department of Anesthesiology and Critical Care Medicine, Multidisciplinary Intensive Care Unit, AP-HP, La Pitié-Salpêtrière Hospital, université Paris 06, université Pierre-et-Marie-Curie, 75013 Paris, France(1)
| | - E Savier
- Department of Digestive and Hepato-Pancreato-Biliary Surgery, AP-HP, La Pitié-Salpêtrière Hospital, université Paris 06, université Pierre-et-Marie-Curie, 75013 Paris, France; Inserm, U1082, plateform IBISA, université de Poitiers, faculté de médecine et de pharmacie, 86021 Poitiers, France
| | - C Vezinet
- Department of Anesthesiology and Critical Care Medicine, Multidisciplinary Intensive Care Unit, AP-HP, La Pitié-Salpêtrière Hospital, université Paris 06, université Pierre-et-Marie-Curie, 75013 Paris, France(1)
| | - Q Lu
- Department of Anesthesiology and Critical Care Medicine, Multidisciplinary Intensive Care Unit, AP-HP, La Pitié-Salpêtrière Hospital, université Paris 06, université Pierre-et-Marie-Curie, 75013 Paris, France(1)
| | - J-C Vaillant
- Department of Digestive and Hepato-Pancreato-Biliary Surgery, AP-HP, La Pitié-Salpêtrière Hospital, université Paris 06, université Pierre-et-Marie-Curie, 75013 Paris, France
| | - J-L Golmard
- ER4 "Modélisation en recherche clinique", université Paris 06, université Pierre-et-Marie-Curie et UF de biostatistique, La Pitié-Salpêtrière Hospital, 75013 Paris, France
| | - G Gorochov
- UMR-S 945, La Pitié-Salpêtrière Hospital, Institut national de la santé et de la recherche médicale, AP-HP, université Paris 06, université Pierre-et-Marie-Curie, 75013 Paris, France
| | - O Langeron
- Department of Anesthesiology and Critical Care Medicine, Multidisciplinary Intensive Care Unit, AP-HP, La Pitié-Salpêtrière Hospital, université Paris 06, université Pierre-et-Marie-Curie, 75013 Paris, France(1)
| | - J-J Rouby
- Department of Anesthesiology and Critical Care Medicine, Multidisciplinary Intensive Care Unit, AP-HP, La Pitié-Salpêtrière Hospital, université Paris 06, université Pierre-et-Marie-Curie, 75013 Paris, France(1)
| | | |
Collapse
|
47
|
Adamczyk L, Adkins JK, Agakishiev G, Aggarwal MM, Ahammed Z, Alekseev I, Anderson DM, Aoyama R, Aparin A, Arkhipkin D, Aschenauer EC, Ashraf MU, Attri A, Averichev GS, Bai X, Bairathi V, Bellwied R, Bhasin A, Bhati AK, Bhattarai P, Bielcik J, Bielcikova J, Bland LC, Bordyuzhin IG, Bouchet J, Brandenburg JD, Brandin AV, Brown D, Bunzarov I, Butterworth J, Caines H, Calderón de la Barca Sánchez M, Campbell JM, Cebra D, Chakaberia I, Chaloupka P, Chang Z, Chatterjee A, Chattopadhyay S, Chen JH, Chen X, Cheng J, Cherney M, Christie W, Contin G, Crawford HJ, Das S, De Silva LC, Debbe RR, Dedovich TG, Deng J, Derevschikov AA, Didenko L, Dilks C, Dong X, Drachenberg JL, Draper JE, Du CM, Dunkelberger LE, Dunlop JC, Efimov LG, Elsey N, Engelage J, Eppley G, Esha R, Esumi S, Evdokimov O, Ewigleben J, Eyser O, Fatemi R, Fazio S, Federic P, Fedorisin J, Feng Z, Filip P, Finch E, Fisyak Y, Flores CE, Fulek L, Gagliardi CA, Garand D, Geurts F, Gibson A, Girard M, Greiner L, Grosnick D, Gunarathne DS, Guo Y, Gupta A, Gupta S, Guryn W, Hamad AI, Hamed A, Haque R, Harris JW, He L, Heppelmann S, Heppelmann S, Hirsch A, Hoffmann GW, Horvat S, Huang X, Huang B, Huang HZ, Huang T, Huck P, Humanic TJ, Igo G, Jacobs WW, Jentsch A, Jia J, Jiang K, Jowzaee S, Judd EG, Kabana S, Kalinkin D, Kang K, Kauder K, Ke HW, Keane D, Kechechyan A, Khan Z, Kikoła DP, Kisel I, Kisiel A, Kochenda L, Koetke DD, Kosarzewski LK, Kraishan AF, Kravtsov P, Krueger K, Kumar L, Lamont MAC, Landgraf JM, Landry KD, Lauret J, Lebedev A, Lednicky R, Lee JH, Li W, Li X, Li X, Li Y, Li C, Lin T, Lisa MA, Liu Y, Liu F, Ljubicic T, Llope WJ, Lomnitz M, Longacre RS, Luo X, Luo S, Ma GL, Ma L, Ma R, Ma YG, Magdy N, Majka R, Manion A, Margetis S, Markert C, Matis HS, McDonald D, McKinzie S, Meehan K, Mei JC, Miller ZW, Minaev NG, Mioduszewski S, Mishra D, Mohanty B, Mondal MM, Morozov DA, Mustafa MK, Nasim M, Nayak TK, Nigmatkulov G, Niida T, Nogach LV, Nonaka T, Novak J, Nurushev SB, Odyniec G, Ogawa A, Oh K, Okorokov VA, Olvitt D, Page BS, Pak R, Pan YX, Pandit Y, Panebratsev Y, Pawlik B, Pei H, Perkins C, Pile P, Pluta J, Poniatowska K, Porter J, Posik M, Poskanzer AM, Pruthi NK, Przybycien M, Putschke J, Qiu H, Quintero A, Ramachandran S, Ray RL, Reed R, Rehbein MJ, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Roth JD, Ruan L, Rusnak J, Rusnakova O, Sahoo NR, Sahu PK, Sakrejda I, Salur S, Sandweiss J, Schambach J, Scharenberg RP, Schmah AM, Schmidke WB, Schmitz N, Seger J, Seyboth P, Shah N, Shahaliev E, Shanmuganathan PV, Shao M, Sharma MK, Sharma A, Sharma B, Shen WQ, Shi SS, Shi Z, Shou QY, Sichtermann EP, Sikora R, Simko M, Singha S, Skoby MJ, Smirnov D, Smirnov N, Solyst W, Song L, Sorensen P, Spinka HM, Srivastava B, Stanislaus TDS, Stepanov M, Stock R, Strikhanov M, Stringfellow B, Sugiura T, Sumbera M, Summa B, Sun XM, Sun Z, Sun Y, Surrow B, Svirida DN, Tang Z, Tang AH, Tarnowsky T, Tawfik A, Thäder J, Thomas JH, Timmins AR, Tlusty D, Todoroki T, Tokarev M, Trentalange S, Tribble RE, Tribedy P, Tripathy SK, Tsai OD, Ullrich T, Underwood DG, Upsal I, Van Buren G, van Nieuwenhuizen G, Vasiliev AN, Vertesi R, Videbæk F, Vokal S, Voloshin SA, Vossen A, Wang F, Wang JS, Wang G, Wang Y, Wang Y, Webb G, Webb JC, Wen L, Westfall GD, Wieman H, Wissink SW, Witt R, Wu Y, Xiao ZG, Xie G, Xie W, Xin K, Xu QH, Xu H, Xu YF, Xu Z, Xu J, Xu N, Yang S, Yang Q, Yang Y, Yang C, Yang Y, Yang Y, Ye Z, Ye Z, Yi L, Yip K, Yoo IK, Yu N, Zbroszczyk H, Zha W, Zhang XP, Zhang J, Zhang J, Zhang Z, Zhang S, Zhang JB, Zhang Y, Zhang S, Zhao J, Zhong C, Zhou L, Zhu X, Zoulkarneeva Y, Zyzak M. Dijet imbalance measurements in Au+Au and pp collisions at sqrt[s_{NN}]=200 GeV at STAR. Phys Rev Lett 2017; 119:062301. [PMID: 28949601 DOI: 10.1103/physrevlett.119.062301] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/15/2016] [Indexed: 06/07/2023]
Abstract
We report the first dijet transverse momentum asymmetry measurements from Au+Au and pp collisions at RHIC. The two highest-energy back-to-back jets reconstructed from fragments with transverse momenta above 2 GeV/c display a significantly higher momentum imbalance in heavy-ion collisions than in the pp reference. When reexamined with correlated soft particles included, we observe that these dijets then exhibit a unique new feature-momentum balance is restored to that observed in pp for a jet resolution parameter of R=0.4, while rebalancing is not attained with a smaller value of R=0.2.
Collapse
Affiliation(s)
- L Adamczyk
- AGH University of Science and Technology, FPACS, Cracow 30-059, Poland
| | - J K Adkins
- University of Kentucky, Lexington, Kentucky 40506-0055
| | - G Agakishiev
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | | | - Z Ahammed
- Variable Energy Cyclotron Centre, Kolkata 700064, India
| | - I Alekseev
- Alikhanov Institute for Theoretical and Experimental Physics, Moscow 117218, Russia
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - D M Anderson
- Texas A&M University, College Station, Texas 77843
| | - R Aoyama
- Brookhaven National Laboratory, Upton, New York 11973
| | - A Aparin
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - D Arkhipkin
- Brookhaven National Laboratory, Upton, New York 11973
| | | | | | - A Attri
- Panjab University, Chandigarh 160014, India
| | - G S Averichev
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - X Bai
- Central China Normal University, Wuhan, Hubei 430079
| | - V Bairathi
- National Institute of Science Education and Research, Bhubaneswar 751005, India
| | - R Bellwied
- University of Houston, Houston, Texas 77204
| | - A Bhasin
- University of Jammu, Jammu 180001, India
| | - A K Bhati
- Panjab University, Chandigarh 160014, India
| | | | - J Bielcik
- Czech Technical University in Prague, FNSPE, Prague 115 19, Czech Republic
| | - J Bielcikova
- Nuclear Physics Institute AS CR, 250 68 Prague, Czech Republic
| | - L C Bland
- Brookhaven National Laboratory, Upton, New York 11973
| | - I G Bordyuzhin
- Alikhanov Institute for Theoretical and Experimental Physics, Moscow 117218, Russia
| | - J Bouchet
- Kent State University, Kent, Ohio 44242
| | | | - A V Brandin
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - D Brown
- Lehigh University, Bethlehem, Pennsylvania 18015
| | - I Bunzarov
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | | | - H Caines
- Yale University, New Haven, Connecticut 06520
| | | | | | - D Cebra
- University of California, Davis, California 95616
| | - I Chakaberia
- Brookhaven National Laboratory, Upton, New York 11973
| | - P Chaloupka
- Czech Technical University in Prague, FNSPE, Prague 115 19, Czech Republic
| | - Z Chang
- Texas A&M University, College Station, Texas 77843
| | - A Chatterjee
- Variable Energy Cyclotron Centre, Kolkata 700064, India
| | | | - J H Chen
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - X Chen
- Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 730000
| | - J Cheng
- Tsinghua University, Beijing 100084
| | - M Cherney
- Creighton University, Omaha, Nebraska 68178
| | - W Christie
- Brookhaven National Laboratory, Upton, New York 11973
| | - G Contin
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - H J Crawford
- University of California, Berkeley, California 94720
| | - S Das
- Institute of Physics, Bhubaneswar 751005, India
| | | | - R R Debbe
- Brookhaven National Laboratory, Upton, New York 11973
| | - T G Dedovich
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - J Deng
- Shandong University, Jinan, Shandong 250100
| | | | - L Didenko
- Brookhaven National Laboratory, Upton, New York 11973
| | - C Dilks
- Pennsylvania State University, University Park, Pennsylvania 16802
| | - X Dong
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | | | - J E Draper
- University of California, Davis, California 95616
| | - C M Du
- Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 730000
| | | | - J C Dunlop
- Brookhaven National Laboratory, Upton, New York 11973
| | - L G Efimov
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - N Elsey
- Wayne State University, Detroit, Michigan 48201
| | - J Engelage
- University of California, Berkeley, California 94720
| | - G Eppley
- Rice University, Houston, Texas 77251
| | - R Esha
- University of California, Los Angeles, California 90095
| | - S Esumi
- University of Tsukuba, Tsukuba, Ibaraki 305-8571, Japan
| | - O Evdokimov
- University of Illinois at Chicago, Chicago, Illinois 60607
| | - J Ewigleben
- Lehigh University, Bethlehem, Pennsylvania 18015
| | - O Eyser
- Brookhaven National Laboratory, Upton, New York 11973
| | - R Fatemi
- University of Kentucky, Lexington, Kentucky 40506-0055
| | - S Fazio
- Brookhaven National Laboratory, Upton, New York 11973
| | - P Federic
- Nuclear Physics Institute AS CR, 250 68 Prague, Czech Republic
| | - J Fedorisin
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - Z Feng
- Central China Normal University, Wuhan, Hubei 430079
| | - P Filip
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - E Finch
- Southern Connecticut State University, New Haven, Connecticut 06515
| | - Y Fisyak
- Brookhaven National Laboratory, Upton, New York 11973
| | - C E Flores
- University of California, Davis, California 95616
| | - L Fulek
- AGH University of Science and Technology, FPACS, Cracow 30-059, Poland
| | | | - D Garand
- Purdue University, West Lafayette, Indiana 47907
| | - F Geurts
- Rice University, Houston, Texas 77251
| | - A Gibson
- Valparaiso University, Valparaiso, Indiana 46383
| | - M Girard
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - L Greiner
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - D Grosnick
- Valparaiso University, Valparaiso, Indiana 46383
| | | | - Y Guo
- University of Science and Technology of China, Hefei, Anhui 230026
| | - A Gupta
- University of Jammu, Jammu 180001, India
| | - S Gupta
- University of Jammu, Jammu 180001, India
| | - W Guryn
- Brookhaven National Laboratory, Upton, New York 11973
| | - A I Hamad
- Kent State University, Kent, Ohio 44242
| | - A Hamed
- Texas A&M University, College Station, Texas 77843
| | - R Haque
- National Institute of Science Education and Research, Bhubaneswar 751005, India
| | - J W Harris
- Yale University, New Haven, Connecticut 06520
| | - L He
- Purdue University, West Lafayette, Indiana 47907
| | - S Heppelmann
- Pennsylvania State University, University Park, Pennsylvania 16802
| | - S Heppelmann
- University of California, Davis, California 95616
| | - A Hirsch
- Purdue University, West Lafayette, Indiana 47907
| | | | - S Horvat
- Yale University, New Haven, Connecticut 06520
| | - X Huang
- Tsinghua University, Beijing 100084
| | - B Huang
- University of Illinois at Chicago, Chicago, Illinois 60607
| | - H Z Huang
- University of California, Los Angeles, California 90095
| | - T Huang
- National Cheng Kung University, Tainan 70101
| | - P Huck
- Central China Normal University, Wuhan, Hubei 430079
| | - T J Humanic
- The Ohio State University, Columbus, Ohio 43210
| | - G Igo
- University of California, Los Angeles, California 90095
| | - W W Jacobs
- Indiana University, Bloomington, Indiana 47408
| | - A Jentsch
- University of Texas, Austin, Texas 78712
| | - J Jia
- Brookhaven National Laboratory, Upton, New York 11973
- State University Of New York, Stony Brook, New York 11794
| | - K Jiang
- University of Science and Technology of China, Hefei, Anhui 230026
| | - S Jowzaee
- Wayne State University, Detroit, Michigan 48201
| | - E G Judd
- University of California, Berkeley, California 94720
| | - S Kabana
- Kent State University, Kent, Ohio 44242
| | - D Kalinkin
- Indiana University, Bloomington, Indiana 47408
| | - K Kang
- Tsinghua University, Beijing 100084
| | - K Kauder
- Wayne State University, Detroit, Michigan 48201
| | - H W Ke
- Brookhaven National Laboratory, Upton, New York 11973
| | - D Keane
- Kent State University, Kent, Ohio 44242
| | - A Kechechyan
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - Z Khan
- University of Illinois at Chicago, Chicago, Illinois 60607
| | - D P Kikoła
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - I Kisel
- Frankfurt Institute for Advanced Studies FIAS, Frankfurt 60438, Germany
| | - A Kisiel
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - L Kochenda
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - D D Koetke
- Valparaiso University, Valparaiso, Indiana 46383
| | | | - A F Kraishan
- Temple University, Philadelphia, Pennsylvania 19122
| | - P Kravtsov
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - K Krueger
- Argonne National Laboratory, Argonne, Illinois 60439
| | - L Kumar
- Panjab University, Chandigarh 160014, India
| | - M A C Lamont
- Brookhaven National Laboratory, Upton, New York 11973
| | - J M Landgraf
- Brookhaven National Laboratory, Upton, New York 11973
| | - K D Landry
- University of California, Los Angeles, California 90095
| | - J Lauret
- Brookhaven National Laboratory, Upton, New York 11973
| | - A Lebedev
- Brookhaven National Laboratory, Upton, New York 11973
| | - R Lednicky
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - J H Lee
- Brookhaven National Laboratory, Upton, New York 11973
| | - W Li
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - X Li
- Temple University, Philadelphia, Pennsylvania 19122
| | - X Li
- University of Science and Technology of China, Hefei, Anhui 230026
| | - Y Li
- Tsinghua University, Beijing 100084
| | - C Li
- University of Science and Technology of China, Hefei, Anhui 230026
| | - T Lin
- Indiana University, Bloomington, Indiana 47408
| | - M A Lisa
- The Ohio State University, Columbus, Ohio 43210
| | - Y Liu
- Texas A&M University, College Station, Texas 77843
| | - F Liu
- Central China Normal University, Wuhan, Hubei 430079
| | - T Ljubicic
- Brookhaven National Laboratory, Upton, New York 11973
| | - W J Llope
- Wayne State University, Detroit, Michigan 48201
| | - M Lomnitz
- Kent State University, Kent, Ohio 44242
| | - R S Longacre
- Brookhaven National Laboratory, Upton, New York 11973
| | - X Luo
- Central China Normal University, Wuhan, Hubei 430079
| | - S Luo
- University of Illinois at Chicago, Chicago, Illinois 60607
| | - G L Ma
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - L Ma
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - R Ma
- Brookhaven National Laboratory, Upton, New York 11973
| | - Y G Ma
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - N Magdy
- State University Of New York, Stony Brook, New York 11794
| | - R Majka
- Yale University, New Haven, Connecticut 06520
| | - A Manion
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | | | - C Markert
- University of Texas, Austin, Texas 78712
| | - H S Matis
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - D McDonald
- University of Houston, Houston, Texas 77204
| | - S McKinzie
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - K Meehan
- University of California, Davis, California 95616
| | - J C Mei
- Shandong University, Jinan, Shandong 250100
| | - Z W Miller
- University of Illinois at Chicago, Chicago, Illinois 60607
| | - N G Minaev
- Institute of High Energy Physics, Protvino 142281, Russia
| | | | - D Mishra
- National Institute of Science Education and Research, Bhubaneswar 751005, India
| | - B Mohanty
- National Institute of Science Education and Research, Bhubaneswar 751005, India
| | - M M Mondal
- Texas A&M University, College Station, Texas 77843
| | - D A Morozov
- Institute of High Energy Physics, Protvino 142281, Russia
| | - M K Mustafa
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - Md Nasim
- University of California, Los Angeles, California 90095
| | - T K Nayak
- Variable Energy Cyclotron Centre, Kolkata 700064, India
| | - G Nigmatkulov
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - T Niida
- Wayne State University, Detroit, Michigan 48201
| | - L V Nogach
- Institute of High Energy Physics, Protvino 142281, Russia
| | - T Nonaka
- University of Tsukuba, Tsukuba, Ibaraki 305-8571, Japan
| | - J Novak
- Michigan State University, East Lansing, Michigan 48824
| | - S B Nurushev
- Institute of High Energy Physics, Protvino 142281, Russia
| | - G Odyniec
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - A Ogawa
- Brookhaven National Laboratory, Upton, New York 11973
| | - K Oh
- Pusan National University, Pusan 46241, Korea
| | - V A Okorokov
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - D Olvitt
- Temple University, Philadelphia, Pennsylvania 19122
| | - B S Page
- Brookhaven National Laboratory, Upton, New York 11973
| | - R Pak
- Brookhaven National Laboratory, Upton, New York 11973
| | - Y X Pan
- University of California, Los Angeles, California 90095
| | - Y Pandit
- University of Illinois at Chicago, Chicago, Illinois 60607
| | - Y Panebratsev
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - B Pawlik
- Institute of Nuclear Physics PAN, Cracow 31-342, Poland
| | - H Pei
- Central China Normal University, Wuhan, Hubei 430079
| | - C Perkins
- University of California, Berkeley, California 94720
| | - P Pile
- Brookhaven National Laboratory, Upton, New York 11973
| | - J Pluta
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - K Poniatowska
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - J Porter
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - M Posik
- Temple University, Philadelphia, Pennsylvania 19122
| | - A M Poskanzer
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - N K Pruthi
- Panjab University, Chandigarh 160014, India
| | - M Przybycien
- AGH University of Science and Technology, FPACS, Cracow 30-059, Poland
| | - J Putschke
- Wayne State University, Detroit, Michigan 48201
| | - H Qiu
- Purdue University, West Lafayette, Indiana 47907
| | - A Quintero
- Temple University, Philadelphia, Pennsylvania 19122
| | | | - R L Ray
- University of Texas, Austin, Texas 78712
| | - R Reed
- Lehigh University, Bethlehem, Pennsylvania 18015
- Lehigh University, Bethlehem, Pennsylvnia 18015
| | | | - H G Ritter
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | | | | | - J L Romero
- University of California, Davis, California 95616
| | - J D Roth
- Creighton University, Omaha, Nebraska 68178
| | - L Ruan
- Brookhaven National Laboratory, Upton, New York 11973
| | - J Rusnak
- Nuclear Physics Institute AS CR, 250 68 Prague, Czech Republic
| | - O Rusnakova
- Czech Technical University in Prague, FNSPE, Prague 115 19, Czech Republic
| | - N R Sahoo
- Texas A&M University, College Station, Texas 77843
| | - P K Sahu
- Institute of Physics, Bhubaneswar 751005, India
| | - I Sakrejda
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - S Salur
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - J Sandweiss
- Yale University, New Haven, Connecticut 06520
| | | | | | - A M Schmah
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - W B Schmidke
- Brookhaven National Laboratory, Upton, New York 11973
| | - N Schmitz
- Max-Planck-Institut fur Physik, Munich 80805, Germany
| | - J Seger
- Creighton University, Omaha, Nebraska 68178
| | - P Seyboth
- Max-Planck-Institut fur Physik, Munich 80805, Germany
| | - N Shah
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - E Shahaliev
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | | | - M Shao
- University of Science and Technology of China, Hefei, Anhui 230026
| | - M K Sharma
- University of Jammu, Jammu 180001, India
| | - A Sharma
- University of Jammu, Jammu 180001, India
| | - B Sharma
- Panjab University, Chandigarh 160014, India
| | - W Q Shen
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - S S Shi
- Central China Normal University, Wuhan, Hubei 430079
| | - Z Shi
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - Q Y Shou
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - E P Sichtermann
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - R Sikora
- AGH University of Science and Technology, FPACS, Cracow 30-059, Poland
| | - M Simko
- Nuclear Physics Institute AS CR, 250 68 Prague, Czech Republic
| | - S Singha
- Kent State University, Kent, Ohio 44242
| | - M J Skoby
- Indiana University, Bloomington, Indiana 47408
| | - D Smirnov
- Brookhaven National Laboratory, Upton, New York 11973
| | - N Smirnov
- Yale University, New Haven, Connecticut 06520
| | - W Solyst
- Indiana University, Bloomington, Indiana 47408
| | - L Song
- University of Houston, Houston, Texas 77204
| | - P Sorensen
- Brookhaven National Laboratory, Upton, New York 11973
| | - H M Spinka
- Argonne National Laboratory, Argonne, Illinois 60439
| | - B Srivastava
- Purdue University, West Lafayette, Indiana 47907
| | | | - M Stepanov
- Purdue University, West Lafayette, Indiana 47907
| | - R Stock
- Frankfurt Institute for Advanced Studies FIAS, Frankfurt 60438, Germany
| | - M Strikhanov
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | | | - T Sugiura
- University of Tsukuba, Tsukuba, Ibaraki 305-8571, Japan
| | - M Sumbera
- Nuclear Physics Institute AS CR, 250 68 Prague, Czech Republic
| | - B Summa
- Pennsylvania State University, University Park, Pennsylvania 16802
| | - X M Sun
- Central China Normal University, Wuhan, Hubei 430079
| | - Z Sun
- Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 730000
| | - Y Sun
- University of Science and Technology of China, Hefei, Anhui 230026
| | - B Surrow
- Temple University, Philadelphia, Pennsylvania 19122
| | - D N Svirida
- Alikhanov Institute for Theoretical and Experimental Physics, Moscow 117218, Russia
| | - Z Tang
- University of Science and Technology of China, Hefei, Anhui 230026
| | - A H Tang
- Brookhaven National Laboratory, Upton, New York 11973
| | - T Tarnowsky
- Michigan State University, East Lansing, Michigan 48824
| | - A Tawfik
- World Laboratory for Cosmology and Particle Physics (WLCAPP), Cairo 11571, Egypt
| | - J Thäder
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - J H Thomas
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | | | - D Tlusty
- Rice University, Houston, Texas 77251
| | - T Todoroki
- Brookhaven National Laboratory, Upton, New York 11973
| | - M Tokarev
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - S Trentalange
- University of California, Los Angeles, California 90095
| | - R E Tribble
- Texas A&M University, College Station, Texas 77843
| | - P Tribedy
- Brookhaven National Laboratory, Upton, New York 11973
| | | | - O D Tsai
- University of California, Los Angeles, California 90095
| | - T Ullrich
- Brookhaven National Laboratory, Upton, New York 11973
| | - D G Underwood
- Argonne National Laboratory, Argonne, Illinois 60439
| | - I Upsal
- The Ohio State University, Columbus, Ohio 43210
| | - G Van Buren
- Brookhaven National Laboratory, Upton, New York 11973
| | | | - A N Vasiliev
- Institute of High Energy Physics, Protvino 142281, Russia
| | - R Vertesi
- Nuclear Physics Institute AS CR, 250 68 Prague, Czech Republic
| | - F Videbæk
- Brookhaven National Laboratory, Upton, New York 11973
| | - S Vokal
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | | | - A Vossen
- Indiana University, Bloomington, Indiana 47408
| | - F Wang
- Purdue University, West Lafayette, Indiana 47907
| | - J S Wang
- Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 730000
| | - G Wang
- University of California, Los Angeles, California 90095
| | - Y Wang
- Tsinghua University, Beijing 100084
| | - Y Wang
- Central China Normal University, Wuhan, Hubei 430079
| | - G Webb
- Brookhaven National Laboratory, Upton, New York 11973
| | - J C Webb
- Brookhaven National Laboratory, Upton, New York 11973
| | - L Wen
- University of California, Los Angeles, California 90095
| | - G D Westfall
- Michigan State University, East Lansing, Michigan 48824
| | - H Wieman
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - S W Wissink
- Indiana University, Bloomington, Indiana 47408
| | - R Witt
- United States Naval Academy, Annapolis, Maryland 21402
| | - Y Wu
- Kent State University, Kent, Ohio 44242
| | - Z G Xiao
- Tsinghua University, Beijing 100084
| | - G Xie
- University of Science and Technology of China, Hefei, Anhui 230026
| | - W Xie
- Purdue University, West Lafayette, Indiana 47907
| | - K Xin
- Rice University, Houston, Texas 77251
| | - Q H Xu
- Shandong University, Jinan, Shandong 250100
| | - H Xu
- Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 730000
| | - Y F Xu
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - Z Xu
- Brookhaven National Laboratory, Upton, New York 11973
| | - J Xu
- Central China Normal University, Wuhan, Hubei 430079
| | - N Xu
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - S Yang
- University of Science and Technology of China, Hefei, Anhui 230026
| | - Q Yang
- University of Science and Technology of China, Hefei, Anhui 230026
| | - Y Yang
- National Cheng Kung University, Tainan 70101
| | - C Yang
- University of Science and Technology of China, Hefei, Anhui 230026
| | - Y Yang
- Central China Normal University, Wuhan, Hubei 430079
| | - Y Yang
- Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 730000
| | - Z Ye
- University of Illinois at Chicago, Chicago, Illinois 60607
| | - Z Ye
- University of Illinois at Chicago, Chicago, Illinois 60607
| | - L Yi
- Yale University, New Haven, Connecticut 06520
| | - K Yip
- Brookhaven National Laboratory, Upton, New York 11973
| | - I-K Yoo
- Pusan National University, Pusan 46241, Korea
| | - N Yu
- Central China Normal University, Wuhan, Hubei 430079
| | - H Zbroszczyk
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - W Zha
- University of Science and Technology of China, Hefei, Anhui 230026
| | | | - J Zhang
- Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 730000
| | - J Zhang
- Shandong University, Jinan, Shandong 250100
| | - Z Zhang
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - S Zhang
- University of Science and Technology of China, Hefei, Anhui 230026
| | - J B Zhang
- Central China Normal University, Wuhan, Hubei 430079
| | - Y Zhang
- University of Science and Technology of China, Hefei, Anhui 230026
| | - S Zhang
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - J Zhao
- Purdue University, West Lafayette, Indiana 47907
| | - C Zhong
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - L Zhou
- University of Science and Technology of China, Hefei, Anhui 230026
| | - X Zhu
- Tsinghua University, Beijing 100084
| | - Y Zoulkarneeva
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - M Zyzak
- Frankfurt Institute for Advanced Studies FIAS, Frankfurt 60438, Germany
| |
Collapse
|
48
|
Adamczyk L, Adkins JK, Agakishiev G, Aggarwal MM, Ahammed Z, Ajitanand NN, Alekseev I, Anderson DM, Aoyama R, Aparin A, Arkhipkin D, Aschenauer EC, Ashraf MU, Attri A, Averichev GS, Bai X, Bairathi V, Behera A, Bellwied R, Bhasin A, Bhati AK, Bhattarai P, Bielcik J, Bielcikova J, Bland LC, Bordyuzhin IG, Bouchet J, Brandenburg JD, Brandin AV, Brown D, Bunzarov I, Butterworth J, Caines H, Calderón de la Barca Sánchez M, Campbell JM, Cebra D, Chakaberia I, Chaloupka P, Chang Z, Chankova-Bunzarova N, Chatterjee A, Chattopadhyay S, Chen X, Chen JH, Chen X, Cheng J, Cherney M, Christie W, Contin G, Crawford HJ, Das S, De Silva LC, Debbe RR, Dedovich TG, Deng J, Derevschikov AA, Didenko L, Dilks C, Dong X, Drachenberg JL, Draper JE, Dunkelberger LE, Dunlop JC, Efimov LG, Elsey N, Engelage J, Eppley G, Esha R, Esumi S, Evdokimov O, Ewigleben J, Eyser O, Fatemi R, Fazio S, Federic P, Federicova P, Fedorisin J, Feng Z, Filip P, Finch E, Fisyak Y, Flores CE, Fulek L, Gagliardi CA, Garand D, Geurts F, Gibson A, Girard M, Greiner L, Grosnick D, Gunarathne DS, Guo Y, Gupta A, Gupta S, Guryn W, Hamad AI, Hamed A, Harlenderova A, Harris JW, He L, Heppelmann S, Heppelmann S, Hirsch A, Hoffmann GW, Horvat S, Huang T, Huang B, Huang X, Huang HZ, Humanic TJ, Huo P, Igo G, Jacobs WW, Jentsch A, Jia J, Jiang K, Jowzaee S, Judd EG, Kabana S, Kalinkin D, Kang K, Kauder K, Ke HW, Keane D, Kechechyan A, Khan Z, Kikoła DP, Kisel I, Kisiel A, Kochenda L, Kocmanek M, Kollegger T, Kosarzewski LK, Kraishan AF, Kravtsov P, Krueger K, Kulathunga N, Kumar L, Kvapil J, Kwasizur JH, Lacey R, Landgraf JM, Landry KD, Lauret J, Lebedev A, Lednicky R, Lee JH, Li X, Li C, Li W, Li Y, Lidrych J, Lin T, Lisa MA, Liu H, Liu P, Liu Y, Liu F, Ljubicic T, Llope WJ, Lomnitz M, Longacre RS, Luo S, Luo X, Ma GL, Ma L, Ma YG, Ma R, Magdy N, Majka R, Mallick D, Margetis S, Markert C, Matis HS, Meehan K, Mei JC, Miller ZW, Minaev NG, Mioduszewski S, Mishra D, Mizuno S, Mohanty B, Mondal MM, Morozov DA, Mustafa MK, Nasim M, Nayak TK, Nelson JM, Nie M, Nigmatkulov G, Niida T, Nogach LV, Nonaka T, Nurushev SB, Odyniec G, Ogawa A, Oh K, Okorokov VA, Olvitt D, Page BS, Pak R, Pandit Y, Panebratsev Y, Pawlik B, Pei H, Perkins C, Pile P, Pluta J, Poniatowska K, Porter J, Posik M, Poskanzer AM, Pruthi NK, Przybycien M, Putschke J, Qiu H, Quintero A, Ramachandran S, Ray RL, Reed R, Rehbein MJ, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Roth JD, Ruan L, Rusnak J, Rusnakova O, Sahoo NR, Sahu PK, Salur S, Sandweiss J, Saur M, Schambach J, Schmah AM, Schmidke WB, Schmitz N, Schweid BR, Seger J, Sergeeva M, Seyboth P, Shah N, Shahaliev E, Shanmuganathan PV, Shao M, Sharma A, Sharma MK, Shen WQ, Shi Z, Shi SS, Shou QY, Sichtermann EP, Sikora R, Simko M, Singha S, Skoby MJ, Smirnov N, Smirnov D, Solyst W, Song L, Sorensen P, Spinka HM, Srivastava B, Stanislaus TDS, Strikhanov M, Stringfellow B, Sugiura T, Sumbera M, Summa B, Sun Y, Sun XM, Sun X, Surrow B, Svirida DN, Szelezniak MA, Tang AH, Tang Z, Taranenko A, Tarnowsky T, Tawfik A, Thäder J, Thomas JH, Timmins AR, Tlusty D, Todoroki T, Tokarev M, Trentalange S, Tribble RE, Tribedy P, Tripathy SK, Trzeciak BA, Tsai OD, Ullrich T, Underwood DG, Upsal I, Van Buren G, van Nieuwenhuizen G, Vasiliev AN, Videbæk F, Vokal S, Voloshin SA, Vossen A, Wang G, Wang Y, Wang F, Wang Y, Webb JC, Webb G, Wen L, Westfall GD, Wieman H, Wissink SW, Witt R, Wu Y, Xiao ZG, Xie W, Xie G, Xu J, Xu N, Xu QH, Xu YF, Xu Z, Yang Y, Yang Q, Yang C, Yang S, Ye Z, Ye Z, Yi L, Yip K, Yoo IK, Yu N, Zbroszczyk H, Zha W, Zhang Z, Zhang XP, Zhang JB, Zhang S, Zhang J, Zhang Y, Zhang J, Zhang S, Zhao J, Zhong C, Zhou L, Zhou C, Zhu X, Zhu Z, Zyzak M. Measurement of D^{0} Azimuthal Anisotropy at Midrapidity in Au+Au Collisions at sqrt[s_{NN}]=200 GeV. Phys Rev Lett 2017; 118:212301. [PMID: 28598664 DOI: 10.1103/physrevlett.118.212301] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/23/2017] [Indexed: 06/07/2023]
Abstract
We report the first measurement of the elliptic anisotropy (v_{2}) of the charm meson D^{0} at midrapidity (|y|<1) in Au+Au collisions at sqrt[s_{NN}]=200 GeV. The measurement was conducted by the STAR experiment at RHIC utilizing a new high-resolution silicon tracker. The measured D^{0} v_{2} in 0%-80% centrality Au+Au collisions can be described by a viscous hydrodynamic calculation for a transverse momentum (p_{T}) of less than 4 GeV/c. The D^{0} v_{2} as a function of transverse kinetic energy (m_{T}-m_{0}, where m_{T}=sqrt[p_{T}^{2}+m_{0}^{2}]) is consistent with that of light mesons in 10%-40% centrality Au+Au collisions. These results suggest that charm quarks have achieved local thermal equilibrium with the medium created in such collisions. Several theoretical models, with the temperature-dependent, dimensionless charm spatial diffusion coefficient (2πTD_{s}) in the range of ∼2-12, are able to simultaneously reproduce our D^{0} v_{2} result and our previously published results for the D^{0} nuclear modification factor.
Collapse
Affiliation(s)
- L Adamczyk
- AGH University of Science and Technology, FPACS, Cracow 30-059, Poland
| | - J K Adkins
- University of Kentucky, Lexington, Kentucky 40506-0055
| | - G Agakishiev
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | | | - Z Ahammed
- Variable Energy Cyclotron Centre, Kolkata 700064, India
| | - N N Ajitanand
- State University of New York, Stony Brook, New York 11794
| | - I Alekseev
- Alikhanov Institute for Theoretical and Experimental Physics, Moscow 117218, Russia
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - D M Anderson
- Texas A&M University, College Station, Texas 77843
| | - R Aoyama
- University of Tsukuba, Tsukuba, Ibaraki, Japan
| | - A Aparin
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - D Arkhipkin
- Brookhaven National Laboratory, Upton, New York 11973
| | | | | | - A Attri
- Panjab University, Chandigarh 160014, India
| | - G S Averichev
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - X Bai
- Central China Normal University, Wuhan, Hubei 430079
| | - V Bairathi
- National Institute of Science Education and Research, HBNI, Jatni 752050, India
| | - A Behera
- State University of New York, Stony Brook, New York 11794
| | - R Bellwied
- University of Houston, Houston, Texas 77204
| | - A Bhasin
- University of Jammu, Jammu 180001, India
| | - A K Bhati
- Panjab University, Chandigarh 160014, India
| | | | - J Bielcik
- Czech Technical University in Prague, FNSPE, Prague 115 19, Czech Republic
| | - J Bielcikova
- Nuclear Physics Institute AS CR, 250 68 Prague, Czech Republic
| | - L C Bland
- Brookhaven National Laboratory, Upton, New York 11973
| | - I G Bordyuzhin
- Alikhanov Institute for Theoretical and Experimental Physics, Moscow 117218, Russia
| | - J Bouchet
- Kent State University, Kent, Ohio 44242
| | | | - A V Brandin
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - D Brown
- Lehigh University, Bethlehem, Pennsylvania 18015
| | - I Bunzarov
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | | | - H Caines
- Yale University, New Haven, Connecticut 06520
| | | | | | - D Cebra
- University of California, Davis, California 95616
| | - I Chakaberia
- Brookhaven National Laboratory, Upton, New York 11973
| | - P Chaloupka
- Czech Technical University in Prague, FNSPE, Prague 115 19, Czech Republic
| | - Z Chang
- Texas A&M University, College Station, Texas 77843
| | | | - A Chatterjee
- Variable Energy Cyclotron Centre, Kolkata 700064, India
| | | | - X Chen
- University of Science and Technology of China, Hefei, Anhui 230026
| | - J H Chen
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - X Chen
- Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 730000
| | - J Cheng
- Tsinghua University, Beijing 100084
| | - M Cherney
- Creighton University, Omaha, Nebraska 68178
| | - W Christie
- Brookhaven National Laboratory, Upton, New York 11973
| | - G Contin
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - H J Crawford
- University of California, Berkeley, California 94720
| | - S Das
- Central China Normal University, Wuhan, Hubei 430079
| | | | - R R Debbe
- Brookhaven National Laboratory, Upton, New York 11973
| | - T G Dedovich
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - J Deng
- Shandong University, Jinan, Shandong 250100
| | | | - L Didenko
- Brookhaven National Laboratory, Upton, New York 11973
| | - C Dilks
- Pennsylvania State University, University Park, Pennsylvania 16802
| | - X Dong
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | | | - J E Draper
- University of California, Davis, California 95616
| | | | - J C Dunlop
- Brookhaven National Laboratory, Upton, New York 11973
| | - L G Efimov
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - N Elsey
- Wayne State University, Detroit, Michigan 48201
| | - J Engelage
- University of California, Berkeley, California 94720
| | - G Eppley
- Rice University, Houston, Texas 77251
| | - R Esha
- University of California, Los Angeles, California 90095
| | - S Esumi
- University of Tsukuba, Tsukuba, Ibaraki, Japan
| | - O Evdokimov
- University of Illinois at Chicago, Chicago, Illinois 60607
| | - J Ewigleben
- Lehigh University, Bethlehem, Pennsylvania 18015
| | - O Eyser
- Brookhaven National Laboratory, Upton, New York 11973
| | - R Fatemi
- University of Kentucky, Lexington, Kentucky 40506-0055
| | - S Fazio
- Brookhaven National Laboratory, Upton, New York 11973
| | - P Federic
- Nuclear Physics Institute AS CR, 250 68 Prague, Czech Republic
| | - P Federicova
- Czech Technical University in Prague, FNSPE, Prague 115 19, Czech Republic
| | - J Fedorisin
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - Z Feng
- Central China Normal University, Wuhan, Hubei 430079
| | - P Filip
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - E Finch
- Southern Connecticut State University, New Haven, Connecticut 06515
| | - Y Fisyak
- Brookhaven National Laboratory, Upton, New York 11973
| | - C E Flores
- University of California, Davis, California 95616
| | - L Fulek
- AGH University of Science and Technology, FPACS, Cracow 30-059, Poland
| | | | - D Garand
- Purdue University, West Lafayette, Indiana 47907
| | - F Geurts
- Rice University, Houston, Texas 77251
| | - A Gibson
- Valparaiso University, Valparaiso, Indiana 46383
| | - M Girard
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - L Greiner
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - D Grosnick
- Valparaiso University, Valparaiso, Indiana 46383
| | | | - Y Guo
- Kent State University, Kent, Ohio 44242
| | - A Gupta
- University of Jammu, Jammu 180001, India
| | - S Gupta
- University of Jammu, Jammu 180001, India
| | - W Guryn
- Brookhaven National Laboratory, Upton, New York 11973
| | - A I Hamad
- Kent State University, Kent, Ohio 44242
| | - A Hamed
- Texas A&M University, College Station, Texas 77843
| | - A Harlenderova
- Czech Technical University in Prague, FNSPE, Prague 115 19, Czech Republic
| | - J W Harris
- Yale University, New Haven, Connecticut 06520
| | - L He
- Purdue University, West Lafayette, Indiana 47907
| | - S Heppelmann
- Pennsylvania State University, University Park, Pennsylvania 16802
| | - S Heppelmann
- University of California, Davis, California 95616
| | - A Hirsch
- Purdue University, West Lafayette, Indiana 47907
| | | | - S Horvat
- Yale University, New Haven, Connecticut 06520
| | - T Huang
- National Cheng Kung University, Tainan 70101
| | - B Huang
- University of Illinois at Chicago, Chicago, Illinois 60607
| | - X Huang
- Tsinghua University, Beijing 100084
| | - H Z Huang
- University of California, Los Angeles, California 90095
| | | | - P Huo
- State University of New York, Stony Brook, New York 11794
| | - G Igo
- University of California, Los Angeles, California 90095
| | - W W Jacobs
- Indiana University, Bloomington, Indiana 47408
| | - A Jentsch
- University of Texas, Austin, Texas 78712
| | - J Jia
- Brookhaven National Laboratory, Upton, New York 11973
- State University of New York, Stony Brook, New York 11794
| | - K Jiang
- University of Science and Technology of China, Hefei, Anhui 230026
| | - S Jowzaee
- Wayne State University, Detroit, Michigan 48201
| | - E G Judd
- University of California, Berkeley, California 94720
| | - S Kabana
- Kent State University, Kent, Ohio 44242
| | - D Kalinkin
- Indiana University, Bloomington, Indiana 47408
| | - K Kang
- Tsinghua University, Beijing 100084
| | - K Kauder
- Wayne State University, Detroit, Michigan 48201
| | - H W Ke
- Brookhaven National Laboratory, Upton, New York 11973
| | - D Keane
- Kent State University, Kent, Ohio 44242
| | - A Kechechyan
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - Z Khan
- University of Illinois at Chicago, Chicago, Illinois 60607
| | - D P Kikoła
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - I Kisel
- Frankfurt Institute for Advanced Studies FIAS, Frankfurt 60438, Germany
| | - A Kisiel
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - L Kochenda
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - M Kocmanek
- Nuclear Physics Institute AS CR, 250 68 Prague, Czech Republic
| | - T Kollegger
- Frankfurt Institute for Advanced Studies FIAS, Frankfurt 60438, Germany
| | | | - A F Kraishan
- Temple University, Philadelphia, Pennsylvania 19122
| | - P Kravtsov
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - K Krueger
- Argonne National Laboratory, Argonne, Illinois 60439
| | | | - L Kumar
- Panjab University, Chandigarh 160014, India
| | - J Kvapil
- Czech Technical University in Prague, FNSPE, Prague 115 19, Czech Republic
| | | | - R Lacey
- State University of New York, Stony Brook, New York 11794
| | - J M Landgraf
- Brookhaven National Laboratory, Upton, New York 11973
| | - K D Landry
- University of California, Los Angeles, California 90095
| | - J Lauret
- Brookhaven National Laboratory, Upton, New York 11973
| | - A Lebedev
- Brookhaven National Laboratory, Upton, New York 11973
| | - R Lednicky
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - J H Lee
- Brookhaven National Laboratory, Upton, New York 11973
| | - X Li
- University of Science and Technology of China, Hefei, Anhui 230026
| | - C Li
- University of Science and Technology of China, Hefei, Anhui 230026
| | - W Li
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - Y Li
- Tsinghua University, Beijing 100084
| | - J Lidrych
- Czech Technical University in Prague, FNSPE, Prague 115 19, Czech Republic
| | - T Lin
- Indiana University, Bloomington, Indiana 47408
| | - M A Lisa
- Ohio State University, Columbus, Ohio 43210
| | - H Liu
- Indiana University, Bloomington, Indiana 47408
| | - P Liu
- State University of New York, Stony Brook, New York 11794
| | - Y Liu
- Texas A&M University, College Station, Texas 77843
| | - F Liu
- Central China Normal University, Wuhan, Hubei 430079
| | - T Ljubicic
- Brookhaven National Laboratory, Upton, New York 11973
| | - W J Llope
- Wayne State University, Detroit, Michigan 48201
| | - M Lomnitz
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - R S Longacre
- Brookhaven National Laboratory, Upton, New York 11973
| | - S Luo
- University of Illinois at Chicago, Chicago, Illinois 60607
| | - X Luo
- Central China Normal University, Wuhan, Hubei 430079
| | - G L Ma
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - L Ma
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - Y G Ma
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - R Ma
- Brookhaven National Laboratory, Upton, New York 11973
| | - N Magdy
- State University of New York, Stony Brook, New York 11794
| | - R Majka
- Yale University, New Haven, Connecticut 06520
| | - D Mallick
- National Institute of Science Education and Research, HBNI, Jatni 752050, India
| | | | - C Markert
- University of Texas, Austin, Texas 78712
| | - H S Matis
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - K Meehan
- University of California, Davis, California 95616
| | - J C Mei
- Shandong University, Jinan, Shandong 250100
| | - Z W Miller
- University of Illinois at Chicago, Chicago, Illinois 60607
| | - N G Minaev
- Institute of High Energy Physics, Protvino 142281, Russia
| | | | - D Mishra
- National Institute of Science Education and Research, HBNI, Jatni 752050, India
| | - S Mizuno
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - B Mohanty
- National Institute of Science Education and Research, HBNI, Jatni 752050, India
| | - M M Mondal
- Institute of Physics, Bhubaneswar 751005, India
| | - D A Morozov
- Institute of High Energy Physics, Protvino 142281, Russia
| | - M K Mustafa
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - Md Nasim
- University of California, Los Angeles, California 90095
| | - T K Nayak
- Variable Energy Cyclotron Centre, Kolkata 700064, India
| | - J M Nelson
- University of California, Berkeley, California 94720
| | - M Nie
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - G Nigmatkulov
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - T Niida
- Wayne State University, Detroit, Michigan 48201
| | - L V Nogach
- Institute of High Energy Physics, Protvino 142281, Russia
| | - T Nonaka
- University of Tsukuba, Tsukuba, Ibaraki, Japan
| | - S B Nurushev
- Institute of High Energy Physics, Protvino 142281, Russia
| | - G Odyniec
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - A Ogawa
- Brookhaven National Laboratory, Upton, New York 11973
| | - K Oh
- Pusan National University, Pusan 46241, Korea
| | - V A Okorokov
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - D Olvitt
- Temple University, Philadelphia, Pennsylvania 19122
| | - B S Page
- Brookhaven National Laboratory, Upton, New York 11973
| | - R Pak
- Brookhaven National Laboratory, Upton, New York 11973
| | - Y Pandit
- University of Illinois at Chicago, Chicago, Illinois 60607
| | - Y Panebratsev
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - B Pawlik
- Institute of Nuclear Physics PAN, Cracow 31-342, Poland
| | - H Pei
- Central China Normal University, Wuhan, Hubei 430079
| | - C Perkins
- University of California, Berkeley, California 94720
| | - P Pile
- Brookhaven National Laboratory, Upton, New York 11973
| | - J Pluta
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - K Poniatowska
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - J Porter
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - M Posik
- Temple University, Philadelphia, Pennsylvania 19122
| | - A M Poskanzer
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - N K Pruthi
- Panjab University, Chandigarh 160014, India
| | - M Przybycien
- AGH University of Science and Technology, FPACS, Cracow 30-059, Poland
| | - J Putschke
- Wayne State University, Detroit, Michigan 48201
| | - H Qiu
- Purdue University, West Lafayette, Indiana 47907
| | - A Quintero
- Temple University, Philadelphia, Pennsylvania 19122
| | | | - R L Ray
- University of Texas, Austin, Texas 78712
| | - R Reed
- Lehigh University, Bethlehem, Pennsylvania 18015
| | | | - H G Ritter
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | | | | | - J L Romero
- University of California, Davis, California 95616
| | - J D Roth
- Creighton University, Omaha, Nebraska 68178
| | - L Ruan
- Brookhaven National Laboratory, Upton, New York 11973
| | - J Rusnak
- Nuclear Physics Institute AS CR, 250 68 Prague, Czech Republic
| | - O Rusnakova
- Czech Technical University in Prague, FNSPE, Prague 115 19, Czech Republic
| | - N R Sahoo
- Texas A&M University, College Station, Texas 77843
| | - P K Sahu
- Institute of Physics, Bhubaneswar 751005, India
| | - S Salur
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - J Sandweiss
- Yale University, New Haven, Connecticut 06520
| | - M Saur
- Nuclear Physics Institute AS CR, 250 68 Prague, Czech Republic
| | | | - A M Schmah
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - W B Schmidke
- Brookhaven National Laboratory, Upton, New York 11973
| | - N Schmitz
- Max-Planck-Institut fur Physik, Munich 80805, Germany
| | - B R Schweid
- State University of New York, Stony Brook, New York 11794
| | - J Seger
- Creighton University, Omaha, Nebraska 68178
| | - M Sergeeva
- University of California, Los Angeles, California 90095
| | - P Seyboth
- Max-Planck-Institut fur Physik, Munich 80805, Germany
| | - N Shah
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - E Shahaliev
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | | | - M Shao
- University of Science and Technology of China, Hefei, Anhui 230026
| | - A Sharma
- University of Jammu, Jammu 180001, India
| | - M K Sharma
- University of Jammu, Jammu 180001, India
| | - W Q Shen
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - Z Shi
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - S S Shi
- Central China Normal University, Wuhan, Hubei 430079
| | - Q Y Shou
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - E P Sichtermann
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - R Sikora
- AGH University of Science and Technology, FPACS, Cracow 30-059, Poland
| | - M Simko
- Nuclear Physics Institute AS CR, 250 68 Prague, Czech Republic
| | - S Singha
- Kent State University, Kent, Ohio 44242
| | - M J Skoby
- Indiana University, Bloomington, Indiana 47408
| | - N Smirnov
- Yale University, New Haven, Connecticut 06520
| | - D Smirnov
- Brookhaven National Laboratory, Upton, New York 11973
| | - W Solyst
- Indiana University, Bloomington, Indiana 47408
| | - L Song
- University of Houston, Houston, Texas 77204
| | - P Sorensen
- Brookhaven National Laboratory, Upton, New York 11973
| | - H M Spinka
- Argonne National Laboratory, Argonne, Illinois 60439
| | - B Srivastava
- Purdue University, West Lafayette, Indiana 47907
| | | | - M Strikhanov
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | | | - T Sugiura
- University of Tsukuba, Tsukuba, Ibaraki, Japan
| | - M Sumbera
- Nuclear Physics Institute AS CR, 250 68 Prague, Czech Republic
| | - B Summa
- Pennsylvania State University, University Park, Pennsylvania 16802
| | - Y Sun
- University of Science and Technology of China, Hefei, Anhui 230026
| | - X M Sun
- Central China Normal University, Wuhan, Hubei 430079
| | - X Sun
- Central China Normal University, Wuhan, Hubei 430079
| | - B Surrow
- Temple University, Philadelphia, Pennsylvania 19122
| | - D N Svirida
- Alikhanov Institute for Theoretical and Experimental Physics, Moscow 117218, Russia
| | - M A Szelezniak
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - A H Tang
- Brookhaven National Laboratory, Upton, New York 11973
| | - Z Tang
- University of Science and Technology of China, Hefei, Anhui 230026
| | - A Taranenko
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - T Tarnowsky
- Michigan State University, East Lansing, Michigan 48824
| | - A Tawfik
- World Laboratory for Cosmology and Particle Physics (WLCAPP), Cairo 11571, Egypt
| | - J Thäder
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - J H Thomas
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | | | - D Tlusty
- Rice University, Houston, Texas 77251
| | - T Todoroki
- Brookhaven National Laboratory, Upton, New York 11973
| | - M Tokarev
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - S Trentalange
- University of California, Los Angeles, California 90095
| | - R E Tribble
- Texas A&M University, College Station, Texas 77843
| | - P Tribedy
- Brookhaven National Laboratory, Upton, New York 11973
| | | | - B A Trzeciak
- Czech Technical University in Prague, FNSPE, Prague 115 19, Czech Republic
| | - O D Tsai
- University of California, Los Angeles, California 90095
| | - T Ullrich
- Brookhaven National Laboratory, Upton, New York 11973
| | - D G Underwood
- Argonne National Laboratory, Argonne, Illinois 60439
| | - I Upsal
- Ohio State University, Columbus, Ohio 43210
| | - G Van Buren
- Brookhaven National Laboratory, Upton, New York 11973
| | | | - A N Vasiliev
- Institute of High Energy Physics, Protvino 142281, Russia
| | - F Videbæk
- Brookhaven National Laboratory, Upton, New York 11973
| | - S Vokal
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | | | - A Vossen
- Indiana University, Bloomington, Indiana 47408
| | - G Wang
- University of California, Los Angeles, California 90095
| | - Y Wang
- Central China Normal University, Wuhan, Hubei 430079
| | - F Wang
- Purdue University, West Lafayette, Indiana 47907
| | - Y Wang
- Tsinghua University, Beijing 100084
| | - J C Webb
- Brookhaven National Laboratory, Upton, New York 11973
| | - G Webb
- Brookhaven National Laboratory, Upton, New York 11973
| | - L Wen
- University of California, Los Angeles, California 90095
| | - G D Westfall
- Michigan State University, East Lansing, Michigan 48824
| | - H Wieman
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - S W Wissink
- Indiana University, Bloomington, Indiana 47408
| | - R Witt
- United States Naval Academy, Annapolis, Maryland 21402
| | - Y Wu
- Kent State University, Kent, Ohio 44242
| | - Z G Xiao
- Tsinghua University, Beijing 100084
| | - W Xie
- Purdue University, West Lafayette, Indiana 47907
| | - G Xie
- University of Science and Technology of China, Hefei, Anhui 230026
| | - J Xu
- Central China Normal University, Wuhan, Hubei 430079
| | - N Xu
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - Q H Xu
- Shandong University, Jinan, Shandong 250100
| | - Y F Xu
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - Z Xu
- Brookhaven National Laboratory, Upton, New York 11973
| | - Y Yang
- National Cheng Kung University, Tainan 70101
| | - Q Yang
- University of Science and Technology of China, Hefei, Anhui 230026
| | - C Yang
- Shandong University, Jinan, Shandong 250100
| | - S Yang
- Brookhaven National Laboratory, Upton, New York 11973
| | - Z Ye
- University of Illinois at Chicago, Chicago, Illinois 60607
| | - Z Ye
- University of Illinois at Chicago, Chicago, Illinois 60607
| | - L Yi
- Yale University, New Haven, Connecticut 06520
| | - K Yip
- Brookhaven National Laboratory, Upton, New York 11973
| | - I-K Yoo
- Pusan National University, Pusan 46241, Korea
| | - N Yu
- Central China Normal University, Wuhan, Hubei 430079
| | - H Zbroszczyk
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - W Zha
- University of Science and Technology of China, Hefei, Anhui 230026
| | - Z Zhang
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | | | - J B Zhang
- Central China Normal University, Wuhan, Hubei 430079
| | - S Zhang
- University of Science and Technology of China, Hefei, Anhui 230026
| | - J Zhang
- Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 730000
| | - Y Zhang
- University of Science and Technology of China, Hefei, Anhui 230026
| | - J Zhang
- Lawrence Berkeley National Laboratory, Berkeley, California 94720
| | - S Zhang
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - J Zhao
- Purdue University, West Lafayette, Indiana 47907
| | - C Zhong
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - L Zhou
- University of Science and Technology of China, Hefei, Anhui 230026
| | - C Zhou
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800
| | - X Zhu
- Tsinghua University, Beijing 100084
| | - Z Zhu
- Shandong University, Jinan, Shandong 250100
| | - M Zyzak
- Frankfurt Institute for Advanced Studies FIAS, Frankfurt 60438, Germany
| |
Collapse
|
49
|
Adamczyk L, Adkins J, Agakishiev G, Aggarwal M, Ahammed Z, Ajitanand N, Alekseev I, Anderson D, Aoyama R, Aparin A, Arkhipkin D, Aschenauer E, Ashraf M, Attri A, Averichev G, Bai X, Bairathi V, Barish K, Behera A, Bellwied R, Bhasin A, Bhati A, Bhattarai P, Bielcik J, Bielcikova J, Bland L, Bordyuzhin I, Bouchet J, Brandenburg J, Brandin A, Brown D, Bunzarov I, Butterworth J, Caines H, Calderón de la Barca Sánchez M, Campbell J, Cebra D, Chakaberia I, Chaloupka P, Chang Z, Chankova-Bunzarova N, Chatterjee A, Chattopadhyay S, Chen X, Chen X, Chen J, Cheng J, Cherney M, Christie W, Contin G, Crawford H, Das S, De Silva L, Debbe R, Dedovich T, Deng J, Derevschikov A, Didenko L, Dilks C, Dong X, Drachenberg J, Draper J, Dunkelberger L, Dunlop J, Efimov L, Elsey N, Engelage J, Eppley G, Esha R, Esumi S, Evdokimov O, Ewigleben J, Eyser O, Fatemi R, Fazio S, Federic P, Federicova P, Fedorisin J, Feng Z, Filip P, Finch E, Fisyak Y, Flores C, Fujita J, Fulek L, Gagliardi C, Garand D, Geurts F, Gibson A, Girard M, Grosnick D, Gunarathne D, Guo Y, Gupta S, Gupta A, Guryn W, Hamad A, Hamed A, Harlenderova A, Harris J, He L, Heppelmann S, Heppelmann S, Hirsch A, Hoffmann G, Horvat S, Huang T, Huang B, Huang H, Huang X, Humanic T, Huo P, Igo G, Jacobs W, Jentsch A, Jia J, Jiang K, Jowzaee S, Judd E, Kabana S, Kalinkin D, Kang K, Kapukchyan D, Kauder K, Ke H, Keane D, Kechechyan A, Khan Z, Kikoła D, Kim C, Kisel I, Kisiel A, Kochenda L, Kocmanek M, Kollegger T, Kosarzewski L, Kraishan A, Krauth L, Kravtsov P, Krueger K, Kulathunga N, Kumar L, Kvapil J, Kwasizur J, Lacey R, Landgraf J, Landry K, Lauret J, Lebedev A, Lednicky R, Lee J, Li W, Li C, Li Y, Li X, Lidrych J, Lin T, Lisa M, Liu H, Liu F, Liu Y, Liu P, Ljubicic T, Llope W, Lomnitz M, Longacre R, Luo X, Luo S, Ma R, Ma G, Ma L, Ma Y, Magdy N, Majka R, Mallick D, Margetis S, Markert C, Matis H, Meehan K, Mei J, Miller Z, Minaev N, Mioduszewski S, Mishra D, Mizuno S, Mohanty B, Mondal M, Morozov D, Mustafa M, Nasim M, Nayak T, Nelson J, Nie M, Nigmatkulov G, Niida T, Nogach L, Nonaka T, Nurushev S, Odyniec G, Ogawa A, Oh K, Okorokov V, Olvitt D, Page B, Pak R, Pandit Y, Panebratsev Y, Pawlik B, Pei H, Perkins C, Pile P, Pluta J, Poniatowska K, Porter J, Posik M, Pruthi N, Przybycien M, Putschke J, Qiu H, Quintero A, Ramachandran S, Ray R, Reed R, Rehbein M, Ritter H, Roberts J, Rogachevskiy O, Romero J, Roth J, Ruan L, Rusnak J, Rusnakova O, Sahoo N, Sahu P, Salur S, Sandweiss J, Saur M, Schambach J, Schmah A, Schmidke W, Schmitz N, Schweid B, Seger J, Sergeeva M, Seto R, Seyboth P, Shah N, Shahaliev E, Shanmuganathan P, Shao M, Sharma A, Sharma M, Shen W, Shi S, Shi Z, Shou Q, Sichtermann E, Sikora R, Simko M, Singha S, Skoby M, Smirnov N, Smirnov D, Solyst W, Song L, Sorensen P, Spinka H, Srivastava B, Stanislaus T, Strikhanov M, Stringfellow B, Sugiura T, Sumbera M, Summa B, Sun X, Sun X, Sun Y, Surrow B, Svirida D, Tang A, Tang Z, Taranenko A, Tarnowsky T, Tawfik A, Thäder J, Thomas J, Timmins A, Tlusty D, Todoroki T, Tokarev M, Trentalange S, Tribble R, Tribedy P, Tripathy S, Trzeciak B, Tsai O, Ullrich T, Underwood D, Upsal I, Van Buren G, van Nieuwenhuizen G, Vasiliev A, Videbæk F, Vokal S, Voloshin S, Vossen A, Wang G, Wang Y, Wang F, Wang Y, Webb G, Webb J, Wen L, Westfall G, Wieman H, Wissink S, Witt R, Wu Y, Xiao Z, Xie W, Xie G, Xu Y, Xu Q, Xu N, Xu Z, Xu J, Yang Y, Yang S, Yang C, Yang Q, Ye Z, Ye Z, Yi L, Yip K, Yoo IK, Yu N, Zbroszczyk H, Zha W, Zhang S, Zhang J, Zhang Y, Zhang J, Zhang J, Zhang S, Zhang X, Zhang Z, Zhao J, Zhong C, Zhou C, Zhou L, Zhu Z, Zhu X, Zyzak M. Measurement of the cross section and longitudinal double-spin asymmetry for dijet production in polarized
pp
collisions at
s=200 GeV. Int J Clin Exp Med 2017. [DOI: 10.1103/physrevd.95.071103] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
50
|
Paquet A, Golse B, Girard M, Olliac B, Vaivre-Douret L. Laterality and Lateralization in Autism Spectrum Disorder, Using a Standardized Neuro-Psychomotor Assessment. Dev Neuropsychol 2017; 42:39-54. [DOI: 10.1080/87565641.2016.1274317] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- A. Paquet
- Faculty of Medicine, Paris Descartes University, Sorbonne Paris Cité, Paris, France
- CESP, University Paris-Sud, UVSQ, INSERM 1018, University of Paris-Saclay, Villejuif, France
- Department of Child and Adolescent Psychiatry, Esquirol Hospital, Limoges, France
- Department of Child Psychiatry, Necker Enfants-Malades University Hospital, Assistance Publique-Hopitaux de Paris, Paris, France
- Research Federation for Psychiatry in Limousin, Hospital Esquirol, Limoges, France
| | - B. Golse
- Faculty of Medicine, Paris Descartes University, Sorbonne Paris Cité, Paris, France
- CESP, University Paris-Sud, UVSQ, INSERM 1018, University of Paris-Saclay, Villejuif, France
- Department of Child Psychiatry, Necker Enfants-Malades University Hospital, Assistance Publique-Hopitaux de Paris, Paris, France
| | - M. Girard
- Research Federation for Psychiatry in Limousin, Hospital Esquirol, Limoges, France
| | - B. Olliac
- Department of Child and Adolescent Psychiatry, Esquirol Hospital, Limoges, France
- INSERM U 1094 Tropical Neuroepidemiology, Limoges, France
| | - L. Vaivre-Douret
- Faculty of Medicine, Paris Descartes University, Sorbonne Paris Cité, Paris, France
- CESP, University Paris-Sud, UVSQ, INSERM 1018, University of Paris-Saclay, Villejuif, France
- Department of Child Psychiatry, Necker Enfants-Malades University Hospital, Assistance Publique-Hopitaux de Paris, Paris, France
- Department of Pediatrics, Child Development, Cochin-Port-Royal University Hospitals of Paris Center, Assistance Publique-Hopitaux de Paris, Paris, France
- Endocrinology Laboratory, Imagine Institut, Necker-Enfants Malades Hospital, Paris, France
| |
Collapse
|